<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>   <meta charset="utf-8" />
<meta http-equiv=Content-Type content="text/html; charset=Windows-1254">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="basagrisi_dosyalar/filelist.xml">
<title>BA�A�RISI</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>userE</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bono</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>16</o:TotalTime>
  <o:Created>2019-01-01T17:53:00Z</o:Created>
  <o:LastSaved>2019-01-01T18:40:00Z</o:LastSaved>
  <o:Pages>22</o:Pages>
  <o:Words>19743</o:Words>
  <o:Characters>112536</o:Characters>
  <o:Company>UNUN</o:Company>
  <o:Lines>937</o:Lines>
  <o:Paragraphs>264</o:Paragraphs>
  <o:CharactersWithSpaces>132015</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:TargetScreenSize>800x600</o:TargetScreenSize>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=dataStoreItem href="basagrisi_dosyalar/item0006.xml"
target="basagrisi_dosyalar/props007.xml">
<link rel=themeData href="basagrisi_dosyalar/themedata.thmx">
<link rel=colorSchemeMapping href="basagrisi_dosyalar/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>120</w:Zoom>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>TR</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:SplitPgBreakAndParaMark/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:__Grammarly_42____i>H4sIAAAAAAAEAKtWckksSQxILCpxzi/NK1GyMqwFAAEhoTITAAAA</w:__Grammarly_42____i>
   <w:__Grammarly_42___1>H4sIAAAAAAAEAKtWcslP9kxRslIyNDa0NDAwtTQzMjMyNgMyLJR0lIJTi4sz8/NACkxqAWWnULAsAAAA</w:__Grammarly_42___1>
  </w:DocumentVariables>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Gothic";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Gothic";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:162;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:162;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073732485 9 0 511 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:162;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:162;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536858881 -1073711013 9 0 511 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:0 134676480 16 0 131072 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Ba�l�k 1 Char";
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
h2
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Ba�l�k 2 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Ba�l�k 3 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:10.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"A��klama Metni Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"G�vde Metni Girintisi Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"G�vde Metni Girintisi 2 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
pre
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"HTML �nceden Bi�imlendirilmi� Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"A��klama Metni";
	mso-style-link:"A��klama Konusu Char";
	mso-style-next:"A��klama Metni";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balon Metni Char";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.Balk1Char
	{mso-style-name:"Ba�l�k 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Ba�l�k 1";
	mso-ansi-font-size:24.0pt;
	mso-bidi-font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:18.0pt;
	font-weight:bold;}
span.Balk2Char
	{mso-style-name:"Ba�l�k 2 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Ba�l�k 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	font-weight:bold;}
span.Balk3Char
	{mso-style-name:"Ba�l�k 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Ba�l�k 3";
	font-family:"Cambria","serif";
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	color:#4F81BD;
	font-weight:bold;}
span.HTMLncedenBiimlendirilmiChar
	{mso-style-name:"HTML �nceden Bi�imlendirilmi� Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML �nceden Bi�imlendirilmi�";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-fareast-language:TR;}
span.AklamaMetniChar
	{mso-style-name:"A��klama Metni Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"A��klama Metni";
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
span.GvdeMetniGirintisiChar
	{mso-style-name:"G�vde Metni Girintisi Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"G�vde Metni Girintisi";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.msobodytextindent, li.msobodytextindent, div.msobodytextindent
	{mso-style-name:msobodytextindent;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.GvdeMetniGirintisi2Char
	{mso-style-name:"G�vde Metni Girintisi 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"G�vde Metni Girintisi 2";}
p.msobodytextindent2, li.msobodytextindent2, div.msobodytextindent2
	{mso-style-name:msobodytextindent2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:18.0pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.AklamaKonusuChar
	{mso-style-name:"A��klama Konusu Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"A��klama Konusu";
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.BalonMetniChar
	{mso-style-name:"Balon Metni Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Balon Metni";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.ListeParagraf1, li.ListeParagraf1, div.ListeParagraf1
	{mso-style-name:"Liste Paragraf1";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpFirst, li.ListeParagraf1CxSpFirst, div.ListeParagraf1CxSpFirst
	{mso-style-name:"Liste Paragraf1CxSpFirst";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpMiddle, li.ListeParagraf1CxSpMiddle, div.ListeParagraf1CxSpMiddle
	{mso-style-name:"Liste Paragraf1CxSpMiddle";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ListeParagraf1CxSpLast, li.ListeParagraf1CxSpLast, div.ListeParagraf1CxSpLast
	{mso-style-name:"Liste Paragraf1CxSpLast";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:10.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11, li.ColorfulList-Accent11, div.ColorfulList-Accent11
	{mso-style-name:"Colorful List - Accent 11";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpFirst, li.ColorfulList-Accent11CxSpFirst, div.ColorfulList-Accent11CxSpFirst
	{mso-style-name:"Colorful List - Accent 11CxSpFirst";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpMiddle, li.ColorfulList-Accent11CxSpMiddle, div.ColorfulList-Accent11CxSpMiddle
	{mso-style-name:"Colorful List - Accent 11CxSpMiddle";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.ColorfulList-Accent11CxSpLast, li.ColorfulList-Accent11CxSpLast, div.ColorfulList-Accent11CxSpLast
	{mso-style-name:"Colorful List - Accent 11CxSpLast";
	mso-style-noshow:yes;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Cambria","serif";
	mso-fareast-font-family:"MS Mincho";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GvdeMetniGirintisiChar1
	{mso-style-name:"G�vde Metni Girintisi Char1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GvdeMetniGirintisi2Char1
	{mso-style-name:"G�vde Metni Girintisi 2 Char1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Calibri;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;
	mso-header-margin:36.0pt;
	mso-footer-margin:36.0pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:20323243;
	mso-list-type:hybrid;
	mso-list-template-ids:-1597314306 1598988842 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l0:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l0:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l0:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l0:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l0:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l0:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l0:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l1
	{mso-list-id:77870187;
	mso-list-type:hybrid;
	mso-list-template-ids:1102468456 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l1:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l2
	{mso-list-id:343215408;
	mso-list-template-ids:1228431502;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3
	{mso-list-id:362364138;
	mso-list-type:hybrid;
	mso-list-template-ids:1419536154 -839598368 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l3:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
@list l3:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l3:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l3:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l3:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l3:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l3:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l3:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l3:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l4
	{mso-list-id:383984971;
	mso-list-type:hybrid;
	mso-list-template-ids:-1778858946 -1794100168 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l4:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;}
@list l4:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l4:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l4:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l4:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l4:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l4:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l5
	{mso-list-id:597250372;
	mso-list-template-ids:1339819034;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level3
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l6
	{mso-list-id:603147894;
	mso-list-type:hybrid;
	mso-list-template-ids:-441815946 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l6:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7
	{mso-list-id:720636337;
	mso-list-type:hybrid;
	mso-list-template-ids:-1007506136 -2137236968 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l7:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l7:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l7:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l7:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l7:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l7:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l7:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l7:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l7:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l8
	{mso-list-id:751391266;
	mso-list-template-ids:1059850566;}
@list l8:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;}
@list l8:level2
	{mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:36.0pt;
	text-indent:-18.0pt;}
@list l8:level3
	{mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;}
@list l8:level4
	{mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l8:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-54.0pt;}
@list l8:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-54.0pt;}
@list l8:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-72.0pt;}
@list l8:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-72.0pt;}
@list l8:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-90.0pt;}
@list l9
	{mso-list-id:816386540;
	mso-list-type:hybrid;
	mso-list-template-ids:-1704145424 1941571700 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l9:level1
	{mso-level-start-at:2;
	mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;}
@list l9:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l9:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l9:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l9:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l9:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l9:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l9:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l9:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l10
	{mso-list-id:879823778;
	mso-list-type:hybrid;
	mso-list-template-ids:-921304488 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l10:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l10:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l10:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l11
	{mso-list-id:880240606;
	mso-list-type:hybrid;
	mso-list-template-ids:117496752 2133365444 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l11:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l11:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l11:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l11:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l11:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l11:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l11:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l11:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l11:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
@list l12
	{mso-list-id:1128086301;
	mso-list-type:hybrid;
	mso-list-template-ids:-1621061722 1417157292 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l12:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-36.0pt;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:126.0pt;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:234.0pt;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:342.0pt;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:1231814688;
	mso-list-template-ids:-698158210;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l14
	{mso-list-id:1261177339;
	mso-list-template-ids:983366336;}
@list l14:level1
	{mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level2
	{mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level3
	{mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level4
	{mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level5
	{mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level6
	{mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level7
	{mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level8
	{mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l14:level9
	{mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l15
	{mso-list-id:1302921694;
	mso-list-template-ids:1913134126;}
@list l15:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l15:level2
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l15:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l15:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l15:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l15:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l15:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l15:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l15:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l16
	{mso-list-id:1435128830;
	mso-list-type:hybrid;
	mso-list-template-ids:1411967202 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l16:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l16:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l16:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17
	{mso-list-id:1453599040;
	mso-list-type:hybrid;
	mso-list-template-ids:567160966 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l17:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l17:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l17:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l18
	{mso-list-id:1714235132;
	mso-list-template-ids:-1125360740;}
@list l18:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l18:level2
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:45.0pt;
	text-indent:-18.0pt;}
@list l18:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-36.0pt;}
@list l18:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-36.0pt;}
@list l18:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-54.0pt;}
@list l18:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-54.0pt;}
@list l18:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-72.0pt;}
@list l18:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-72.0pt;}
@list l18:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:252.0pt;
	text-indent:-90.0pt;}
@list l19
	{mso-list-id:1734965091;
	mso-list-template-ids:-900575658;}
@list l19:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l20
	{mso-list-id:1872841271;
	mso-list-template-ids:2054825488;}
@list l20:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l20:level2
	{mso-level-start-at:5;
	mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level3
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level4
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:102.0pt;
	text-indent:-48.0pt;}
@list l20:level5
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l20:level6
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-54.0pt;}
@list l20:level7
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l20:level8
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-72.0pt;}
@list l20:level9
	{mso-level-legal-format:yes;
	mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9\.";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-90.0pt;}
@list l21
	{mso-list-id:1920869555;
	mso-list-type:hybrid;
	mso-list-template-ids:302678924 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l21:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l21:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l22
	{mso-list-id:2014800848;
	mso-list-template-ids:-1621210828;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l23
	{mso-list-id:2017884447;
	mso-list-type:hybrid;
	mso-list-template-ids:2001923486 67698709 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l23:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l23:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l23:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;}
@list l23:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l24
	{mso-list-id:2045785680;
	mso-list-template-ids:-789964158;}
@list l24:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l24:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l25
	{mso-list-id:2082947439;
	mso-list-type:hybrid;
	mso-list-template-ids:-225042084 2803764 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l25:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:144.0pt;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:216.0pt;
	text-indent:-18.0pt;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:252.0pt;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:288.0pt;
	text-indent:-18.0pt;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:324.0pt;
	text-indent:-18.0pt;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:360.0pt;
	text-indent:-9.0pt;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Normal Tablo";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=TR link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:16.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<div style='mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:16.0pt;mso-bidi-font-size:11.0pt;
line-height:115%;font-family:"Tahoma","sans-serif"'>BA�A�RISI <o:p></o:p></span></b></p>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-family:"Tahoma","sans-serif"'>Yazanlar:
Esme Ekizo�lu, Elif Kocasoy-Orhan, Bet�l Baykan</span></b><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-size:12.0pt;mso-bidi-font-size:11.0pt;
line-height:115%;font-family:"Tahoma","sans-serif"'><o:p></o:p></span></b></p>

<p class=MsoNormal style='border:none;mso-border-alt:solid windowtext .5pt;
padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style='mso-bidi-font-weight:
normal'><span lang=EN-US style='font-family:"Tahoma","sans-serif"'>Son
g�ncelle�tirme tarihi: 01.01.2019<o:p></o:p></span></b></p>

</div>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>G�R�� ve SINIFLAMA<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br>
�nsanlar� etkileyen a�r�l� durumlardan en yayg�n olan� ba�a�r�s�d�r. Ba�a�r�s�
n�rolojik hastal�klar�n yan� s�ra sistemik hastal�klara&nbsp;da e�lik edebilen
bir <span class=GramE>semptomdur</span>. Ba�a�r�s�yla hayat� boyunca tan��mam��
insan yok gibidir ve toplumda en s�k g�r�len belirtilerden bir tanesidir. Bir
�al��mam�za g�re yurdumuzda n�roloji polikliniklerine ba�vuran hastalar�n
toplam 2/3��n�n ba�a�r�s� vard�r ve 1/3�� sadece ba�a�r�s� i�in ba�vurmaktad�r.
Bu hastalar�n en az 1/4 kadar�nda �iddetli ve ciddi k�s�tl�l�k yapan migren
oldu�u g�sterilmi�tir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tan�y�
kolayla�t�rmak i�in ve etyolojik yakla��mla ba�a�r�s�n� daha iyi ele almak i�in
de�i�ik ba�a�r�s� tiplerini s�n�flamak esast�r. Ba�a�r�s�n�n etyolojisi,
s�kl���, �iddeti ve ya�amsal sonu�lar� �ok b�y�k farkl�l�klar g�sterebilir ve
ba�ar�l� bir tedavinin ilk basama�� do�ru ve �zg�l bir tan�d�r. Hastalar�n �o�u
ba�a�r�lar�n�n ciddi bir sorunun belirtisi oldu�undan korkar. Fakat �o�unda iyi
seyirli ancak uzun y�llar boyu ataklarla seyreden bir s�re� s�z konusudur.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>T�m
d�nyada kullan�lan ve genel kabul g�ren bir s�n�flamaya sahip olmak t�bb�n her
dal� i�in �nemlidir. Ba�a�r�s� bozukluklar� hakk�nda �ok fazla �nyarg�
oldu�undan bu durum ba�a�r�s� i�in �zellikle do�rudur.&nbsp;<span
style='mso-bidi-font-style:italic'>Uluslararas� Ba�a�r�s�&nbsp;</span>Derne�i <span
style='mso-bidi-font-style:italic'>(International Headache Society (IHS))</span>&nbsp;ilk
olarak 1988 y�l�nda ba�a�r�lar�n� ayr�nt�l� �ekilde s�n�flamaya y�nelik bir
�al��ma yapm��t�r. Ba�a�r�s� tan�s�nda standart olu�turan ve �zellikle klinik
ara�t�rmalarda kullan�lmas� ama�lanan bu ilk s�n�flama sistemi t�m d�nyada
yayg�n bir kabul g�rm��, yeni bilimsel geli�meler do�rultusunda 2004 ve 2013�de
(IHS beta) <span class=GramE>revizyonlar�</span> yap�lm�� ve son s�n�flama Ocak
2018�de yay�nlanm��t�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>IHS
s�n�flama sisteminde ba�a�r�lar� ba�l�ca iki temel grupta ele al�nmaktad�r: <i
style='mso-bidi-font-style:normal'>primer ba�a�r�s� bozukluklar�</i> (1.-4.
Kategoriler) ve <i style='mso-bidi-font-style:normal'>sekonder ba�a�r�s�
bozukluklar�</i> (5.-12. Kategoriler) (<b>Tablo 1A ve B</b>). Sekonder
ba�a�r�s� bozukluklar�nda ba�a�r�s� beyin t�m�r�, inme veya metabolik bozukluk
gibi bir ba�ka hastal��a ba�l�d�r ve IHS <span class=GramE>kriterleri</span> bu
grup ba�a�r�lar�n� etyolojik nedenlerine dayanarak s�n�flayan bir sistem
sa�lamaktad�r. Primer ba�a�r�s�nda ise altta saptanabilir ba�ka bir neden
yoktur ve IHS <span class=GramE>kriterleri</span> ba�a�r�lar�n� belli klinik
�zelliklerine g�re s�n�flayan tan�mlay�c� bir sistem ortaya koymu�tur. IHS <span
class=GramE>kriterleri</span> D�nya Sa�l�k �rg�t� (WHO) taraf�ndan kabul g�rm��
ve bu sistemin ana hatlar� Uluslararas� Hastal�k S�n�flamas�na da al�nm��t�r.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>IHS
s�n�flamas�n� bu b�l�m�n s�n�rlar� i�inde t�m�yle ele almak m�mk�n olmad���ndan
�nce tan�sal yakla��m, ard�ndan baz� s�k kar��la��lan primer ba�a�r�lar� b�l�m i�inde
k�saca tart���lacakt�r; sekonder ba�a�r�s�na neden olan n�rolojik hastal�klar
i�in kitab�n ilgili b�l�mlerine bak�lmal�d�r.</span><span style='font-size:
13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:9.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all>
</span></b><b><span style='font-size:12.0pt;mso-bidi-font-size:14.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Tablo 1A</span></b><b><span style='font-size:
12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>.&nbsp;</span></b><span style='font-size:
12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararas�
Ba�a�r�s� Derne�i (IHS) 2018 S�n�flama Sistemine G�re Primer Ba�a�r�s�
Bozukluklar� (B�l�m 1)</span><span style='font-size:12.0pt;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='text-indent:-18.0pt;line-height:normal;
mso-list:l18 level1 lfo1'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Migren<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='text-indent:0cm;line-height:normal;
mso-list:l18 level2 lfo1;tab-stops:58.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Auras�z migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='text-indent:0cm;line-height:normal;
mso-list:l18 level2 lfo1;tab-stops:58.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aural� migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:18.0pt;mso-add-space:auto;
text-indent:36.0pt;line-height:normal'><span style='font-size:12.0pt;
mso-ansi-language:TR'>1.2.1. Tipik aural� migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����� </span>1.2.1.1. Ba�a�r�l� tipik aura<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����� </span>1.2.1.2. Ba�a�r�s�z tipik aura<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.2.
Beyinsap� aural� migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.3.
Hemiplejik migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����� </span>1.2.3.1. Ailesel hemiplejik migren<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>����������������� </span>1.2.3.1.1. Ailesel hemiplejik migren
(FHM1)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>����������������� </span>1.2.3.1.2. Ailesel hemiplejik
migren<span style='mso-spacerun:yes'>� </span>(FHM2)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>����������������� </span>1.2.3.1.3. Ailesel hemiplejik
migren<span style='mso-spacerun:yes'>� </span>(FHM3)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:2'>����������������� </span>1.2.3.1.4. Ailesel hemiplejik
migren, di�er lokus<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-left:54.0pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����� </span>1.2.3.2. Sporadik hemiplejik migren (SHM)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
line-height:normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.4.
Retinal migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������� </span>1.3. Kronik migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������� </span>1.4. Migren <span class=GramE>komplikasyonlar�</span>
<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������������� </span>1.4.1. Status migrenozus<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������������� </span>1.4.2. �nfarkt olmaks�z�n
kal�c� aura<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������������� </span>1.4.3. Migren�z infarkt<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:54.0pt'><span style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-tab-count:1'>����������������� </span>1.4.4. Migren auras�yla
tetiklenen n�bet<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'>����������� </span>1.5. Olas� migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������������� </span>1.5.1. Auras�z olas�
migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������������� </span>1.5.2. Aural� olas�
migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'>����������� </span>1.6. Migrenle ili�kili olabilecek
epizodik <span class=GramE>sendromlar</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������������� </span>1.6.1. Yineleyen
gastrointestinal rahats�zl�k<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt 72.0pt'><span style='font-size:12.0pt;
mso-ansi-language:TR'><span style='mso-tab-count:3'>����������������������� </span>1.6.1.1.
Siklik kusma <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:3'>����������������������� </span>1.6.1.2.
Abdominal migren<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������������� </span>1.6.2. Selim
paroksizmal vertigo<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������������� </span>1.6.3. Selim
paroksizmal tortikollis<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:36.0pt 54.0pt'><span style='font-size:12.0pt;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Gerilim tipi ba�a�r�s�<span
style='mso-spacerun:yes'>� </span><o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.2. Seyrek epizodik gerilim tipi
ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span
style='mso-spacerun:yes'>�</span><span style='mso-tab-count:1'>���� </span>1.2.1.
Perikranyal duyarl�l���n e�lik etti�i seyrek epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>1.2.2.
Perikranyal duyarl�l���n e�lik etmedi�i seyrek epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.2. S�k epizodik gerilim tipi
ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.2.1.
Perikranyal duyarl�l���n e�lik etti�i s�k epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.2.2.
Perikranyal duyarl�l���n e�lik etmedi�i s�k epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.3. Kronik gerilim tipi
ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.3.1.
Perikranyal duyarl�l���n e�lik etti�i kronik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.3.2.
Perikranyal duyarl�l���n e�lik etmedi�i kronik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2.4. Olas� gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.4.1.
Olas� seyrek epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.4.2.
Olas� s�k epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>2.4.3.
Olas� kronik epizodik gerilim tipi ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Trigeminal otonomik sefalaljiler
(TOS)<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:36.0pt 58.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>3.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>K�me ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:90.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik k�me ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:85.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-31.5pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik k�me ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.2.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>K�sa s�reli tek yanl� nevraljiform ba�a�r�s� ataklar�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Konjunktival kanlanma ve ya�armal� k�sa s�reli tek yanl� nevraljiform
ba�a�r�s� (SUNCT)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik SUNCT<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.1.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik SUNCT<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kranyal otonomik <span class=GramE>semptomlar�n</span> e�lik etti�i k�sa
s�reli tek yanl� nevraljiform ba�a�r�s� (SUNA)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Epizodik SUNA<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:108.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level4 lfo1;tab-stops:18.0pt 36.0pt 112.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.3.2.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Kronik SUNA<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:90.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-36.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua, remisyonlu alt tip<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.4.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hemikranya kontinua, remisyonsuz alt tip<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olas� trigeminal otonomik ba�a�r�lar�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olas� k�me ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olas� paroksizmal hemikranya<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olas� k�sa s�reli tek yanl� nevraljiform ba�a�r�s� ataklar�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:81.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-27.0pt;line-height:normal;mso-list:l18 level3 lfo1;tab-stops:18.0pt 36.0pt 85.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.5.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Olas� hemikranya kontinua<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:18.0pt 36.0pt 85.5pt'><span style='font-size:12.0pt;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l18 level1 lfo1;
tab-stops:18.0pt 36.0pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Di�er primer ba�a�r�lar�<o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer �ks�r�k ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer egzersiz ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Cinsel etkinli�e e�lik eden primer ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer g�kg�r�lt�s� ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>So�ukla uyar�lan ba�a�r�s� <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>D�� bas�n�la ili�kili ba�a�r�s� <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Primer saplan�c� ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Num�ler ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 58.5pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hipnik ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:0cm;line-height:normal;mso-list:l18 level2 lfo1;
tab-stops:18.0pt 36.0pt 63.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Yeni g�nl�k �srarc� ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 36.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:14.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>BA�A�RILI
HASTAYA TANISAL YAKLA�IM</span></b><span lang=EN-US style='font-size:13.5pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�s�
bulunan bir hasta de�erlendirilirken,&nbsp;<span style='mso-bidi-font-style:
italic'>ilk yap�lmas� gereken sekonder ba�a�r�s�n�n d��lanmas�d�r</span>. Bu
karar �yk�ye, genel t�bbi ve n�rolojik muayenelere dayand�r�l�r. E�er ku�kulu
�zellikler mevcutsa, tan� i�in baz� testlerin yap�lmas� gerekli olabilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Sekonder ba�a�r�s� bozukluklar� d��land���nda,
yap�lmas� gereken primer ba�a�r�s� bozuklu�unun do�ru tan�s�n�n konmas�</span>d�r.
Ayn� hastada birden fazla ba�a�r�s� varsa, her biri ayr� ayr� tan� al�r.
�lkemizde yap�lan prevalans �al��malar�nda migren i�in rastlanma s�kl��� %16,4
iken gerilim tipi ba�a�r�s�n�n s�kl��� %31,7 olarak belirlenmi�tir. Bu denli
s�k g�r�len hastal�klara rastlant�sal olarak ba�ka hastal�klar�n da e�lik etme
olas�l��� do�al olarak y�ksektir. Bu nedenle, ba�a�r�s� tan�mlayan bir hastada
daha �nceden tan� konmu� bir primer ba�a�r�s� olsa bile, yeni tan�mlad���
ba�a�r�s� hakk�nda, bu ba�a�r�s� �zelliklerinin �nceki a�r�lar�yla uyumlu olup
olmad���n� anlamaya y�nelik olarak tekrar bilgi almak ve hastay� muayene etmek
gerekir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
1B.</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararas� Ba�a�r�s�
Derne�i (IHS) 2018 S�n�flama Sisteminde Sekonder Ba�a�r�s�
Bozukluklar�&nbsp;(B�l�m 2) <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 31.5pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=ListeParagraf1 style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:
  -18.0pt;line-height:normal'><u><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.<span
  style='mso-spacerun:yes'>� </span>Ba� ve/veya boyun <span class=GramE>travmas�</span>
  ile ili�kili ba�a�r�s�</span></u><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.1.&nbsp;Travma
  sonras� akut ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.2.&nbsp;Travma
  sonras� kronik ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.3.&nbsp;Kam��
  darbesi tipi yaralanmaya ba�lanan akut ba�a�r�s� (whiplash: ani ivmelenme/
  yava�lama <span class=GramE>travmas�</span>)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.4. Kam��
  darbesi tipi&nbsp;yaralanmaya ba�lanan kronik ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.5.
  Kranyotomi sonras� akut ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-align:justify;line-height:normal;
  tab-stops:18.0pt'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>5.6.
  Kranyotomi sonras� kronik ba�a�r�s�<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>6.<span style='mso-spacerun:yes'>�
  </span><u>Kranyal ya da servikal damarsal hastal�klara ba�lanan ba�a�r�s�</u><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.1.&nbsp;�skemik
  inme ya da ge�ici iskemik ata�a ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.2.
  Travmatik olmayan kafa i�i kanamaya ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.3.
  Y�rt�lmam�� damarsal malformasyona ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.4.&nbsp;Arterite
  ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.5.&nbsp;Karotis
  ya da vertebral arter a�r�s� (diseksiyon ve giri�im sonras�)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.6.&nbsp;Beyin
  ven trombozuna ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.7.&nbsp;Di�er
  kafai�i akut damarsal bozuklu�a ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6.8. Genetik
  vask�lopatiye ba�lanan ba�a�r�s� (CADASIL, MELAS vb)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'>6.9. Pituiter apopleksiye ba�lanan
  ba�a�r�s� <o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>7.&nbsp;<u>Damar-d��� kafai�i
  hastal�klarla ili�kili ba�a�r�s�</u></span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.1.&nbsp;Beyin
  omurilik s�v�s� (BOS) bas�n� y�ksekli�ine ba�lanan ba�a�r�s�</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.2.&nbsp;D���k
  beyin omurilik s�v�s� bas�nc�na ba�lanan ba�a�r�s�</span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.3.&nbsp;�nfeksiyon
  olmayan inflamatuar hastal��a ba�lanan ba�a�r�s� (aseptik menenjit, HaNDL vb)</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.4. Kafai�i
  neoplazmalara ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.5.&nbsp;�ntratekal
  injeksiyonlara ba�l� ba�a�r�s�</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.6.&nbsp;Epileptik
  n�betlere ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>7.7.&nbsp;Chiari
  malformasyon tip 1�e ba�lanan ba�a�r�s�</span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'>7.8. Di�er vask�ler olmayan
  kafai�i hastal�klara ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>8.&nbsp;<u>Madde kullan�m� veya
  yoksunlu�u ile ili�kili ba�a�r�s�</u></span><span lang=EN-US
  style='font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.1.&nbsp;Madde
  kullan�m� veya maddeye maruziyet ile ili�kili ba�a�r�s�</span><span
  lang=EN-US style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.2.&nbsp;�la�
  a��r� kullan�m� ba�a�r�s� (�AKB)</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>8.3. Madde
  kesilmesine ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>9.&nbsp;<u>�nfeksiyona ba�lanan
  ba�a�r�s�</u></span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>9.1.&nbsp;Kafai�i
  infeksiyona ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>9.2.&nbsp;Sistemik
  infeksiyona ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>10.&nbsp;<u>Homeostaz bozuklu�una
  ba�lanan ba�a�r�s�</u></span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.1. Hipoksi
  ve/veya hiperkapniye ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.2.&nbsp;Diyaliz
  ba�a�r�s�</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.3.&nbsp;Preeklampsi
  veya eklampsiye ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.4.&nbsp;Hipotiroidizme
  ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.5.&nbsp;A�l��a
  ba�lanan ba�a�r�s�</span><span lang=EN-US style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.6.
  Kardiyak ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10.7.Di�er homeostaz
  bozukluklar�na ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>11.<u>Kafatas�, boyun, g�zler,
  kulaklar, burun, sin�sler, di�ler, a��z veya di�er y�z ve kafa yap�lar�na
  ba�lanan ba�a�r�s� veya y�z a�r�s�</u><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.1.&nbsp;Kafa
  kemi�i bozuklu�una ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.2.&nbsp;Boyun
  hastal�klar�na ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.3.&nbsp;G�z
  bozuklu�una ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.4.&nbsp;Kulak
  bozuklu�una ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.5.&nbsp;Rinosin�zite
  ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.6.&nbsp;Di�ler,
  �ene veya ili�kili yap�lar�n bozuklu�una ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.7.&nbsp;Temporomandib�ler
  eklem hastal���na ba�lanan ba�a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.8.
  Stilohiyoid ligaman�n inflamasyonuna ba�lanan ba�a�r�s� veya y�z a�r�s�<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>11.9. Di�er
  kafatas�, boyun, g�zler, kulaklar, burun, sin�sler, di�ler, a��z veya di�er
  y�z ve kafa yap�lar�na ba�lanan ba�a�r�s� veya y�z a�r�s�<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=619 valign=top style='width:464.4pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:18.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:
  normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>12.&nbsp;<u>Psikiyatrik hastal�klara
  ba�lanan ba�a�r�s� (<span class=GramE>12.1</span> Somatizasyon bozuklu�u ve
  12.2 Psikotik bozuklu�a ba�l�)<o:p></o:p></u></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
  18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
1C.</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararas� Ba�a�r�s�
Derne�i (IHS) 2018 S�n�flama Sisteminde A�r�l� Kranyal N�ropatiler, Di�er
Fasyal A�r�lar ve Di�er Ba�a�r�lar� (B�l�m 3)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>13.&nbsp;<u>Kranyal nevraljiler ve y�z
a�r�s�n�n santral nedenleri</u><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.1.&nbsp;Trigeminal
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.2.&nbsp;Glossofaringeal
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.3.&nbsp;Nervus
intermedius nevraljisi<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.4.&nbsp;Oksipital
nevralji<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.5.&nbsp;Boyun
dil <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.6. A�r�l� optik
n�rit<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.7.&nbsp;�skemik
ok�ler motor sinir paralizisine ba�lanan ba�a�r�s�<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.8.
Tolosa-Hunt <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.9.
Paratrigeminal ok�losempatetik <span class=GramE>sendrom</span> (Reader�s
sendromu)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.10.
Yineleyen a�r�l� oftalmoplejik n�ropati<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.11. Yanan
a��z <span class=GramE>sendromu</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.12. Kal�c� idyopatik
y�z a�r�s�<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
18.0pt;line-height:normal'><span style='font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>13.13. Y�z
a�r�s�n�n santral nedenleri<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>14. Di�er ba�a�r�s� bozukluklar�: Ba�ka
yerde s�n�flanamayan ya da tan�mlanamayan ba�a�r�lar�<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l�
Hastada �yk� Al�nmas�</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l�
hastalar�n tan�s�n�n konulmas�nda en �nemli nokta <span style='mso-bidi-font-style:
italic'>ba�a�r�s� �yk�s�n�n tam olarak al�nmas�</span>d�r. Ba�a�r�s�
hastalar�n�n �o�unda t�bbi ve n�rolojik muayeneler normal bulunur. Bu nedenle,
do�ru tan� i�in elimizdeki en yararl� gere� ayr�nt�l� �yk�d�r. Ba�a�r�s� �yk�s�
hastan�n ba�a�r�lar�n�n ayr�nt�l� bir tablosunu �izmeli, ayr�ca varsa tan�y�
veya tedaviyi etkileyebilecek di�er t�bbi durumlar hakk�nda da bilgi
sa�lamal�d�r.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�s�
�yk�s�nde a�a��daki parametreler mutlaka sorulmal�d�r:</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Ba�a�r�s�n�n tipi ve karakteri</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Ba�lang�� �ekli</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>S�kl���</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Yeri</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>�iddeti</span><span lang=EN-US
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Aura ve prodromal belirtilerin
     olup olmamas�</span><span lang=EN-US style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>E�lik eden belirtilerin olup
     olmamas� (bulant�, kusma, foto-,fono-,osmofobi, allodini gibi)</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Presipite eden fakt�rlerin olup
     olmamas�</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Uyku d�zeni</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Emosyonel fakt�rler</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Aile �yk�s�</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Medikal, cerrahi veya do�um �yk�s�</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Alerji, ta��t tutmas� vb. de
     i�eren �zge�mi� �yk�s�</span><span lang=EN-US style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l5 level1 lfo2;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>�nceki medikasyonlar ve tedaviler</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
</ul>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l2 level1 lfo3;tab-stops:list 36.0pt'><span
     lang=EN-US style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
     mso-fareast-font-family:"Times New Roman";mso-fareast-language:TR'>Madde
     kullan�m�</span><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
     mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR;mso-fareast-language:
     TR'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR;mso-fareast-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>�lk
de�erlendirme s�ras�nda, sekonder ba�a�r�s� bozuklu�u olas�l���n� d���nd�ren, <b
style='mso-bidi-font-weight:normal'>Tablo 2</b>�de ayr�nt�l� olarak bildirilen
ve a�a��da listelenen <b style='mso-bidi-font-weight:normal'>&nbsp;<span
style='mso-bidi-font-weight:bold'>�</span></b><i>ba�a�r�s� alarm belirtileri</i><b>�</b><span
style='mso-bidi-font-weight:bold'>&nbsp;mutlaka<b> </b></span>g�zden
ge�irmelidir: <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>�lk veya hayat�n�n en �iddetli
     ba�a�r�s�</span><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Akut ba�lang��</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>S�kl��� veya �iddeti giderek artan
     ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Yeni ba�layan ba�a�r�s�:</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>Kanserli hastada</span><span
      lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>50 ya� �zerinde</span><span
      lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
  <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
      line-height:normal;mso-list:l22 level2 lfo4;tab-stops:list 72.0pt'><span
      style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
      "Times New Roman";mso-ansi-language:TR'>Kafa <span class=GramE>travmas�n�n</span>
      ard�ndan</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
      mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 </ul>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Egzersizle birlikte ortaya ��kan
     ba�a�r�s� (�ks�r�k, <span class=GramE>efor</span>, cinsel aktivite gibi)</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Belirli bir �ekle uymayan
     ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Tedaviye yan�t vermeyen ba�a�r�s�</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Sabah olan veya uykudan uyand�ran
     ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Hi� yer de�i�tirmeyen ba�a�r�s�</span><span
     lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Al���lmad�k, uzun s�ren veya sebat
     eden aura</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>Eski ba�a�r�s� �zelliklerinde
     a��klanamayan de�i�iklik</span><span lang=EN-US style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l22 level1 lfo4;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:TR'>N�rolojik ba�ka yak�nmalar�n veya
     bulgular�n e�lik etti�i ba�a�r�s� (ate�, ense sertli�i, papil�dem, g�rme
     kayb�, epileptik n�bet, lateralizan bulgular, kafa kar���kl���-�a�k�nl�k,
     uyku hali gibi)</span><span lang=EN-US style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all>
Tablo 2. </span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'>Ba�a�r�s�n�n de�erlendirilmesinde baz� uyar�c�
belirtiler ve bulgular ile inceleme �emalar�<b> </b></span><span lang=EN-US
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=695
 style='width:520.9pt;border-collapse:collapse;mso-yfti-tbllook:1184;
 mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;padding:
  0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>BA�A�RISI</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border:inset 1.0pt;border-left:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>AYIRICI TANI</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border:inset 1.0pt;border-left:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>�NER�LEN �NCELEME</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50 ya��ndan
  sonra ortaya ��kan ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Temporal
  arterit, YKL </span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sedimentasyon,
  n�rolojik g�r�nt�leme y�ntemleri</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ani ba�layan
  ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Subaraknoid
  kanama, hipofiz apopleksisi, AVM ya da YKL�nin i�ine kanama</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa)</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�iddeti
  giderek artan ba�a�r�s�</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL, subdural
  hematom,<span style='mso-spacerun:yes'>� </span>a��r� ila� kullan�m�</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>analjezik</span></span><span
  style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'> ila�lar�n g�zden ge�irilmesi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sistemik
  hastal�kla birlikte ba�a�r�s� (ate�, ense sertli�i, d�k�nt�ler)</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Menenjit,
  ensefalit, sistemik infeksiyon, kollajen vask�ler hastal�k</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon, ilgili serolojik ve biyokimyasal testler</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Kanser ya da
  HIV�li hastada yeni ba�layan ba�a�r�s�</span><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Menenjit
  (kronik ya da karsinomat�z), beyin abseleri (toksoplazma vb), metastazlar</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa), ilgili serolojik testler</span><span
  lang=DE style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Lateralizan
  n�rolojik <span class=GramE>semptomlar</span></span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL, AVM,
  inme, kollajen vask�ler hastal�k </span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>kollajen
  vask�ler hastal�klar�n ara�t�r�lmas� </span><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=185 valign=top style='width:138.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Papil�dem</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=236 valign=top style='width:176.85pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>YKL,
  idyopatik intrakranyal hipertansiyon, menenjit</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=274 valign=top style='width:205.55pt;border-top:none;border-left:
  none;border-bottom:inset 1.0pt;border-right:inset 1.0pt;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�rolojik
  g�r�nt�leme y�ntemleri,</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>lomber
  ponksiyon (kontrendikasyon yoksa)</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;text-indent:14.2pt;line-height:normal'><span style='font-size:10.0pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>YKL: Yer kaplay�c� lezyon, AVM: Arterio-ven�z
malformasyon, HIV: Human Immundeficiency Virus, &nbsp;</span><span lang=EN-US
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Bu t�r ku�kuland�r�c�
durumlar yoksa normal n�rolojik muayenesi olan ve �yk�s� uyumlu bir hastada
primer ba�a�r�s� tan�s� i�in g��l� bir izlenim olu�tu�unda g�r�nt�leme
y�ntemleri gibi yard�mc� inceleme y�ntemleri �o�u kez gerekli de�ildir, hatta
baz� sak�ncalar� da olabilir. �rne�in rastlant�sal olarak saptanan araknoid
kist, nonspesifik beyaz madde lezyonlar� benzeri bulgular hastan�n yakla��m�n�,
moralini ve hatta tedavi se�imini olumsuz y�nde etkileyebilir <b
style='mso-bidi-font-weight:normal'>(�ekil1 A ve B</b>).</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:35.25pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi1.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>�ekil 1A-B</span><span
style='mso-bidi-font-size:11.0pt;color:purple;font-weight:normal'>.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Her ikisi de auras�z
migrenli olan ve n�rolojik ba�ka bulgusu olmayan hastalarda yap�lan MRG ve BT
incelemelerinin s�ras�yla araknoid kist ve serebellar kalsifikasyon gibi
yak�nmalar� ile ili�kisiz baz� lezyonlar� g�stermesi bu hastalar�n gereksiz
�ekilde endi�elenmesine ve bir�ok ek inceleme yap�lmas�na neden olmu�tur.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Primer ba�a�r�lar� i�inde
en s�k kar��la��lanlar migren ve gerilim tipi ba�a�r�lar�d�r. Bunlarla
kar��la�t�r�ld���nda �ok daha seyrek olmakla birlikte (2000 ki�ide bir veya
daha ender) �ok �iddetli, s�k ba�a�r�lar�na neden olmalar�, geleneksel a�r�
kesicilere yan�t vermemeleri ve farkl� tedaviler gerektirmeleri
nedeniyle&nbsp;trigeminal <span style='mso-bidi-font-style:italic'>otonomik
sefalaljiler (k�me ba�a�r�s�, paroksizmal hemikranya</span>&nbsp;gibi) �nemli
bir di�er primer ba�a�r�s� grubunu olu�turmaktad�r. �o�u kez bu hastalar do�ru
tan� alamamalar� nedeniyle y�llarca �iddetli a�r�lar �ekebilmektedir. �u an
i�in d�nyada en s�k ���nc� ba�a�r�s� tipi ise iyatrojenik bir tablo olan&nbsp;<span
style='mso-bidi-font-style:italic'>analjezik ila� a��r� kullan�m ba�a�r�s�</span>d�r
(�AKB). Bu nedenle, tedavi i�in kullan�lan analjeziklerin en az 3 ay boyunca
ayda 10 g�nden fazla al�nmas�n�n kendi ba��na kronik bir ba�a�r�s� nedeni
oldu�u konusunda hastalar mutlaka en ba�tan uyar�lmal� ve dikkatli bir �ekilde
takip edilmelidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l� hastaya
yakla��mda a�a��daki �zellikler ayr�nt�l� olarak ele al�nmal�d�r:</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<b><span
style='mso-bidi-font-style:italic'>1. Hastan�n �zellikleri:</span></b>&nbsp;<span
style='mso-bidi-font-style:italic'>Ba�a�r�s�n�n <i>�ba�lang�� ya���</i></span><i
style='mso-bidi-font-style:normal'>&nbsp;</i>tan� konulmas�nda �nemli ipu�lar�
verir. Primer ba�a�r�lar� genellikle �ocukluk veya gen� eri�kinlik ya�lar�nda
ortaya ��kar, oysa 50 ya��ndan sonra ba�layan ba�a�r�lar� �ncelikle sekonder
nedenleri (kitle lezyonu veya temporal arterit gibi) akla getirmelidir.
Migrenlilerin sadece %2�sinde a�r�n�n ba�lang�c� 50 ya��n �zerindedir. K�me
tipi ba�a�r�s� 30�50 ya� civar�nda ba�lar. Gerilim tipi ba�a�r�s� ise genelde
20-40 ya�lar�nda ortaya ��kar. Hipnik ba�a�r�s� <span class=GramE>sendromu</span>
genellikle 50 ya��ndan sonra ortaya ��kar. Gen�lik y�llar�nda da g�r�lebilen
ama genelde 40 ya�lar�n �zerinde rastlanan �AKB s�k kar��la��lan bir ba�a�r�s�
nedeni olarak hat�rlanmal�d�r. Ya�l�larda ba�a�r�s� daha seyrek g�r�l�r, ancak
genellikle �nemli bir soruna i�aret eder. Etyoloji ya�a g�re farkl�l�k
g�sterir, ayr�ca tan� ve tedaviyi etkileyecek komorbid durumlar�n bulunma
olas�l��� da ya�l� hasta grubunda daha fazlad�r. Hastan�n&nbsp;<b
style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'>�<span
style='mso-bidi-font-style:italic'>cinsiyeti�</span></i>&nbsp;</b>de �nem
ta��yabilir. Migren i�in kad�nlarda erkeklere oranla 3-4 kat fazla bir
s�kl�ktan s�z edilebilirken, gerilim tipi ba�a�r�lar�nda b�yle bir cinsiyet
ay�r�m� s�z konusu de�ildir. K�me ba�a�r�lar�nda ise erkek egemenli�i
�arp�c�d�r. <span style='mso-bidi-font-style:italic'>Gebelik s�ras�nda ba�</span>a�r�s�n�n
kaybolmas� migrenlilerde s�kt�r veya (tersine) a�r�n�n gebelikte ortaya
��kmas�, ven�z tromboz gibi sekonder ba�a�r�lar� a��s�ndan �nemlidir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>2. Ba�a�r�s�n�n karakteri ve �iddeti</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;hasta
taraf�ndan&nbsp;<span style='mso-bidi-font-style:italic'>zonklay�c�,
s�k��t�r�c�, bas�n� hissi, i�ne batar gibi, patlay�c�, �im�ek gibi, elektrik
�arpar gibi</span>&nbsp;�eklinde farkl� ifadelerle tan�mlanabilir. Hasta
ba�a�r�s�n� tan�mlamakta zorlan�rsa, �damar atar gibi�, �bir sarg�yla s�k�lm��
gibi�, �b��ak saplan�r gibi� �eklinde �rnekler verilip hangisine benzedi�i
sorulabilir. A�r�n�n �iddeti de �ok �nemlidir. Migren ba�a�r�lar�na k�yasla
gerilim tipi ba�a�r�lar� �o�unlukla daha hafif �iddettedir. Migren a�r�s�
pulsatil&nbsp;bir a�r�d�r, hareketle artar, �iddetlidir ve genelde hastay�
g�nl�k hayat�n� devam ettiremez hale getirir. Hasta karanl�k ve hareketsiz bir
yer ister, ���k ve g�r�lt�den ka��n�r. Zonklay�c� veya bas�n� hissi olu�turan
ba�a�r�lar� migren i�in tipikken, s�k��t�r�c� ba�a�r�s�, en s�k gerilim tipi
ba�a�r�s�nda ifade edilir. Hastalar gerilim tipi ba�a�r�lar�n� s�kl�kla bant
gibi veya mengene ile s�k�lm�� gibi olarak tan�mlarlar. Kronik gerilim tipi
ba�a�r�s� kal�c� donuk ve doluluk hissi ile giden bir a�r�d�r. Migren
ba�a�r�s�n�n k���k ya�larda eri�kinlerdekinden farkl� karakter ta��d��� da
unutulmamal�d�r. �ocukluk ya�lar�nda, s�kl�kla iki yanl� ve frontal yerle�imli
olmas� ve yar�m-bir saat gibi k�sa s�reler migren i�in tipiktir. K�me tipi ba�a�r�s�
ise derinden gelen can s�k�c� ve rahats�z edici bir a�r�d�r. Hasta yatamaz,
yerinde duramaz ve s�rekli gezinmek durumundad�r. Otonomik sefalaljilerin
�nemli ve �ok ay�rt ettirici bir �zelli�i, her zaman �ok �iddetli olmalar� ve
�e�itli otonom bulgular�n e�lik etmesidir. �dyopatik saplan�c� ba�a�r�s�nda
de�i�en b�lgelerde i�ne veya b��ak batar gibi a�r�lar tan�mlan�rken, trigeminal
nevralji gibi nevraljik a�r�larda �im�ekvari veya elektrik �arpar gibi a�r�
ifadesi kullan�l�r. Her t�r a�r� tipi ve �iddeti sekonder nedenlere ba�l�
olarak da g�r�lebilir. Organik a�r�larda, a�r�n�n �iddeti ve tabiat� genelde
de�i�ken ve ilerleyicidir. Beyin t�m�r�n�n a�r�s� genelde gerilim tipi
ba�a�r�s�n� �a�r��t�r�r. Bir anevrizman�n veya arterio-ven�z malformasyonun kanamas�
s�kl�kla s�rekli, �iddetli, k�nt veya zonklay�c� a�r� yarat�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>3. Ba�a�r�s�n�n ba�lang�c�</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;ile ilgili bilgiler
de tan� i�in ipu�lar� sa�lar. Kafa <span class=GramE>travmas�n�n</span>
ard�ndan ortaya ��kan ba�a�r�s� bir �post-konk�zyon� ba�a�r�s� bozuklu�unu veya
kafai�i bir patolojik s�re� olas�l���n� akla getirmelidir. Ancak kafa <span
class=GramE>travmas�</span> hem migreni, hem de k�me ba�a�r�lar�n�
tetikleyebilir. Do�um �ncesi veya sonras� d�nemde ortaya ��kan ba�a�r�s� bir
kortikal ven veya dural sin�s trombozunu akla getirmelidir. Ba�a�r�s�n�n ortaya
��k���n�n ate�le birlikte olmas� infektif bir nedeni d���nd�r�r. Efor (�rne�in
a��rl�k kald�rma, spor sonras�) subaraknoid kanamay� veya selim bir tablo olan <span
class=GramE>efor</span> ile ili�kili ba�a�r�s�n� ortaya ��karabilir.&nbsp;<i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>Ba�a�r�s�n�n
zamansal gidi�i</span></i>&nbsp;de �ok yol g�stericidir. <span class=GramE>�rne�in
migren �zelliklerine sahip ba�a�r�lar� �eken bir hastada belirli bir s�redir
(�o�unlukla bir y�l veya daha fazla) bu tip ba�a�r�lar�n�n tekrarl�yor olmas�,
a�r� aralar�nda t�m�yle normale d�nmesi veya kronik ba�a�r�l� durumlarda yine
belirli bir s�redir devam ediyor olmas� (3 ay veya daha fazla) ve a�r�
�iddetinde ku�ku duyuracak bir progresyon veya ba�ka n�rolojik belirtilerin
olmamas� beklenir. Bununla birlikte epizodik migren ataklar�na sahip
hastalar�n, a��r� derecede s�k a�r� kesici kullan�m� (analjezik,
antiromatizmal, ergotamin, triptan, narkotik ila�lar gibi) ard�ndan ataklar�nda
s�kla�ma ve a�r� karakterinin de�i�mesi ve ba�a�r�lar�n�n s�rekli bir hal
almas� s�k kar��la��lan bir durum olup, �<i style='mso-bidi-font-style:normal'>ila�
a��r� kullan�m� ba�a�r�s�</i>� (�AKB) olarak adland�r�lan sekonder bir
ba�a�r�s�n�n klinik g�sterisidir.<b><i>&nbsp;</i></b></span></span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>4. Ba�a�r�s�n�n yerle�imi</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;de klinisyen i�in
�nemlidir. Sadece y�zde ve hep ayn� yanda ise a�r� tipi de dikkate al�nd���nda
nevraljik a�r�lar veya n�ropatik a�r�lar �ncelikle d���n�lebilir ancak g�z� ve
ba��n di�er b�l�mlerini (�akak, al�n gibi) i�ermesi �n tan�lar�
de�i�tirmelidir. Bu t�r a�r�lar e�er hep tek yanl� ve ayn� tarafta ise,
�zellikle otonomik belirtilerin varl���nda, otonomik sefalaljileri akla daha
�nce getirmelidir. Migrenlilerin �o�u a�r� taraf�n�n ataktan ata�a
de�i�ebildi�ini s�ylese de, %20�yi a�an hastada a�r�n�n hep ayn� yanda oldu�u
unutulmamal�d�r. Migrenin aksine, k�me ba�a�r�s�nda hastalar�n sadece %10-15�i
ataktan ata�a a�r�n�n taraf de�i�tirdi�ini s�yler. Temporal arter b�lgesine <span
class=GramE>lokalize</span> bir a�r�, hastan�n ya�� ve a�r�n�n ba�lang�� ya��
ileri oldu�unda, temporal arteriti �ncelikle d���nd�rmelidir. Boyundan ba�layan
veya boyna da yay�lan a�r�lar servikal bir k�keni akla getirebilirse de, migren
ataklar�na b�y�k s�kl�kla servikal spazm�n e�lik etti�i unutulmamal�d�r.
Gerilim tipi ba�a�r�s� ise tipik olarak iki yanl�d�r. �ki yanl� veya bir yanda
daha bask�n olmakla birlikte di�er yanda da hissedilen ba�a�r�lar�, otonomik
sefalaljiler ve nevraljik a�r�lar i�in d��lay�c� bir �zelliktir. Bu t�r
a�r�larda migren veya gerilim tipi ba�a�r�lar� en s�k olmakla birlikte �AKB
gibi sekonder nedenler de d���n�lmelidir. Supratentoryal alanda a�r� olu�turan
yap�lar�n ba�l�ca innervasyonu trigeminal sinirden kaynaklan�r. �nfratentoryal
a�r� olu�turan yap�lar�n innervasyonu ise �st servikal sinirlerden,
glossofaringeus ve vagus sinirlerinden kaynaklan�r. Supratentoryal lezyonlar
genellikle frontal ba�a�r�lar�na yol a�arken, infratentoryal lezyonlar s�kl�kla
oksipital b�lgede a�r� olu�turur. Ancak, trigemino-servikal <span class=GramE>komplekse</span>
farkl� yap�lardan y�nelen n�ronlar�n �rt��mesi nedeni ile bu paternin d���na
��kan yay�lmalar da s�z konusu olabilir. Ba�a�r�s� net bir bi�imde g�z
�evresine s�n�rl� ise, g�z hastal��� veya d�k�nt� �ncesi oftalmik zoster akla
gelmelidir. Trigeminal nevralji maksiller ve mandib�ler alanlarda daha s�kt�r.
Beyin t�m�r� saptanan hastalar�n yar�s�ndan biraz fazlas� ba�a�r�s�ndan
yak�n�r; bunlar�n da %80�inde a�r� t�m�r�n bulundu�u taraftad�r. Serebrovask�ler
hastal�klarla ili�kili ba�a�r�lar� yayg�n veya <span class=GramE>lokalize</span>
olabilir. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>5. Ba�a�r�s�n� tetikleyen nedenler:</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>&nbsp;</span></b><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Presipite edici fakt�rler tan�ya yard�mc�
oldu�u gibi ba�a�r�s�n�n �nlenmesinde ve koruyucu tedavisinde de �nemlidir.</span><span
style='mso-ansi-language:TR'> </span><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>Migrende ya�am stili d�zenlenmesinde en �nemli unsur
d�zensiz beslenme ve uzun s�reli a�l���n �n�ne ge�ilmesidir. Biyolojik yola��
tam bilinmemekle birlikte migren ataklar�n�n tetikleyicileri aras�nda
hipogliseminin �nemli oldu�u d���n�lmektedir. Migrenli hastalar�n en az
1/3��nde de yetersiz s�v� al�m�n�n ba�a�r�s�n� tetikledi�i bildirilmi�tir.
Hastalar�n %30 ile %70�inde a�l�k hem migren hem de gerilim tipi ba�a�r�s�n�
tetiklemektedir. </span><span style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=ColorfulList-Accent11CxSpFirst style='margin-left:0cm;mso-add-space:
auto;text-align:justify'><span class=GramE><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Migreni ortaya ��karan sebepler aras�nda
uykusuzluk, a��r� uyku, stres, stres sonras� rahatlama, �zel baz� yiyecekler
(en s�k olarak �ikolata, peynirler, alkoll� i�ecekler, �zellikle k�rm�z� �arap,
turun�giller, monosodyum glutamat, nitrat ve aspartat i�eren yiyecekler),
yorgunluk, menstr�asyon, lodos hava durumu, y�kseklik ve bas�n� de�i�iklikleri,
fiziksel baz� uyaranlar (parlak ���k, y�ksek ses, parf�m, kimyasallar), baz�
ila�lar (nitrogliserin, sildenafil, dipridamol gibi) yer almaktad�r. </span></span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Tetikleyici yiyecekleri
k�saca g�zden ge�irecek olursak; alkol�n hangi mekanizma ile ba�a�r�s�na neden
oldu�u tam bilinmese de hayvan modelinde etanol�n meningeal damarlarda
vazodilatasyona yol a�t��� g�sterilmi�tir. Peynirin i�indeki biyojenik <span
class=GramE>aminlerin</span> ba�a�r�s�n� tetikledi�i d���n�lmektedir.
Migrenlilerde serotonin i�erdi�i bilinen �ikolata yeme iste�inin migren prodromunun
bir par�as� oldu�u da d���n�lmektedir. Histaminin intraven�z verildi�inde ve
inhalasyon yoluyla al�nd���nda ba�a�r�s�n� tetikledi�i bilinmektedir. Kokain
kullan�m� ve kokain yoksunlu�u da migren benzeri ba�a�r�lar�n� tetikleyebilir.
Di�er yandan, stres, a�l�k, uyku de�i�ikli�i (yetersiz uyku veya a��r� uyku ya
da ��len uykusu gibi zaman� kaym�� uyku) gibi tetikleyici nedenlerin migren
kadar gerilim tipi ba�a�r�s� i�in de s�z konusu oldu�unu unutmamak gerekir.
Oysa koku (keskin parf�m kokusu, sigara kokusu), parlak ���k, <span
class=GramE>r�zgar</span> (lodos), sigara duman�, mayal� i�kiler (k�rm�z�
�arap) �zellikle migrene �zg� tetikleyicilerdir. Gerilim tipi ba�a�r�lar�n�n
koku ile tetiklenmedi�i, koku teti�inin migren ve gerilim tipi ba�a�r�s� i�in
ay�rt edici �zellik olarak say�labilece�i bilinmektedir. G�r�lt�, her t�r
ba�a�r�s�nda k�t� etki g�sterirken a�r� s�ras�nda ���k ve koku, �zellikle
migren a�r�s�nda y�ksek oranda rahats�z edicidir.&nbsp;K�me tipi ba�a�r�s�nda
alkol akut ata�� ortaya ��kar�r. Egzersizler genelde organik/sekonder
ba�a�r�lar�n� tetikler ama egzersizle tetiklenen primer ba�a�r�lar� da vard�r.
Akut ba�layan fakat daha �ncesinde olmayan ba�a�r�s�nda tetikleyen neden
�zellikle �nemlidir. �rne�in �ks�rmek, �k�nmak gibi kafai�i bas�nc� artt�ran
veya g��l� bir <span class=GramE>efor</span> ya da cinsel ili�ki gibi
etkinlikleri takiben geli�en akut ba�a�r�s� akla ilk olarak subaraknoid
kanamay� getirmelidir. N�rolojik ve fizik muayenenin normal olmas� halinde,
�zellikle de yineleyen bir durum s�z konusuysa, ��ks�r�k ba�a�r�s��, �orgazm ba�a�r�s��,
�<span class=GramE>efor</span> ba�a�r�s��, �g�kg�r�lt�s� ba�a�r�s�� gibi
idyopatik durumlar da akla gelmelidir. Bu t�r seyrek rastlanan primer
ba�a�r�lar�n�n �zelli�i, ba�ka durumlarda ortaya ��kmamas�, sadece tan�mlanan
bu �zel durumlarda ortaya ��kmas� ve tekrarlay�c� olmas�d�r. Kas k�kenli
a�r�lar, duyarl� b�lgenin palpasyonu veya zorlanmas� ile tetiklenebilir.
Trigeminal nevralji, tetik noktaya dokunmakla ortaya ��kar�labilir. Bu
noktalar�n yemek yeme, konu�ma, so�u�a maruz kalma, di�leri f�r�alama, dokunma,
t�ra� olma veya y�z y�kama gibi basit uyaranlarla uyar�lmas� bir ata��
tetikleyebilir. Ba�a�r�s�n� att�ran nedenlerden boyun spazm�n�n migrene de
s�kl�kla e�lik etti�i unutulmamal�d�r. Ba� ve beden hareketleri (merdiven
��kma, e�ilip kalkma gibi) migren i�in �zellikle artt�r�c� rol oynarken,
gerilim tipi ba�a�r�s�nda etkili olmas� beklenmez.</span><span
style='font-family:"Times","serif";mso-ansi-language:TR'> </span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli hastalar�n
yakla��k yar�s�nda fiziksel aktivite ba�a�r�s�n� tetiklemektedir. Stresin
migren ataklar�n� tetikledi�ini bildiren yay�nlar olmas�na kar��n, baz�
�al��malar stresin gerilim tipi ba�a�r�s�nda migrenden daha etkili oldu�unu
g�stermektedir. <o:p></o:p></span></p>

<p class=ColorfulList-Accent11CxSpLast style='margin-left:0cm;mso-add-space:
auto;text-align:justify'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�s�n�&nbsp;<i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:bold'>iyile�tiren
nedenler</span></i>&nbsp;i�inde uyumak, karanl�k ve sessiz ortam migren i�in
�o�u kez iyile�tirici bir role sahiptir. K�me ba�a�r�s�nda y�ksek yo�unluklu oksijen
soluma (15 lt/dakika) saniyeler veya dakikalar i�inde a�r�y� ge�irebilir. Ba�a
so�uk uygulamak yine migren i�in iyile�tirici bir uygulama olabilir. Gebelik ve
menopoz d�nemleri de migrenli kad�nlarda rahatlama d�nemleri olarak
hat�rlanabilir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>5. Ba�a�r�s�n�n s�kl��� ve s�resi</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;tan�da �nemli
ipu�lar� verir ve tedavimizi y�nlendirir. Sekonder nedenlerle ortaya ��kan
ba�a�r�s� genelde �zel bir patern g�stermez, s�kl��� ve �iddeti progresiftir.
Primer ba�a�r�lar�nda a�r� s�kl��� kritik �neme sahiptir. Migren ataklar� belli
bir d�zende gelir, genelde ayda 2-8 kez olur. Bir g�n i�inde birden fazla atak
al���lm�� de�ildir. E�er ila� a��r� kullan�m� s�z konusu de�ilse, g�nl�k veya
g�n a��r� migren ata�� (<span style='mso-bidi-font-style:italic'>kronik migren</span>)
olduk�a seyrek kar��la��lan bir durumdur. Migren ata��n�n analjezik ila�
kullan�lmad���nda 4 saat ile 3 g�n aras� bir s�re devam etmesi beklenir. Yetmi�
iki saatten uzun s�rmesi durumunda, <i style='mso-bidi-font-style:normal'>�<span
style='mso-bidi-font-style:italic'>migren statusu�</span></i>&nbsp;terimi
kullan�l�r. Oysa epizodik gerilim tipi ba�a�r�lar�nda bir ritim s�z konusu de�ildir
ve atak s�releri dakikalardan g�nlere hatta haftalara dek olduk�a de�i�kendir,
bir g�n i�inde birka� kez de ortaya ��kabilir. Otonomik sefalaljiler s�re
konusunda daha tutarl� bir gruptur. Bunlar i�inde en uzun s�reli ve g�rece en
seyrek olan� k�me ba�a�r�s�d�r. K�me ba�a�r�s� �o�unlukla 15 dakika ile 3 saat
aras� bir s�reye sahiptir, bununla birlikte daha uzun s�rmesi de tan�y�
d��lamaz. �lk ba�lang�� g�nleri ve sonlan�� g�nleri d���nda, s�kl��� iki g�nde
birden g�nde 8�e dek de�i�ir. Paroksizmal hemikranya ise daha k�sa s�reli (2-30
dakika) ve g�n i�inde �ok daha fazla say�da gelmesi ile (g�nde 10�dan fazla)
k�me ba�a�r�s�ndan ayr�labilir. Otonomik sefalaljiler i�inde en k�sa s�reli
olan� ise SUNCT ve SUNA olup s�re 1-600 saniye aras�nda de�i�ir ve g�nde
y�zlerce kez&nbsp;bile olabilir. Nevraljik a�r�lar bundan da daha k�sa
s�relidir (saniyelik), seyrek veya g�n i�inde �ok say�da olabilir. Hemikranya
kontinuada ise a�r�n�n hi� kesilmeden aylard�r s�r�yor olmas� ve arada migren�z
�iddetlenmeler kurald�r.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>6. Ba�a�r�s�na e�lik edenler</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;de tan� i�in ipu�lar�
vermektedir. Migrende gastrointestinal <span class=GramE>semptomlar</span>
olarak bulant� ve kusma g�r�l�r. Ayr�ca �dizziness�, fotofobi, fonofobi,
tinnitus ve bulan�k g�rme e�lik edebilir, hastalar�n yakla��k %10�unda pitozis,
hafif g�z ya�armas�, g�z kanlanmas� gibi otonomik bulgular bulunabilir. K�me
tipi ba�a�r�s�nda ve di�er otonomik sefalaljilerde ise g�z ya�armas�, y�z
k�zarmas�, burun t�kan�kl��� veya ak�nt�s� gibi �e�itli otonomik belirtiler ve
parsiyel Horner Sendromu tek yanl� ve belirgin olarak g�r�l�r ve tan� <span
class=GramE>kriterleri</span> i�in de bu bulgular�n e�lik etmesi
gereklidir.&nbsp;Kronik gerilim tipi ba�a�r�s�nda ise genellikle hastan�n
elinde somatik, emosyonel ve fizik <span class=GramE>semptomlar�</span>
g�steren uzun bir liste vard�r. Gerilim tipi ba�a�r�s�na hemen hi� bir�ey e�lik
etmez.&nbsp;<i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:
bold'>Aura</span></i>&nbsp;varl���nda art�k ba�a�r�s�n�n �zellikleri �nem
ta��maz, hatta auray� ba�a�r�s� izlemeyebilir (a�r�s�z aura). Aural�
migrenlilerin t�kay�c� damar hastal�klar� y�n�nden artm�� bir riske sahip
olduklar� ve �zellikle sigara veya �strojen kullan�m�n�n bu riski genel topluma
g�re daha da artt�rd��� bilinmeli ve hastalar bu konuda uyar�lmal�d�r. Ayr�ca,
hemipleji ve beyinsap� bulgular� �eklinde aura varl���nda triptanlar�n
kullan�lmas�n�n sak�ncal� olabilece�i unutulmamal�d�r. Migrenlilerin %70�inde
ve daha nadiren di�er ba�a�r�l� olgularda <i style='mso-bidi-font-style:normal'>allodini</i>
saptan�r. Bu durum a�r� uyand�rmas� beklenmeyen dokunma, sa� tarama, g�zl�k
takma gibi normal bir uyaran ile a�r� ve a��r� duyarl�l�k hissedilmesi olarak
tan�mlan�r. Patofizyolojisinde santral duyarl�la�ma rol oynamaktad�r. Bu
bulgunun varl��� triptan grubu ila�lara yan�ts�zl�k ve kronik migrene d�n���m
a��s�ndan �nem ta��maktad�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sekonder
ba�a�r�s� bozukluklar�na s�kl�kla �ift g�rme, epileptik n�betler, tinnitus ve
fokal n�rolojik bulgu gibi �zellikler e�lik eder. Sekonder ba�a�r�lar�nda,
lezyonun yerle�imine g�re s�kl�kla n�rolojik bulgular mevcuttur. Kafai�i
kitleleri hastalar�n yar�s�nda bulant� ile veya bulant�s�z (projektil) kusma
ile birlikte g�r�l�r. Temporal arterit kafa derisinde s�n�rl� bir hassasiyet,
halsizlik, polimiyaljia romatika, subfebril ate� veya ba�ka bir sistemik
belirti ile ya da g�rme kayb� veya inme ile ili�kili olabilir. E�er mevcutsa
�ene klodikasyosu temporal arterit i�in patognomoniktir. Ate� ve ense sertli�i
menenjite i�aret eder.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>7. Emosyon ve sosyal fakt�rler:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>�yk� al�n�rken hastaya
aile, evlilik ve i� ili�kileri sorulmal� ve stres fakt�rleri varsa ortaya
��kar�lmal�d�r. Bu t�r sorular�n sorulmas� i�in uygun ortam, zaman ve hastan�n
doktora g�veni sa�lanmal�d�r. Bu s�rada tedaviyi <span class=GramE>y�nlendirebilecek<span
style='mso-spacerun:yes'>� </span>gebelik</span> iste�i, kendini �i�man bulmas�
gibi baz� bilgiler de elde edilir. Ayr�ca �AKB tedavisi gibi baz� durumlarda
hastan�n tedavisi s�ras�nda aile deste�i almas� �ok �nemlidir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>8. �zge�mi� ve uyku paterni:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Hekim hastan�n ge�irmi�
oldu�u t�m medikal ve cerrahi hastal�klar� ve durumlar� (do�um, menopoz gibi)
ve varsa kafa <span class=GramE>travmas�n�</span> bilmelidir. Herhangi yeni bir
hastal�k veya tedavi ba�a�r�s�n�n nedeni olabilir, ya da tedavi stratejisinde
�nem ta��r. Hastaya �nceden lomber ponksiyon ya da beyin cerrahisi giri�imi
yap�ld�ysa bilinmesi, intrakranyal hipotansiyona ba�l� post�ral ba�a�r�lar�n�
de�erlendirmek i�in �nem ta��r. Baz� <span class=GramE>spesifik</span> allerjik
etkenler veya yiyecekler ba�a�r�s�na sebep olabilir. Glokom, yeni saptanan
hipertansiyon, diyaliz, hipotirodi, sin�zit gibi hastal�klar ve yeni ba�lanm��
oral kontraseptif <span class=GramE>dahil</span> t�m tedaviler&nbsp;mutlaka
bilinmelidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Kronik
ba�a�r�l� hastan�n �zge�mi�indeki ba�ar�l� ve ba�ar�s�z tedaviler ba�a�r�s�
tan�s�n�n ortaya konulmas�na ve uygun tedavi se�imine yard�mc� olur. Hastan�n
daha �nce denedi�i ve yan etki g�rmeyip fayda g�rd��� tedavinin devam� genelde
do�ru bir yakla��md�r. Ayr�ca ba�a�r�s� ile e� zamanl� ba�lanm�� herhangi bir
ilac�n ba�a�r�s�n� tetiklemi� olma olas�l��� mutlaka ak�lda tutulmal�d�r.
Nitratlar, amantadin, sildenafil, dipridamol, simetidin, reserpin, indometazin,
hormonal tedaviler, baz� antibiyotikler ba�ta olmak �zere �e�itli ila�lar
ba�a�r�s�n� ba�latabilir. Kad�nlarda oral kontraseptif kullan�m� veya
postmenopozal hormon tedavisi a�r�n�n �iddetini, s�kl���n�, s�resini
de�i�tirebilir ve <span class=GramE>komplikasyonlar�n�</span> artt�rabilir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>K�me
tipi ba�a�r�s� s�k olarak,&nbsp;<span style='mso-bidi-font-style:italic'>hipnik
ba�a�r�s�</span>&nbsp;ise tipik olarak her gece ayn� zamanda uyand�r�r.
Migrenlilerde ba�a�r�s� genellikle uyan�kken ba�lar, migren a�r�s� genelde uyku
ile d�zelme e�ilimindedir, ancak uzun ataklarda ertesi sabah da a�r� devam
edebilir. Kronik gerilim tipi ba�a�r�s� olan hasta s�k s�k ve erken uyan�r.
Uyku bozuklu�u ayn� zamanda bir depresyon belirtisi olabilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Depresyon</span>&nbsp;uykuya dalmada g��l�k,
uykuyu s�rd�rmede g��l�k veya sabah erken uyanma ile gidebilir. Anksiyete ile
ili�kili ba�a�r�s�nda hasta uykuya dalmakta zorluk �eker. Hipertansiyon a�r�s�
uyan�rken olur ve g�n ilerledik�e azal�r.&nbsp;<span style='mso-bidi-font-style:
italic'>Uyku apnesi</span>&nbsp;s�k rastlanan bir durumdur, �zellikle kilolu
ki�ilerde sabah ba�a�r�lar�na yol a�abilir. Bu a��dan hastalar sorgulanmal�,
ku�kulu durumlarda da polisomnografi incelemesi yap�lmal�d�r. Uyku sorunlar�
ayr�ca profilatik tedavide ila� se�iminde de �nem ta��r.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></i><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>9. Aile �yk�s�:</span></b><b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migren kal�tsal bir
hastal�kt�r ve ailede genelde migrenli ba�ka hastalar vard�r. �zellikle aural�
migren olgular�nda bu yatk�nl�k daha belirgindir, genetik k�keni ortaya ilk
konan ciddi bir aural� migren formu olan&nbsp;<i style='mso-bidi-font-style:
normal'><span style='mso-bidi-font-weight:bold'>ailesel hemiplejik migrende</span></i>&nbsp;ailede
etkilenmi� bir ba�ka bireyin varl��� tan� i�in gereklidir. E�er aile �yk�s�
yoksa ayn� tablo <i style='mso-bidi-font-style:normal'>sporadik hemiplejik
migren</i> olarak adland�r�l�r. K�me tipi ba�a�r�s�nda aile �yk�s� nadirdir.
Kronik gerilim tipi ba�a�r�s�nda ise ailede depresyon �yk�s� bildirilmi�tir.
Ailesel ba�a�r�lar�nda ortak �evresel fakt�rler de rol oynayabilir, b�t�n
ailede karbon monoksit ile ili�kili ba�a�r�s�na yol a�abilir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<b>&nbsp;</b></span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l�
Hastan�n Muayenesi</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l�
hastan�n muayenesinde ayr�nt�l� fizik muayene ve n�rolojik muayene yap�lmas�
temeldir. Ba�a�r�s� ile ba�vuran hastada �ncelikle vital bulgular
de�erlendirilmelidir. Hipertansiyona ba�l� ba�a�r�s�nda diastolik&nbsp; bas�n�
110 mmHg ve �st�d�r. Hipertansiyon tedavi ile kontrol alt�na al�n�nca ba�a�r�s�
da genellikle takip eden g�nler i�inde d�zelir. Ba�a�r�s� hipertansiyon veya
hipertansiyon nedeniyle kullan�lan ila�lar�n yan etkisi olarak ortaya
��kabilece�i gibi, migren gibi ba�a�r�l� durumlar�n atak s�ras�nda kan
bas�nc�nda s�kl�kla ge�ici y�kselmeye yol a�abilece�i de ak�lda tutulmal�d�r.
Ate� varl��� sistemik bir infeksiyonu, ense sertli�inin olmas� menenjit
tan�s�n� d���nd�r�r. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>Ba�a�r�s�ndan yak�nan bir hastada, ba� ve boyun b�lgesinin
muayenesi �ncelikli olarak yap�lmal�d�r. </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>Temporal arterlerde belirginle�me,
bo�umlanma, geni�leme ve hassasiyet bulunmas�, klinik uyumluysa temporal
arteriti d���nd�rmelidir, ancak bu bulgular akut migren ata��na da e�lik
edebilir. Baz� hastalarda g�z bulgular� da e�lik eder. �rne�in k�me tipi
ba�a�r�s� i�in karakteristik �zellikler; konjunktival k�zar�kl�k, tek tarafl�
pitoz, k�smi Horner <span class=GramE>sendromu</span> gibi bulgulard�r. Ayr�ca
ba�a�r�l� olguda g�z �evresinde a�r� da e�lik ediyorsa glokomu d��lamak gereklidir.
Kafai�i bas�n� art���nda ise g�z dibinde papil�dem saptan�r.&nbsp;<span
style='mso-bidi-font-style:italic'>Bu nedenle ba�a�r�s� olan bir hastan�n g�z
dibi bak�lmadan muayenesi tamamlanm�� kabul edilmemelidir. Y�z b�lgesinde </span>tetik
nokta varl��� trigeminal nevralji i�in karakteristiktir, SUNCT gibi baz� otonom
sefalaljilerde de g�r�lebilir. <span style='mso-bidi-font-style:italic'>Bunun
yan�s�ra kulak-burun-bo�az infeksiyonlar�n� d��lamak i�in bu b�lgelerin
ayr�nt�l� muayenesi yap�lmal�; boyun b�lgesinin muayenesinde h</span>areket
k�s�tl�l���, spazm ve gerginlik de�erlendirilmelidir. Ayr�ca temporomandib�ler
eklemler hassasiyet, hareket k�s�tl�l���, asimetri ve �t�k�rdama� a��s�ndan
incelenmelidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�s�nda
Yard�mc� Tan� Y�ntemleri</span></b><span style='font-size:13.5pt;font-family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>1. Radyolojik incelemeler</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Akut
sin�zit varl���nda sin�s grafileri anlaml�d�r, kronik sin�zitin ba�a�r�s�
nedeni olmad��� bilinmelidir. Art�k �ok seyrek kullan�lan di�er direkt filmler;
frakt�rleri, ayr�k s�t�rleri, pineal gland itilmesini, d�vme bak�r g�r�n�m� ile
kafai�i bas�n� art���n� g�sterebilir; intrakranyal kalsifikasyonlar, sella
b�y�kl��� ve erozyonlar� konusunda bilgi verir. Ayr�ca litik lezyonlar ile
hiperosteozis ve metastazlar� g�sterebilir. Baziler invajinasyon konusunda
yard�mc� olur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bilgisayarl�
<span class=GramE>tomografi</span> (BT) ve manyetik rezonans g�r�nt�leme (MRG)
daha �nce belirtilmi� olan sekonder ba�a�r�s� ku�kusu olan durumlarda istenir,
primer ba�a�r�lar�nda gerekli de�ildir. BT akut ba�a�r�s�nda en kolay, h�zl� ve
en �ok kullan�lan y�ntemdir. Ayr�ca, BT kronik ba�a�r�s�nda, subakut/kronik
subdural hematom ve hidrosefaliyi d��lamak&nbsp;konusunda yard�mc� olur, beyin
�demini g�sterebilir. Di�er yandan �yk� ve&nbsp;muayene K�BAS d���nd�r�yorsa,
lomber ponksiyon (LP) yap�lmadan �nce kitle etkisinin d��lanmas� amac�yla, kafa
<span class=GramE>travmas�</span> s�z konusuyla ve a��k-kapal� k�r�klar varsa
h�zla BT yap�lmas� uygun olabilir. MRG g�n�m�zde bir�ok a��dan BT incelemesinin
�n�ne ge�mi�tir. MRG �e�itli sekanslarda farkl� de�erlendirmelere olanak
sa�layarak ba�l�ca demiyelinizan lezyonlar, primer maligniteler ya da metastazlar,
�zellikle arka �ukur t�m�rleri ve inmeleri BT�ye k�yasla daha iyi g�sterir.</span><span
style='font-size:7.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>2. Lomber ponksiyon,</span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;kafai�i&nbsp;
infeksiyon ve SAK tan�lar�n� koymak amac�yla klinik ��phe varsa ense sertli�i
ve ate� mevcudiyetinde yap�lmal�d�r. Post-LP ba�a�r�s� riski vard�r. G�rece
yeni tan�mlanan bir tablo olan HaNDL (headache and neurological deficits with
cerebrospinal fluid lymphocytosis) <span class=GramE>sendromunda</span> da
ba�a�r�s� ile birlikte ge�ici n�rolojik defisitleri olan hastalarda LP
lenfositozu g�stermek ve tan�y� desteklemek amac�yla yap�l�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>3. Di�er tan� testleri: </span></b><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kan say�m�, sedimentasyon
h�z�, elektrokardiyografi, tiroid fonksiyon testleri, B12 d�zeyi gibi rutin
biyokimya ara�t�rmalar� ba�a�r�s�n�n sekonder nedenlerini ve hastan�n genel
durumunu ara�t�rmak i�in yap�lmal�d�r.&nbsp;Elektroensefalografiye ba�a�r�s�nda
�ok ba�vurulmaz. E�er ba�a�r�s� epileptik ataklarla birlikte ise yap�labilir.
Pozitron <span class=GramE>emisyon</span> tomografisi, fonksiyonel MRG gibi
�al��malar ise migrenin patofizyolojisini a��klama y�n�nden ara�t�rmalarda
kullan�lan y�ntemlerdir. Transkranyal magnetik stim�lasyon ve di�er
elektrofizyolojik y�ntemler de ara�t�rma ama�l� uygulanmaktad�r.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�s�n�n
�iddetinin ortaya konmas�nda daha net bir yakla��m�n kullan�lmas� yararl�d�r ve
ki�inin kendi kendine doldurdu�u <i style='mso-bidi-font-style:normal'>Migren
K�s�tl�l��� De�erlendirme (MIDAS) Sorgulama Formu</i> T�rk�e�ye adapte
edilmi�tir. Bu formla ki�inin g�nl�k ya�am�nda kaybetti�i g�n say�s� (i�e/okula
gitmedi�i g�nler ve y�ksek oranda k�s�tlanman�n ya�and��� g�nler)
�l��lmektedir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Ba�a�r�l�
bir hastan�n takibinde&nbsp;<i>ba�a�r�s� g�nl���</i>&nbsp;kullan�lmas� �ok
�nemlidir, bu g�nl�kten tedavi s�recinin objektif olarak izlenmesinin d���nda
tan� i�in de �nemli ipu�lar� ve tetikleyici fakt�rlerin saptanmas� sa�lanabilir
(�ekil 2). Hastaya bir ba�a�r�s� g�nl��� verilerek atak say�s�, s�resi,
kullan�lan ila� ve a�r�n�n tedaviye cevap verip vermedi�inin yaz�lmas� ve
�iddeti hafif, orta, �iddetli �eklinde kaydetmesi istenir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:16.3pt'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:16.3pt'><b><u><span style='font-size:10.0pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:blue;
mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi2.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>�ekil 2</span><span
style='mso-bidi-font-size:11.0pt;color:purple;font-weight:normal'>.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>�rnek bir ba�a�r�s� g�nl���</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;margin-right:0cm;margin-bottom:
0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;line-height:normal'><b><span
style='font-size:14.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>SIK RASTLANAN PR�MER
BA�A�RILARI</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>M�GREN</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren,
t�m ba�a�r�s� tipleri i�inde doktora en fazla ba�vuru nedeni olan durumdur. Migren
tan�s� i�in �zel bir laboratuvar testi veya radyolojik inceleme yoktur.
�nsanl�k tarihi kadar eski bir hastal�k olan migren toplum i�in olduk�a �nemli
bir sa�l�k sorunudur, D�nya Sa�l�k �rg�t� taraf�ndan en �ok k�s�tl�l�k yapan
hastal�klar aras�nda ele al�nm��t�r. Kad�nlar�n yakla��k %20'sinin, erkeklerin
ise %8'inin migrenli oldu�u bilinmektedir. Atak s�ras�ndaki olumsuz etkileri
d���nda okul ve i� performans�nda d��me ve sosyal problemler gibi kronik
etkileri vard�r.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Karakteristik
�zellikleri tekrarlay�c� olmas�, ata��n ila�s�z olarak 4 saatten fazla s�rmesi
(ve 3 g�nden az), tek yanl� olu�u (%80 hastada), zonklay�c� olmas�, atak
s�ras�nda s�kl�kla ���ktan ve sesten rahats�zl�k, merdiven ��kma gibi fiziksel
eylemlerle a�r�da art��, a�r�ya s�kl�kla bulant� veya kusman�n e�lik etmesi,
a�r�n�n orta �iddette veya �iddetli olmas�d�r. Migren �o�u kez �ncesinde bir
n�rolojik defisit olmaks�z�n ortaya ��karken <i style='mso-bidi-font-style:
normal'>(<span style='mso-bidi-font-weight:bold'>auras�z migren</span>)</i>,
migrenli hastalar�n %10�15 kadar�nda a�r�lar�n hemen �ncesinde 5�60 dakika aras�
s�ren, ge�ici n�rolojik belirtiler g�r�lebilir <i style='mso-bidi-font-style:
normal'>(<span style='mso-bidi-font-weight:bold'>aural� migren</span>)</i>. En
s�k g�rsel (hemianopsi, beyaz ���klar ya da k�r�k �izgiler g�rme gibi) veya
dilde, y�zde, kolda uyu�ma, g��s�zl�k, konu�mada bozulma gibi bulgular�n
birka�� veya vertigo gibi di�er arka sistem bulgular�, hatta uyan�kl�k kusuru
�eklinde&nbsp;<span style='mso-bidi-font-weight:bold'>aura</span>&nbsp;olabilir.
Hemen ard�ndan veya 1 saat i�inde a�r� ortaya ��kabilir ya da nadiren auray�
ba�a�r�s� izlemeyebilir. Migren ataklar� �oklukla epizodik ataklar �eklinde
gelirken, en az 3 ayd�r her g�n veya g�na��r� olacak �ekilde kronikle�mi�
olarak da g�r�lebilir. Bu durumda ay�r�c� tan�da �AKB de d���n�lmelidir. B�yle
bir durumda a�r� kesicilere en az 2 ay gibi bir s�re ara verilmeden a�r�lar�n
kontrol� m�mk�n de�ildir ve a�r� kesiciler a��r� kullan�ld��� s�rede yap�lan
profilaktik tedavi �abalar� da �o�u kez ba�ar�s�zl�kla sonu�lan�r.&nbsp;<b>Tablo
3</b>�te IHS s�n�flamas�ndaki ilgili b�l�mler �zetlenmi�tir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span></b><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;mso-outline-level:1'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-font-kerning:18.0pt;
mso-ansi-language:TR'>Tablo 3.&nbsp;</span></b><span style='font-size:12.0pt;
font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararas� Ba�a�r�s�
Derne�i: Migren Kriterleri (2018)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 36.0pt'><span style='font-size:12.0pt;line-height:115%;mso-ansi-language:
TR'><span style='mso-tab-count:2'>����������� </span><o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l8 level2 lfo5;
tab-stops:18.0pt 40.5pt'><![if !supportLists]><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:
TR'><span style='mso-list:Ignore'>1.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Auras�z Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�m: 4-72 saat s�ren ataklarla
kendini g�steren tekrarlayan ba�a�r�s�. Ba�a�r�s�n�n tipik �zellikleri: Tek
tarafl� zonklay�c� tarzda, orta �iddetli veya �iddetli olmas�, rutin fiziksel
aktiviteyle k�t�le�me ve mide bulant�s� ve/veya fotofobi ve fonofobinin e�lik
etmesidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 81.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>A.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>B-D <span class=GramE>kriterlerine</span>
uyan en az 5 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>B.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>4-72 saat aras� s�ren ba�a�r�s�
ataklar� (tedavi edilmeden ya da tedavisi ba�ar�s�z olan)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt 36.0pt 81.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Ba�a�r�s� a�a��dakilerden en az iki �zelli�i ta��mal�d�r:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Tek tarafl� yerle�im<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Zonklay�c� karakter<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Orta �iddetli ya da �iddetli a�r� <o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l12 level1 lfo7;tab-stops:18.0pt 45.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Rutin fiziksel aktiviteyle k�t�le�me ya da rutin fiziksel
aktiviteden ka��nmaya neden olma (�rne�in: y�r�me ya da merdiven ��kma)<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:18.0pt 36.0pt 81.0pt'><![if !supportLists]><span style='font-size:
12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>D.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Ba�a�r�s� s�ras�nda a�a��dakilerden en az biri g�r�l�r:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -18.0pt -13.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Mide bulant�s� ve/veya kusma<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:49.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -18.0pt -13.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Fotofobi ve fonofobi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l6 level1 lfo6;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>E.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>S�n�flamada yer alan ba�ka bir ba�a�r�s� tan�s� ile a��klanamamaktad�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span style='font-size:12.0pt;
background:yellow;mso-highlight:yellow;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l8 level2 lfo5;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-family:
Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span></b><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aural� Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�m: Tam d�zelen tek yanl�,
g�rsel, duysal veya merkezi sinir sistemi ile ili�kili di�er belirtilerle kendini
g�steren, genellikle basamaks� �ekilde geli�en dakikalar s�ren yineleyici
ataklar. Aura <span class=GramE>semptomlar�n�</span> s�kl�kla ba�a�r�s� ve
migrenle ili�kili belirtiler izler. <o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-top:0cm;margin-right:0cm;margin-bottom:
0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;text-indent:
0cm;line-height:normal;mso-list:l8 level3 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 49.5pt'><![if !supportLists]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-bidi-font-family:
Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span></b><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tipik Aural� Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam d�zelen a�a��daki aura semptomlar�ndan en az biri g�r�l�r:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>G�rsel<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Duysal<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l3 level1 lfo10;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Konu�ma ve/veya lisan bozuklu�u<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>���������� </span>ii.
Motor, beyinsap� ve retinal <span class=GramE>semptomlar</span> g�r�lmez<o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l16 level1 lfo9;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>A�a��daki �zelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:67.5pt;margin-bottom:.0001pt;text-indent:-13.5pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun s�rede basamaks� ilerleme
g�steren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya daha fazla <span
class=GramE>semptom</span> g�r�l�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan k�sa s�rer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek tarafl�d�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura s�ras�nda veya sonras�ndaki 60 dakika i�inde ba�a�r�s� ba�lar<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>D. S�n�flamada yer alan ba�ka bir
ba�a�r�s� tan�s� ile a��klanamamaktad�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.2. Beyinsap�
Aural� Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>Daha �nce kullan�lm�� terimler: Baziler arter
migreni, baziler migren, baziler tip migren.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam d�zelen a�a��daki beyinsap� semptomlar�ndan en az ikisi g�r�l�r:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1. Dizartri<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>2. Vertigo<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tinnitus<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hipoakuzi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Diplopi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Duysal defisitle ili�kilendirilmeyen ataksi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:0cm;line-height:normal;mso-list:l4 level1 lfo8;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 49.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Uyan�kl�k d�zeyinde azalma (GKS </span><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'>&#8804;</span><span
style='font-size:12.0pt;mso-ansi-language:TR'>13)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>���������� </span>ii.
Motor ve retinal <span class=GramE>semptomlar</span> g�r�lmez<o:p></o:p></span></p>

<p class=ListeParagraf1 style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l17 level1 lfo11;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>A�a��daki �zelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:54.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun s�rede basamaks�
ilerleme g�steren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya
daha fazla <span class=GramE>semptom</span> g�r�l�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan k�sa s�rer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek tarafl�d�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l7 level1 lfo12;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>4.</span></span><![endif]><span style='font-size:12.0pt;
mso-ansi-language:TR'>Aura s�ras�nda veya sonras�ndaki 60 dakika i�inde
ba�a�r�s� ba�lar<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>D. S�n�flamada yer alan ba�ka bir
ba�a�r�s� tan�s� ile a��klanamamaktad�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 31.5pt 36.0pt 40.5pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:12.0pt;mso-ansi-language:TR'>1.2.3. Hemiplejik
Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l10 level1 lfo13;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l10 level1 lfo13;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'>. Tam d�zelen motor g��s�zl�k g�r�l�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:63.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-31.5pt;line-height:normal;mso-list:l9 level1 lfo14;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 36.0pt 45.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>ii.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Tam d�zelen g�rsel, duysal bulgular ve/veya konu�ma/lisan bozuklu�u g�r�l�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>C.
A�a��daki �zelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:67.5pt;margin-bottom:.0001pt;text-indent:-13.5pt;line-height:normal;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><span style='font-size:
12.0pt;mso-ansi-language:TR'>1. 5 dakika ya da daha uzun s�rede basamaks�
ilerleme g�steren en az bir aura semptomu, ve/veya birbirini izleyen 2 veya
daha fazla <span class=GramE>semptom</span> g�r�l�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Her bir aura <span class=GramE>semptomu</span> 5 dakikadan uzun ve 60
dakikadan k�sa s�rer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 49.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>En az bir aura <span class=GramE>semptomu</span> tek tarafl�d�r.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l8 level1 lfo5;tab-stops:-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura s�ras�nda veya sonras�ndaki 60 dakika i�inde ba�a�r�s� ba�lar<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin:0cm;margin-bottom:.0001pt;
mso-add-space:auto;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 40.5pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:1'>����� </span>D.
S�n�flamada yer alan ba�ka bir ba�a�r�s� tan�s� ile a��klanamamaktad�r<s><o:p></o:p></s></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.2.4. Retinal Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l21 level1 lfo15;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>B ve C <span class=GramE>kriterlerine</span> uyan en az 2 atak<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l21 level1 lfo15;
tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span class=GramE><span style='font-size:12.0pt;
mso-ansi-language:TR'>i</span></span><span style='font-size:12.0pt;mso-ansi-language:
TR'><span style='mso-tab-count:1'> </span>. Tam d�zelen mono-ok�ler, pozitif
ve/veya negatif g�rsel belirtiler (sintilasyonlar, skotom veya k�rl�k), atak
s�ras�nda a�a��dakilerden en az biri ile do�rulanm�� olmal�:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l15 level1 lfo16;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Klinik g�rme alan� muayenesi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l15 level1 lfo16;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hastan�n �izerek ifade etti�i mono-ok�ler g�rme alan� bozuklu�u<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 67.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><span style='mso-tab-count:2'>���������� </span>ii.
A�a��daki �zelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>5 dakika ya da daha uzun s�rede basamaks� ilerleme g�r�l�r<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 40.5pt 45.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Semptomlar 5 dakikadan uzun ve 60 dakikadan k�sa s�rer<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:67.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l25 level1 lfo17;tab-stops:
-31.5pt -27.0pt -13.5pt 40.5pt 45.0pt 49.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aura s�ras�nda veya sonras�ndaki 60 dakika i�inde ba�a�r�s� ba�lar<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:31.5pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-13.5pt;line-height:normal;mso-list:l21 level1 lfo15;tab-stops:
-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 40.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>S�n�flamada yer alan ba�ka bir ba�a�r�s� tan�s� ile a��klanamamaktad�r ve
di�er amarozis fugaks nedenleri d��lanm��t�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt 31.5pt 49.5pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;line-height:normal;
tab-stops:18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span
style='font-size:12.0pt;mso-ansi-language:TR'>1.3. Kronik Migren<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:18.0pt 54.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�m: �� aydan daha fazla s�re
boyunca ve ayda 15 veya daha �ok g�n olan; ayda en az 8 g�n migren
�zelliklerini ta��yan ba�a�r�s�.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:18.0pt;margin-bottom:.0001pt;line-height:normal;tab-stops:-31.5pt -27.0pt -13.5pt 18.0pt'><span
style='font-size:12.0pt;mso-ansi-language:TR'>Tan�sal <span class=GramE>kriterler</span>:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>A.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Migren veya gerilim tipi
ba�a�r�s� benzeri, 3 aydan uzun s�re boyunca ayda 15 veya daha �ok g�n olan, B
ve C <span class=GramE>kriterlerine</span> uyan ba�a�r�s�<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>B.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>Auras�z migren <span class=GramE>kriterlerine</span>
uyan en az 5 veya aural� migren kriterlerine uyan en az 2 atak ge�irmi� hastada
geli�mesi<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;line-height:normal;mso-list:l1 level1 lfo18;
tab-stops:18.0pt 31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span style='mso-list:Ignore'>C.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;mso-ansi-language:TR'>3 aydan uzun s�reyle, ayda en az
8 g�n a�a��daki �zelliklerden herhangi birine uymas�:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Auras�z migren <span class=GramE>kriterleri</span><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Aural� migren <span class=GramE>kriterleri</span><o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;line-height:normal;mso-list:l0 level1 lfo19;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;mso-ansi-language:
TR'>Hasta taraf�ndan ba�lang��ta migren oldu�unun d���n�lmesi ve triptan veya
ergot t�revleri ile iyile�mesi<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-indent:-18.0pt;mso-list:l1 level1 lfo18;
tab-stops:31.5pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>D.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>S�n�flamada yer
alan ba�ka bir ba�a�r�s� tan�s� ile a��klanamamaktad�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
54.0pt'><span style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenden
s�z edildi�i zaman �o�unlukla ba�a�r�s� sadece �iddetli a�r� boyutu ile
de�erlendirilmektedir. Oysa a�r�, migrenin sadece bir d�nemi olup,&nbsp;<span
style='mso-bidi-font-style:italic'>migreni serebral disfonksiyona ba�l� olarak
�ekillenen ve farkl� d�nemler i�inde ortaya ��kan bir <span class=GramE>semptomlar</span>
kompleksi olarak ele almak daha uygundur</span>. Migrenin bu d�nemlerini, a�r�
�ncesinde ortaya ��kan ve ki�inin duygu durumunda veya kognitif i�levlerinde
de�i�ikliklerle �ekillenen, kimi zaman da otonom ve sistemik belirtilerinin
e�lik etti�i&nbsp;<span style='mso-bidi-font-weight:bold'>premonit�r <span
class=GramE>semptomlar�</span> i�eren <i style='mso-bidi-font-style:normal'>prodrom
d�nemi</i></span>, varsa <i style='mso-bidi-font-style:normal'>aura d�nemi</i>,
ard�ndan a�r�n�n ba�lamas�, a�r�n�n ya�and��� d�nem ve a�r�n�n sonlanmas� ile
�ekillenen <i style='mso-bidi-font-style:normal'>�a�r�� d�nemi</i> ve son
olarak da&nbsp;<i style='mso-bidi-font-style:normal'><span style='mso-bidi-font-weight:
bold'>postdrom</span>&nbsp;d�nemi</i> olarak s�ralayabiliriz (<b>Tablo 4</b>).
Hastadan iyi bir �yk� al�nd���nda migrenlilerin yakla��k %50-60��nda prodrom
belirtilerinin bir ya da daha fazlas�yla kar��la��ld��� g�r�lecektir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
4. </span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenin
Prodrom D�neminde Rastlanabilen Semptomlar</span><span style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;padding:
  0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>N�ropsikolojik
  <span class=GramE>semptomlar</span></span></b><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;height:84.5pt'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt;height:84.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>A��r�
  duyarl�l�k-tepkisellik, depresif duygu durumu</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�fori,
  nadiren hiperaktive</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Durgunluk/donukluk,
  <span class=GramE>konsantrasyon</span> ve dikkatte azalma, d���ncede
  yava�lama</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Kelime bulma
  g��l���, konu�urken tak�lma</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artm�� ���k,
  ses, koku duyarl�l���</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Esneme, uyuma
  iste�i</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sistemik/otonom
  <span class=GramE>semptomlar</span></span></b><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes;height:70.25pt'>
  <td width=521 valign=top style='width:390.5pt;border:inset 1.0pt;border-top:
  none;padding:0cm 3.5pt 0cm 3.5pt;height:70.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ense sertli�i</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Halsizlik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>A�l�k, tatl� yeme
  iste�i, i�tah art��� veya i�tahs�zl�k</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>A��r� su
  i�me, v�cutta su tutulmas�, s�k idrara ��kma</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Kar�nda
  �i�lik hissi, kab�zl�k veya ishal hali<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:14.2pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>G�z ya�armas�</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Patofizyolojisi <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-weight:bold'>Migren patofizyolojisi</span><span style='font-size:
10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>&nbsp;genellikle santral serotoninerjik ve
adrenerjik a�r� <span class=GramE>mod�le</span> eden sistemleri i�ine alan
n�rovask�ler teoriye g�re a��klanmaya �al���l�r. N�rojenik inflamasyonun migren
a�r�s�ndan sorumlu oldu�u ve trigeminovask�ler sistemin aktive oldu�u
d���n�lmektedir. Eskiden patofizyolojik a��klama olarak vask�ler ba�a�r�s�n�n
damarlar�n dilatasyonu ile ortaya ��kt��� d���n�l�yordu. Wolf�un ilk
�al��malar� a�r�ya duyarl� intrakranyal yap�lar� g�stermi�tir.&nbsp; Bu yap�lar
ven�z sinusler, dural, meningeal ve di�er arter ve venler, Willis polligonu
yapan b�y�k arterlerin proksimal k�s�mlar�, 5<span class=GramE>.,</span> 7., 9.
ve 10. kranyal sinirler ve �st servikal sinirlerin a�r�ya duyarl� lifleri, kafa
taban�ndaki dura-materin damarlara kom�u par�alar�, paranazal sinus mukozalar�,
di�ler, kaslar, deri ve deri alt� dokusudur. Beyin parankiminin a�r�ya duyarl�
olmad���, cerrahlar�n yapt��� ara�t�rmalar sonucunda bildirilmi�tir.
Hipotalamusun oreksin sisteminin migren ve k�me ba�a�r�s�ndaki otonom
belirtilerin geli�mesinde potansiyel rol� �zerinde de durulmaktad�r. Premonitor
d�neme ili�kin PET �al��malar� bu fazda, limbik sistemle merkezi ili�kisi
bilinen posterior ve lateral hipotalamus ile kom�u mezensefalonun ventral
tegmentum b�lgesinde aktivasyon g�stermi�tir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi3.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>�ekil 3.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;Ba�a�r�s�
patofizyolojisinde �nem ta��yan yap�lar �ekilde g�sterilmi�tir. Korteks,
talamus (Tal), hipotalamus (Ht), limbik sistem ve periakuaduktal gri madde
(PAG) ba�ta olmak �zere beyinsap� yap�lar� aras�nda yo�un ba�lant�lar
bulunmaktad�r ve bu yap�lar trigeminoservikal <span class=GramE>kompleks</span>
ile ba�lant�l�d�r.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
olu�umunda kortikal aktivite varl��� bug�n kabul g�ren bir g�r��t�r. Migrene
ba�l� kan ak�m� de�i�iklikleri ve fonksiyonel MRG sinyali <b style='mso-bidi-font-weight:
normal'><i style='mso-bidi-font-style:normal'>kortikal yay�lan depresyon</i></b>
olarak bilinen, Leao taraf�ndan tan�mlanm�� tabloyla benzer zamansal (2�6
mm/dakika h�z�yla yay�lma) ve yerle�imsel �zellikler g�stermektedir. Kortikal
yay�lan depresyon glial ve n�ronal membranlarda a��r� bir depolarizasyon ile
iyonik ak�mlar�n bozulmas�, h�cre d��� potasyumun artmas�, glutamat sal�n�m� ve
bunu izleyen ge�ici art��� izleyen serebral kan ak�m� azalmas� ile
karakterizedir. Kortikal yay�lan depresyonun auran�n alt�nda yatan temel
mekanizma oldu�u kan�tlanm��t�r, ancak hala tam a��kl��a kavu�mam�� sorular
vard�r. Anahtar rol� olan glutamat sal�n�m�n�n h�cre i�ine Ca<sup>2+</sup>
giri�ine neden olmas� voltaj kap�l� Ca<sup>2+</sup> kanallar� ile ili�kili
mutasyonlar�n rol oynad���n� g�sterirken, sinaptik aral�ktan transporter
arac�l� ta��nma i�in ise sodyum�potasyum-ATPaz (Na+�K+-ATPaz) pompas�n�n
devreye girdi�i bilinmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli
olgularda normallerle k�yasland���nda transkranyal magnetik stim�lasyonla
fosfen olu�ma e�i�inin d���k veya de�i�ken olmas� altta yatan bilinmeyen
yatk�nl�k fakt�rlerine i�aret etmektedir. Migren patofizyolojisinde beyinsap�
mekanizmalar�n�n da katk�s� oldu�u kesindir. &nbsp;Bulant�, otonom <span
class=GramE>semptomlar</span> gibi e�lik�iler bu yap�lardaki de�i�ik
sinyallerden kaynaklanmaktad�r. Dorsolateral pons ve mezensefalon, PET
�al��malar�nda aktivite g�r�len yap�lard�r ve periakuaduktal gri madde (PAG) de
�nem ta��maktad�r. </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Trigeminal
yolak ya da trigeminovask�ler sistem burada tutulan ana yap�d�r. Kalsitonin
geni ile ili�kili peptid (CGRP) denen serebral otoreg�lasyonda �nemli rol� olan
n�ropeptidin migren ata�� s�ras�nda artt��� ve bu sistemin aktivasyonunda rol
oynad���n�n g�sterilmesi son y�llardaki �nemli geli�melerdendir ve erenumab,
fremanezumab gibi yeni tedavi stratejilerine y�n vermi�tir. Periferik
trigeminal duysal yap�lardan ikincil n�ronlara nosiseptif duysal iletim, ba�ta
CGRP olmak �zere pituiter adenilat siklaz aktivat�r polipeptid-38 (PACAP-38),
glutamat ve nitrik oksid yoluyla olmaktad�r. Trigeminal nosiseptif n�ronlar�n
d���nda astrositlerin etkisiz elemanlar olmay�p dalgalar yoluyla migren
mekanizmalar�nda katk�s� oldu�u da baz� �al��malarda savunulmu�tur. Trigeminal
duysal n�ronlar� etkileyenin, mekanik bas�n ve iyonik de�i�imlerin (artm�� K,
artm�� osmolarite, azalm�� pH gibi) yan� s�ra substans P, bradikinin, endotelin
ve CGRP gibi peptidler ve glutamat, serotonin, histamin, ATP, adenozin gibi
n�rotransmitterler oldu�una inan�lmaktad�r. CGRP d�zeyi kronik migrenlilerde
ataklar aras�nda da y�ksek olmaya devam etmektedir. Nitrik oksit vask�ler
h�crelerden konstriksiyon s�ras�nda sal�nan ve �nemli rol oynayan maddelerden
biridir. �nen ve ��kan a�r� kontrol sistemleri, beyinsap� kan damarlar�n�
inerve eden ��kan serotoninerjik sistemi (midbrain raphe) i�erir ve talamusa,
hipotalamus ve kortekse do�ru yay�l�r. Bu sistem hem uyku hem de n�roendokrin
kontrol� sa�lar. �nen a�r�y� <span class=GramE>mod�le</span> eden
serotoninerjik sistem, beyinsap�n�n PAG k�sm�ndan ba�lar, medullan�n rafe
magnusuna ula��r ve medulla spinalisin dorsal boynuzunda sonlan�r. PAG�n�n
stim�lasyonu insanda potent analjeziyi ortaya ��kar�r. Noradrenerjik a�r�
kontrol sistemi ponsun lokus seruleusundan kaynaklan�r. �nen n�ronlar medulla
spinaliste sonlan�r. ��kan noradrenerjik sistem, lokus seruleustan ba�lar,
mikrosirk�lasyonu inerve eder ve serebral kortekse yay�l�r. Merkezi sinir
sistemi periferik a�r� resept�rlerinden gelen a�r�y� <span class=GramE>mod�le</span>
eden sistemler yoluyla gelen uyar�lar� kontrol eder. Serotoninerjik sistemde
5-HT (5-hidroksi triptamin) adrenerjik sistemde oldu�u gibi, enkafalin
n�ronlar�yla etkile�ir. Norepinefrini, GABA i�eren intern�ronlar kullan�l�r.
Primer duysal n�ronlardan uyar�lar yaln�zca MSS�ne de�il perifere de gider.
Periferik trigeminal n�ronlar da sensitizasyon <span class=GramE>fenomeni</span>
g�sterirler, aljezik bir uyarana maruz kal�nca ayn� veya farkl� uyaran i�in
cevap e�i�i d��mektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'>�</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>�e�itli
y�ntemlerle yap�lan elektrofizyolojik �al��malar, uyar�lm�� potansiyellerin
kullan�ld��� ara�t�rmalar migrende MSS uyar�labilirli�inin artt���n�
kan�tlamaktad�r. Migrenlilerde kontrollere k�yasla �habituasyon� yan�t�n�n yani
tekrarlanan uyar�lara verilmesi beklenen azalm�� yan�t�n kayboldu�u hatta
yan�tl�l���n artt��� g�r�lmektedir. Bu habituasyon kayb� ataklar aras�nda
saptan�rken hemen atak �ncesinde ve atak s�ras�nda normale d�nmektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Fonksiyonel
g�r�nt�leme �al��malar� da migrenli beynin interiktal d�nemde bile a��r�
yan�tl� oldu�unu g�stermi�tir. Ayr�ca devaml� hale gelmi� sensitizasyon
sonras�, benzer tetiklerle daha d���k e�iklerde a�r� geli�imi yani bir �e�it
a�r� belle�inin olu�mas� da n�ral plastisite olarak yorumlanmaktad�r.
Fonksiyonel MRG �al��malar�nda a�r� s�kl��� artt�k�a a�r�y� kolayla�t�ran
matrikste dinlenim durumu a��nda artm�� konnektivite saptanmaktad�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bug�n
i�in ara�t�r�lan �nemli bir soru genetik olarak belirlenen iyonik
dengesizliklerle ili�kili aura faz� sonras�nda hangi mekanizmalar�n
trigeminovask�ler sistemi aktive etti�idir. Son y�llarda kortikal yay�lan
depresyonun inflamatuar bir yola�� aktive ederek ve pannexin-1 megakanallar�n�
a�arak meningeal nosisept�rleri uyard��� g�sterilmi�tir. Pannexin-1 aktivasyonu
(high mobility group B1 (HMGB1)) yoluyla parenkimal inflamasyonu uyarmaktad�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bir
di�er �nemli soru da, kan beyin bariyeri bozulmad��� halde perfierik
mekanizmalar�n nas�l etkili oldu�udur. Bununla birlikte anti-CGRP monoklonal
antikorlar�n etkisi periferik mekanizmalar� desteklemektedir; fremanezumab ve
di�er antikorlar A&#948; liflerini dolay�s�yla santral y�ksek e�ikli n�ronlar�
etkilemektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Geneti�i</span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Son
y�llarda ba�a�r�s�, �zellikle de migren geneti�i konusunda �nemli geli�meler olmu�tur.
Bug�n i�in migren, genetik fakt�rlerin �evresel fakt�rlerle etkile�im
g�sterdi�i <span class=GramE>kompleks</span> �ok genli (poligenik) bir hastal�k
olarak kabul edilmektedir. Aural� migrende genetik fakt�rlerin auras�z migrene
g�re daha fazla rol� oldu�u konusunda �e�itli bulgular vard�r. Sorumlu lokuslar
ve yatk�nl�k genlerinin tam olarak hangileri oldu�u ve say�s� hen�z
bilinmemektedir. Migrenin ailesel �zellik g�sterdi�i uzun zamand�r bilinmekte
ve deneyimli klinisyenler taraf�ndan tan�ya yard�m amac�yla bile kullan�lmaktayd�.
Buna kar��n yo�un ara�t�rmalara ra�men �u an i�in sadece migrenlilerin �ok
k���k bir oran�n� olu�turan ve karakteristik bir klinik tablo olan <i
style='mso-bidi-font-style:normal'>ailesel&nbsp;<span style='mso-bidi-font-style:
italic'>hemiplejik migren</span>in (familyal hemiplejik migren (FHM))</i>
genleri bulunabilmi�, ancak �ok daha s�k g�r�len auras�z migren formlar�n�n
genlerine hen�z ula��lamam��t�r. Otozomal dominant tipte genetik ge�i� g�steren
tek genli (monogenik) bu aural� migren formunun kalsiyum kanal� (<i
style='mso-bidi-font-style:normal'>CACNA1A</i>), Na-K-ATPaz pompas� (<i
style='mso-bidi-font-style:normal'>ATP1A2</i>) ve sodyum kanal� (<i
style='mso-bidi-font-style:normal'>SCN1A</i>) ile ili�kili baz� genlerdeki
mutasyonlardan kaynaklad��� kesin olarak kan�tlanm��t�r. Bu veriler de migrenin
bir kanalopati, yani iyon kanal hastal��� oldu�u g�r���n� desteklemektedir. Bu
mutasyonlar� ta��yan baz� aile bireylerinde auras�z migren ya da tamamen normal
fenotip bulunabilmesi olay�n di�er ilgin� bir boyutudur. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Notch3</span></i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> mutasyonu saptanan
serebral otozomal dominant arteryopati, subkortikal infarktlar ve
l�koensefalopati ile giden CADASIL gibi baz� nadir genetik tablolarda da migren
�ok s�k rastlanan ve bazen ilk dikkati �eken yak�nmad�r.</span><span
style='font-size:6.5pt;font-family:"Arial","sans-serif";color:#222222;
background:white'> </span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>�te
yandan bu genlerin s�k rastlanan di�er migren fenotipleri i�in birka� olgu
d���nda anlaml� bir <span class=GramE>yatk�nl�k<span style='mso-spacerun:yes'>�
</span>olu�turmad�klar�</span> g�r�lm��t�r. Yap�lan ba�lant� analizi
�al��malar�nda �ok farkl� kromozomlar �zerinde birbirinden ba��ms�z ba�lant�
b�lgeleri g�sterilmi�tir. Saptanan 44 ba��ms�z tek n�kleotid polimorfizminin
migrenle ili�kili oldu�u g�sterilmi�tir ve bunlar 38 farkl� genomik lokusde yer
almaktad�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'>� </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Baz�
�al��malarda elde edilen sonu�lar izleyen di�er �al��malar taraf�ndan,
metodolojik nedenlerle ve daha da �nemlisi etnik farkl�l�klar nedeniyle
do�rulanamam��t�r. Aday olarak kabul edilebilen genlerde �ok say�da yap�lm��
olan polimorfizmlerle ili�kilendirme �al��malar� mevcuttur, ancak bunlar�n da
�nemi net de�ildir. Son genetik veriler, CSNK1D, MEF2D, TGFBR2, PHACTR1, ASTN1,
TRPM8, LRP1 gibi bir�ok farkl� genle ili�kinin bulundu�u y�n�ndedir. Bu
genlerin �o�u glutamaterjik iletimde g�revlidir ve migrende saptanm�� olan
artm�� kortikal eksitabiliteyle ba�lant�l� olabilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
geneti�i ara�t�rmalar�n�n gelecekte s�k rastlanan ve a��r formlar�n genlerini
ayd�nlatmas�, <span class=GramE>spesifik</span> tan� ve tedavi beklentisi
a��s�ndan �nem ta��maktad�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Baz� �zel Migren Tipleri <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kronik Migren<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararas�
Ba�a�r�s� Derne�i ba�a�r�s� s�n�flama komitesinin 2018 y�l�nda yay�nlad��� tan�
kriterlerine g�re kronik migren; auras�z ve aural� migrenden sonra <span
class=GramE>1.3</span> kodlamas�yla ���nc� migren tipi olarak s�n�flamada
yerini alm��t�r. Hastan�n en az 3 ay s�reyle, ayda 15 veya daha fazla g�n
ba�a�r�s� ya�amas� ve bu ba�a�r�lar�ndan en az 8 g�n�n�n migren �zellikleri
ta��mas� kronik migren olarak tan�mlanmaktad�r (Tablo 3). Aural� ya da auras�z
ataklar olabilir ve ba�a�r�s�na ba�l� k�s�tl�l��� en yo�un ya�ayan
gruplardand�r. Ba�a�r�s� migren veya gerilim tipi �zelliklerini g�sterebilir.
Genellikle yo�un olarak a�r� kesici kullan�m� s�z konusudur. Hemen herg�n
ba�a�r�s�ndan yak�nan bu hastalar�n klinik tablolar�n� anlayabilmek ve ay�r�c�
tan� yapabilmek i�in ba�a�r�s� g�nl��� mutlaka gereklidir. Ay�r�c� tan�da
sekonder ba�a�r�lar�n�n yan� s�ra kronik gerilim tipi ba�a�r�s�, yeni
ba�lang��l� g�nl�k �srarc� ba�a�r�s� ve �AKB de dikkatle sorgulanmal�d�r.
Kronik migrenli hastalar�n bir k�sm�nda hem kronik migren hem de �AKB birlikte
olabilir. Ama ila� a��r� al�m� engellendi�inde epizodik migren ataklar� geri
d�n�yorsa esas tan�n�n �AKB oldu�u d���n�lmelidir. Oysa ila�lar�n
d�zenlenmesine ra�men kronik s�re� devam ediyorsa altta yatan nedenin kronik
migren oldu�u anla��l�r. Kronik migren tan�l� hastalar genellikle analjezik
tedavilere diren�lidirler. Kronik migren grubunda botulinum toksin uygulama
endikasyonu olan olgular yer al�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Vestib�ler Migren (Migren�z
Vertigo)<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Son
s�n�flamada apendiks b�l�m�nde yer alan ve hen�z bir migren alt tipi olarak
yay�nlanmayan bu tan� g�n ge�tik�e klinisyenlerin dikkatini �ekmeye devam
etmektedir. Migren tan�l� hastalar�n yakla��k %10�unda vestib�ler migren tan�s�
i�in yeterli bulgular oldu�u bildirilmektedir. Ba� d�nmesinin �zelliklerini
g�zden ge�irdi�imizde ger�ek vertigo olabilece�i gibi, �dizzines� �eklinde
nonspesifik ya da sadece pozisyonel olarak ortaya ��kabilmektedir. Vertigo
s�resi ise olduk�a de�i�kendir, dakikalar ya da g�nler boyunca s�rebilir.
Migren ile ili�kili <span class=GramE>semptomlar�n</span> vertigo ile ili�kisi
de de�i�kendir. Bu <span class=GramE>semptomlar</span> vertigodan �nce, sonra
ya da e� zamanl� olarak ortaya ��kabilir. Migren tan�l� bir olguda vestib�ler
migren tan�s� i�in vertigo ataklar�na ba�a�r�s�n�n e�lik etmesi zorunlu
de�ildir. Ge�ici i�itsel <span class=GramE>semptomlar</span>, bulant�, kusma ve
ara� tutmas� s�kl�kla vestib�ler semptomlara e�lik eder.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><span
style='mso-spacerun:yes'>�</span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bu
klinik tablonun tan�s�n�n anla��lmas� kadar olas� e�lik edebilecek santral ve
periferik vestib�ler sistem hastal�klar�n�n d��lanmas� da �nemlidir. Vestib�ler
migren tan�s� ile hastaya tedavi se�eneklerini sunmadan �nce ayr�nt�l� olarak
kulak burun bo�az muayenesi ve i�itme testlerinin yap�lm�� olmas� gereklidir
(Bak�n�z: <b style='mso-bidi-font-weight:normal'>vertigo</b>).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;background:yellow;
mso-highlight:yellow;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Menstr�el Migren<o:p></o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Kesin
tan�mlamalar de�i�mekle birlikte menstr�el migren tan�m� perimenstr�el d�nemde
olu�an migren ataklar�n� tan�mlamaktad�r. Klinik g�zlemler, migren
ba�a�r�lar�n�n menstr�el d�nem �ncesinde daha s�k ve daha �iddetli oldu�unu
ortaya ��karm��t�r. Bu ba�a�r�lar� di�er migren ba�a�r�lar�n�n cevap verdi�i
tedavilere diren�li kalabilir, uzayabilir ve �ok daha �iddetli olabilir.
Menstr�asyon&nbsp; s�ras�nda migren ataklar� s�k g�r�lmesine kar��n, e�er
ataklar�n %90�� menstr�asyon s�ras�nda oluyorsa bu menstr�el migren ad�n� al�r.
Ba�a�r�s�n�n menstr�el migren olarak tan�mlanabilmesi i�in ataklar�n %90��n�n
adetten �nceki 2 g�n ve <span class=GramE>adetin</span> son g�n� aras�nda
olmas� gerekmektedir. Migren riski <span class=GramE>adetin</span> ilk 3 g�n�
daha fazlad�r. Bu tablonun alt�nda �strojene ili�kin d�ng�lerin yatt���
d���n�lmekle birlikte net olarak kan�tlanm�� bir mekanizma yoktur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migren ve Komorbiditeler <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Depresyon:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren prodromu, atak
d�nemi ve ikisi aras�ndaki d�nemlerde psikiyatrik <span class=GramE>semptomlar�n</span>
s�k g�r�ld��� bildirilmi�tir. Liveing 1873 y�l�nda depresyon ve yorgunlu�u
migrenin tipik �zellikleri olarak tan�mlam��t�r. Wolf migrenli hastalarda,
karakteristik �zellik olarak, a��r� fiziksel yorgunluk ve apatinin bulundu�unu
kaydetmi�tir.&nbsp;Migren ile depresyon aras�ndaki ili�ki g�zden ge�irildi�inde
dikkate de�er bir benzerlik oldu�u g�r�lmektedir. Her iki bozukluk da kad�n ve
gen� eri�kinlerde daha s�kt�r, �rk ve sosyal s�n�f a��s�ndan benzer bir da��l�m
g�sterir. Farkl� incelemelerde, her iki bozukluk i�in de benzer prevalans
g�r�lmektedir. Bu bulgular�n ve yap�lan az say�daki �al��malar�n �����nda
migren ve depresyon etyolojik olarak ili�kili bulunmu�tur. Bu nedenle ya ortak
bilinmeyen patolojik mekanizmalar� payla�maktad�rlar ya da bozukluklardan
birisinin di�erine yol a�mas� veya onun geli�mesine neden olmas� �eklinde bir
sebep-sonu� ili�kisi s�z konusudur. Migren hastalar�nda depresyonu tan�mak ve
tedavi etmek �nemlidir. ��nk� depresyon, migrenin kronikle�mesi olas�l��� i�in
�nemli bir g�stergedir ve bu hastalarda migren ila�lar�na diren�, ila� a��r�
kullan�m� geli�mesi ve artm�� �z�rl�l�k ile ilintilidir. Ayr�ca migrenlilerde
bipolar bozukluk, anksiyete ve posttravmatik stres bozuklu�u da daha s�k
bildirilmektedir. Psikiyatrik bozukluklar�n e�lik etti�i migren olgular�nda
tedavi ba�ar�s�n�n da daha k�t� oldu�u g�zlenmi�tir. Bunun d���nda da kronik
a�r�, ba�a�r�s� ve depresyon aras�ndaki ili�ki, psikiyatrik ve psikososyal
a��dan&nbsp;ayr�ca g�zden ge�irilmesi gereken bir konudur.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>�nflamatuar Barsak
Hastal�klar�:</span></i><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>
Temel olarak gastrointestinal sistemi etkileyerek kar�n a�r�s�na yol a�abilen
kronik sistemik inflamatuar bir hastal�k grubudur. Toplum geneliyle
kar��la�t�r�ld���nda migren s�kl���n�n bu hastalarda daha fazla oldu�u
g�r�lm��t�r ve prevalans�n iki kat art�� g�sterebildi�ini bildiren �al��malar
vard�r. Bu iki hastal�k grubunun birlikteli�i, inflamatuar barsak hastal���nda
olu�an inflamasyonun migren a�r�lar�n� kolayla�t�r�c� etkisi oldu�u g�r��� ile
a��klanmaktad�r. Hastal�k alevlenmesi riski nedeniyle bu hastalardaki akut
migren ata�� tedavisinde nonsteroidal anti-inflamatuar (NSA�) analjezikler
kullan�lmamal�, birinci basamak tedavide triptanlar tercih edilmelidir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Fibromiyalji:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren hastalar�n�n
yakla��k ��te birine fibromiyalji de e�lik etmekte olup, bu iki a�r�l� durumun
birlikteli�i baz� patofizyolojik s�re�lerin ortak oldu�u g�r���n�
desteklemektedir. �stelik bu iki hastal���n birlikte oldu�u bireylerde di�er
medikal ve psikiyatrik komorbiditelerin de �ok daha fazla g�r�ld���
bildirilmi�tir. Klinik pratikte migren ve fibromiyalji birlikteli�i ak�lda tutularak,
tedavi planlamas�nda buna uygun yakla��lmal�d�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Epilepsi:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren ve epilepsi de baz�
ortak patofizyolojik mekanizmalar� payla�an hastal�klard�r ve genetik
�al��malarla aralar�ndaki ba�lant� g�sterilmi�tir. Her ikisi de beyin
fonksiyonlar�nda ge�ici de�i�imlere yol a�arlar ve zamansal a��dan birliktelik
g�sterebilirler. �zellikle �ocukluk �a��nda g�r�len abdominal migren ile
abdominal epilepsi aras�nda bir ili�kinin bulundu�u belirtilerek ay�r�c� tan�da
bu olas�l���n akla gelmesi �nerilmektedir.<span style='mso-spacerun:yes'>�
</span>Bunun yan� s�ra oksipital paroksizmli selim �ocukluk �a��
epilepsilerinde de ba�a�r�s� g�r�lebilmekte ve g�rsel aura ile birlikte iktal
EEG de�i�iklikleri kaydedilmektedir (Bkz: <i style='mso-bidi-font-style:normal'>Epilepsi</i>).
�nceden aural� migren tan�s� alm�� hastalarda, ba�a�r�s� s�ras�nda EEG�de
epileptiform bulgular�n g�r�lmesi durumunda ise <i style='mso-bidi-font-style:
normal'>migren auras�yla tetiklenen n�bet</i> d���n�lmelidir. Migren tipi
ba�a�r�s�, epileptik bir belirti olarak ortaya ��kar ve EEG�de epileptik bir
n�bet paterni ile birliktelik g�sterirse <u>iktal epileptik ba�a�r�s�</u>
olarak tan� almaktad�r. <i style='mso-bidi-font-style:normal'>Postiktal
ba�a�r�s� </i>ise epilepsi hastalar�nda en s�k g�r�len peri-iktal ba�a�r�s�d�r.
Burada a�r� epileptik n�betten sonra en ge� 3 saat i�inde ba�lamakta ve n�bet
bittikten sonraki 72 saat i�inde iyile�mektedir. Epilepsi ile birliktelik
durumunda migren ba�a�r�s�nda profilaksi endikasyonu da varsa, teratojeniteleri
ba�ta olmak �zere yan etki <span class=GramE>profilleri</span> g�z �n�ne
al�narak, benzer �ekilde valproat ve topiramat se�enekleri kullan�labilir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>�nme:</span></i><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'> Migren hastalar� aras�nda
�zellikle aural� migreni olanlarda vask�ler olaylar daha s�k g�r�lmektedir.
Migren, �zellikle inme ve miyokard infarkt�s� gibi vask�ler patolojiler i�in
bir risk fakt�r� olarak kabul edilmekte, altta yatan olas� mekanizmalar
aras�nda endotelyal i�lev bozuklu�u, hiperkoag�labilite, vazospazm, yay�lan
kortikal depresyon, genetik �zellikler veya immobilizasyon gibi fakt�rler
s�ralanmaktad�r. Aural� migrende, �zellikle kad�n hastalarda, ak madde
lezyonlar� daha s�k g�r�lmekte olup sessiz infarkt geli�imi riski de y�ksek
bulunmu�tur. Bunun yan� s�ra, bu hastalarda geli�ebilen bir di�er patolojik
durum olan <i style='mso-bidi-font-style:normal'>migren�z infarkt</i>, aural�
migren ata��n�n bir <span class=GramE>komplikasyonu</span> olarak kabul
edilmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Uluslararas�
Ba�a�r�s� Derne�i�nin (IHS) 2018 S�n�flamas�nda tipik bir aural� migren ata��
s�ras�nda ba�layan, n�rog�r�nt�leme ile uygun vask�ler alanda g�sterilen
iskemik beyin lezyonuyla ili�kili bulunan bir veya daha fazla migren auras�n�n
varl��� migren�z infarkt olarak tan�mlanmaktad�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tan�
<span class=GramE>kriterleri</span> a�a��daki gibidir: <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>B
ve C <span class=GramE>kriterlerine</span> uyan migren ata��<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Bir
veya daha fazla aura <span class=GramE>semptomunun</span> 60 dakikadan uzun
s�rmesi d���nda �nceki ataklar� tipik olan aural� migreni olan bir hastada
geli�mi�tir<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>N�rog�r�nt�leme
incelemeleri ilgili alanda iskemik infarkt g�stermektedir<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>S�n�flamada
yer alan ba�ka bir ba�a�r�s� tan�s� ile a��klanamamaktad�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
Tedavisi </span></b><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
nedeniyle hastalar�n hayat kalitesi belirgin derecede d��er, ataklar�n tedavi
edilmesi �o�unlukla gereklidir.<span style='mso-spacerun:yes'>� </span>Ayr�ca tablonun
s�kl��� ile birlikte d���n�ld���nde migren ata�� s�ras�nda hastan�n i�ini
yapamaz duruma gelmesi toplumsal anlamda da kay�plara yol a�maktad�r. Migren
tan�s� koyulduktan sonra hastaya migrenin hayat� tehdit eden bir beyin
hastal��� olmad��� ve tedavisinin belli bir d�zene g�re ve hekimle i�birli�i
i�inde yap�lmas� gerekti�i a��klanmal�d�r. Son y�llarda yap�lan epidemiyolojik
�al��malar �zellikle aural� migrenin 45 ya� alt� kad�nlarda artm�� bir iskemi
riski (3,8-6,2 kat) yaratt���n� g�stermi�tir. Bu durum sigara ve di�er risk
fakt�rleri bulundu�unda artmaktad�r ve bu nedenle hastalar
bilgilendirilmelidir. Migrenli olgularda sessiz infarktlar�n ve sessiz ak
akmadde lezyonlar�n�n da artm�� oldu�u g�sterilmi�tir (<b>�ekil 4</b>).</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.25pt;margin-bottom:.0001pt;line-height:normal'><b><u><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi4.jpg"><span
style='mso-bidi-font-size:11.0pt;color:purple'>�ekil 4.</span></a></span></u></b><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Migrenli olgularda
normallere g�re daha s�k rastland��� bildirilmi� olan ve tam olarak �nemi
bilinmeyen beyaz madde lezyonlar� bazen ciddi boyutlara ula�abilmektedir.
Aural� migreni olan bu olguda hatal� olarak multipl skleroz tan�s� ile
ara�t�rmalar yap�lm��t�.</span><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:blue;mso-ansi-language:TR'>&nbsp;&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Karanl�k
ve sakin bir odada, buz paketi koyarak dinlenmek a�r�n�n giderilmesini
kolayla�t�r�r. E�er uyunabilirse genellikle hasta a�r�dan kurtulmu� olarak
uyan�r. Hastal��� tetikleyen fakt�rlerden ka��nma, ���n atlamama, uyku
saatlerinin d�zenli olmas�n�n sa�lamas� gibi baz� basit tedbirlerle a�r�n�n
s�kl��� azalt�labilir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrenin
�la�la Tedavisi </span></i></b><span style='font-size:13.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migrende
ila� tedavisi ataklardan korunmaya y�nelik �<i>profilaktik</i>� veya �nleyici/koruyucu
tedavi ve ata��n a�r�, bulant�, kusma gibi yak�nmalar�n�n giderilmesine y�nelik
�<i>atak (akut/a�r�) tedavisi</i>� olarak iki �ekilde yap�l�r. Profilaktik
tedavi belirli bir s�re boyunca d�zenli ila� kullanarak a�r� s�kl���n� ve
�iddetini azalt�lmaya y�neliktir. Migren tedavisi herkese ayn� �ablonun
uygulanmad���, her hastaya �zel olarak karar verilmesi gereken bir tedavi
�eklidir.</span><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
Tedavisi&nbsp;</span></i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>(<b>Tablo
5a ve b</b>) </span><span lang=IT style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:IT'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde hafif ve orta �iddetli ataklarda aspirin, asetaminofen, naproksen,
etodolak veya ibuprofen gibi a��z yolu ile al�nan basit ve NSA� analjezikler
veya kafein ile kombine edilmi� analjezikler etkilidir. Ancak kombine
ila�lardan ka��nmak tercih edilmelidir. S�k atakl� olgularda (ayda be�den
fazla) analjezik kullan�m s�n�rlar� belirlenmeli ve hasta �AKB konusunda
uyar�lmal�d�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
i�in �zel olan atak tedavisinde <i style='mso-bidi-font-style:normal'>ergot
preparatlar�</i> ve <i style='mso-bidi-font-style:normal'>triptan grubu</i>
(sumatriptan, eletriptan, rizatriptan, frovatriptan gibi) gibi tedaviler �nemli
bir yer tutmaktad�r. Ergo t�revi ila�lar�n uzun s�reli kullan�mda daha da
belirginle�en genel damar daralt�c� riskleri, �ok daha ucuz olmalar�na kar��n,
bu tip yan etkileri ta��mayan se�ici serotoninerjik ila�lar olan triptanlar�n
g�n�m�zde migren <span class=GramE>spesifik</span> ila�lar olarak ergo
t�revlerine tercih edilmelerine neden olmu�tur. Triptanlar 5HT1B ve1D resept�r
agonistidir. �iddetli bir atak i�in NSA� ila� kullanmadan do�rudan triptanlar
tercih edilebilir. Bulant�s� �ok belirgin oldu�u i�in oral alamayan hastalarda
kas i�i ve damardan <span class=GramE>enjeksiyonlar</span> d���nda hastan�n
kendine uygulayabilece�i deri alt� injeksiyon �eklinde ve nazal sprey �eklinde
de triptan grubu ila�lar �retilmi�tir. Bu ila�lar hastan�n her atakta doktor
ba�vurusu yapmaktan kurtulmas� a��s�ndan �ok �nem ta��maktad�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde opiodlerin ve kortikosteroidlerin yeri yoktur. <i style='mso-bidi-font-style:
normal'>Anti-emetikler</i> ise yararl� kabul edilmektedir, NSA�den 20 dakika
�nce al�nmalar� hem bulant�y� giderir, hem de mideden emilimi artt�r�r, ayr�ca
hafif a�r� giderici etkileri de oldu�u ileri s�r�lmektedir. Metoklopramid (10-20
mg oral veya �V, �M) ve domperidon (20-30 mg) kullan�labilir; QT uzamas�,
distoni ve diskinezi riski a��s�ndan dikkatli olunmal�d�r.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Atak
tedavisinde ila�lar�n ba�a�r�s� ba�lang�c�nda m�mk�n oldu�unca erken al�nmas�
�nerilmektedir. Migren tedavisinin hastan�n ya�am kalitesini y�kseltmeye
y�nelik oldu�u unutulmamal� ve tedavi her hastan�n durumuna ve �zel
gereksinimlerine g�re y�nlendirilmelidir. �rne�in uyuyarak ata��n� ge�irebilen
ve ila� almay� sevmeyen ya da yan etki g�ren bir hastaya di�erlerine iyi gelen
bir analjezi�i almas� i�in �srar etmek uygun de�ildir.</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
5A.&nbsp;</span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
atak tedavisinde g�n�m�zde s�k kullan�lan baz� �zg�l olmayan ila�lar</span><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�la�</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�nerilen Doz</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Etkinlik
  D�zeyi</span></b><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Olas� veya
  S�k Yan Etki</span></b><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Tercih
  edilece�i Komorbid Durum</span></b><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Olumsuz
  Komorbid Durum veya Kontrendikasyon</span></b><span lang=DE style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Asetil
  salisilik asit</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1000 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri, kanama e�ilimi</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Koroner arter
  hastal���, ge�ici iskemik atak</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>B�brek
  hastal���, karaci�er hastal���, peptik �lser, gastrit, kanamal� durumlar</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Parasetamol (<u>+</u>Kafein)</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>500-1000 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>?+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Nadir
  (karaci�er, kan ve deri)</span><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gebelik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Karaci�er
  hastal���</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Naproksen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>550-1100 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artrit ve di�er
  a�r�l� durumlar</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�lser,
  gastrit</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Metamizol
  oral ve �.V.</span><span lang=IT style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:IT'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1000mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Hipotansiyon
  Agran�lositoz,</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Porfiri, kan
  diskrazileri, glikoz 6P dehidrogenaz eksikli�i</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Diklofenak </span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50-100 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Artrit ve
  di�er a�r�l� durumlar</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�lser,
  gastrit, �rtiker, kolit, karaci�er ve b�brek yetmezli�i</span><span lang=DE
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Flurbiprofen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>100-300 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Romatizmal
  hastal�klar, dismenore</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Renal ve
  hepatik fonksiyon bozuklu�u, s�v� retansiyonu, �dem</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=89 valign=top style='width:67.05pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�buprofen</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.6pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>200-8000</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=61 valign=top style='width:45.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.3pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Gastrointestinal
  sistem yan etkileri</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=124 valign=top style='width:93.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Romatizmal
  hastal�klar, dismenore</span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=150 valign=top style='width:112.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Renal ve
  hepatik fonksiyon bozuklu�u, s�v� retansiyonu, �dem</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
35.4pt;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><br
clear=all style='mso-special-character:line-break'>
</span></b><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Tablo
5B.&nbsp;</span></b><span style='font-size:12.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Migren
atak tedavisinde g�n�m�zde s�k kullan�lan baz� �zg�l ila�lar</span><span
lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>�la�</span></b><b style='mso-bidi-font-weight:normal'><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>�nerilen Doz</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Etkinlik D�zeyi</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=108 valign=top style='width:80.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Olas� veya S�k Yan Etki</span></b><b style='mso-bidi-font-weight:
  normal'><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=104 valign=top style='width:77.95pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Tercih edilece�i Komorbid Durum</span></b><b
  style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></b></p>
  </td>
  <td width=130 valign=top style='width:97.75pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;
  font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:TR'>Olumsuz Komorbid Durum veya Kontrendikasyon</span></b><b
  style='mso-bidi-font-weight:normal'><span lang=DE style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
  mso-ansi-language:DE'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Eletriptan
  (Oral)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>40 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=108 rowspan=6 valign=top style='width:80.9pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Ate� basmas�,
  k�rg�nl�k,&nbsp; halsizlik, asteni, sersemlik hali, ba� d�nmesi, bulant�,
  g���ste bas�n�, s�k�nt� hissi ve a�r�</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=104 rowspan=6 valign=top style='width:77.95pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Yok</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=130 rowspan=6 valign=top style='width:97.75pt;border-top:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Baziler tip
  migren, hemiplejik migren, periferik arter hastal���, Prinzmetal anjinas�,
  kontrol edilemeyen hipertansiyon</span><span lang=EN-US style='font-size:
  12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Naratriptan
  (Oral)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Oral)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Subk�tan)<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Sumatriptan
  (Nazal)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>50-100mg<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>6 mg<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>20mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Zolmitriptan
  (Oral, nazal)</span><span lang=EN-US style='font-size:12.0pt;font-family:
  "Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Rizatriptan</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>10 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td width=154 valign=top style='width:115.3pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Frovatriptan*</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=78 valign=top style='width:58.25pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2,5 mg</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=65 valign=top style='width:48.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>++</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>*Frovatriptan
daha uzun etkilidir ve perimenstr�el migrende koruyucu tedavide
kullan�labilmektedir.</span><span lang=DE style='font-size:13.5pt;font-family:
"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=DE style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>�zellikle hemiplejik migren, baziler migren ve
uzam�� aural� migren hastalar�nda vazokonstrikt�r ila�lar kullan�lmamal� veya
s�n�rl� tutulmal�d�r.</span><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;<span
style='mso-bidi-font-style:italic'> Aural� migren olarak adland�r�lan
ataklarda, a�r� ba�lamadan �nce aura d�neminde verilen triptan grubu ila�lar�n
etkisiz kalaca��n� bilmek �nemlidir</span>. Bir di�er �nemli bilgi de
migrenlilerde allodini durumu geli�ti�inde art�k triptana cevab�n
kaybolmas�d�r.&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><i><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span></i><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><i><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Profilaktik
Tedavi</span></i><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Atak tedavisine yeterli cevap vermeyen ve/veya atak tedavilerinin yan
etkilerinin tolere edilemez d�zeyde oldu�u, ayda 5�den fazla say�da migren
ata�� ge�iren hastalarda profilaktik tedavi indikedir. Ayr�ca 48 saatten uzun
s�ren migren ataklar�, hasta taraf�ndan subjektif olarak dayan�lmaz �iddette
bulunan migren a�r�lar� ve <span class=GramE>komplike</span> migren ataklar�
(hemiplejik migren, baziler migren, uzam�� aural� migren, migrenle ili�kili
infarkt gibi nadir durumlar) y�ksek oranda profilaksi gerektirir. Migrene ba�l�
kay�plar�n (i�g�c�, sosyal ya�am) yani k�s�tl�l���n d�zeltilmesi ve ya�am
kalitesinin y�kseltilmesi de tek ba��na profilaksi indikasyonu kabul
edilmelidir.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>&nbsp;</span></i><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Koruyucu tedavide kullan�lan ila�lar migren atak s�kl���n� ve �iddetini
azalt�rlar ve migren s�kl���n�n y�zde ellinin �st�nde azalmas� tedavinin
etkinli�ini g�sterir. Profilaktik ila�lar d���k dozlarda ba�lanarak yava� yava�
artt�r�l�r ve etkinli�i de�erlendirebilmek i�in iki �� ay beklemek ve etkin
dozda en az 6 ay tedaviye devam etmek gerekir. Profilakside kullan�lan ila�lar
�e�itli gruplardand�r, �rne�in <i style='mso-bidi-font-style:normal'>hipertansiyon
kontrol� ama�l� ila�lar </i>(<i style='mso-bidi-font-style:normal'>beta-blokerler:</i></span><i><span
style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span></i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>propranolol, metoprolol, n�bivolol veya verapamil gibi), <i
style='mso-bidi-font-style:normal'>epilepsi ila�lar�</i> (valproik asid,
topiramat, gabapentin, pregabalin gibi) <i style='mso-bidi-font-style:normal'>depresyon
ila�lar�</i> (amitriptilin, venlafaksin, duloksetin gibi) ve flunarizin
say�labilir. Profilaksi alt�ndaki bir hastan�n kulland��� ilac�n olas� yan
etkileri konusunda �nceden bilgi sahibi olmas� ve hekim kontrol�nde kalmas�
�nemlidir. Bu ila�lar�n b�y�k k�sm� migren indikasyonu olmayan ila�lar
oldu�undan hastaya yan etkileri konusunda ayr�nt�l� bilgi verilmeli ve
bilgilendirilmi� olur imzalat�lmal�d�r. �la� se�erken hastan�n durumuna ve
di�er hastal�klar�na g�re olumlu (</span><span style='font-size:13.5pt;
line-height:115%;font-family:Wingdings;color:black;mso-ansi-language:TR'>J</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>) veya olumsuz durumlar (</span><span
style='font-size:13.5pt;line-height:115%;font-family:Wingdings;color:black;
mso-ansi-language:TR'>L</span><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>) dikkatle
ele al�nmal�d�r (<b>Tablo 6</b>). �n�m�zdeki y�llarda <i style='mso-bidi-font-style:
normal'>CGRP ile ili�kili monoklonal antikorlar�n</i> profilakside kullan�m�
devreye girecektir. <i style='mso-bidi-font-style:normal'>Botulinum toksin</i>
tedavisi de profilaktik ama�l� olup sadece kronik migrende indikedir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Kontroll� �al��malar�n
g�venli ve etkin olduklar�n� g�stermesine ra�men, aural� migrende
beta-blokerlerin kullan�m� tart��mal�d�r. Ca kanal blokerleri, valproat,
topiramat, gabapentin ve lamotrijin aural� migrenlilerde di�er se�enekler
aras�nda say�labilir.&nbsp;</span><span style='font-size:13.5pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US;font-weight:
normal'>Migren profilaksisinde ila� g�nde 1 veya en fazla 2 dozda al�nmal�d�r
ve bir ba�a�r�s� g�nl���n�n kullan�m� sa�lanmal�d�r. Hasta bir sorunla
kar��la�t���nda doktora ula�abilmeli ve 3 ayda bir kontrolleri
yap�lmal�d�r.&nbsp; Profilaksiye yan�ts�z olguda g�nl��� dikkatle ele al�nmal�,
hastan�n beklenti d�zeyi ve atak tedavisi, dozu, ilac� gerekti�i gibi kullan�p
kullanmad���, yan etkiler g�zden ge�irilmelidir.<o:p></o:p></span></h2>

<p class=MsoNormal><span style='mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Hastan�n iyi uyku d�zeni, beslenme ve spor gibi, ya�am <span class=GramE>hijyenine</span>
dikkat etmesi, tetikleyicilerden uzak durmas� ���tlenmelidir.
Profilaksinin&nbsp;endike oldu�u olgularda en s�k yap�lan hatalar aras�nda
tedavide gecikme, d���k doz ve k�sa s�re kullan�m ve ila� se�erken
komorbiditeye dikkat edilmemesi say�labilir.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;<b>Tablo&nbsp; 6.</b>&nbsp;Migren
profilaksisinde ila� se�iminde kormorbitenin rol�</span><span lang=DE
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:DE'><o:p></o:p></span></p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Komorbid durum</span></b><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><b><span style='font-size:10.0pt;line-height:115%;
  font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Etki</span></b><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Profilaksi se�imi</span></b><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + hipertansiyon</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker, kalsiyum kanal blokeri</span><span
  lang=DA style='font-size:12.0pt;line-height:115%;mso-ansi-language:DA'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + anjina</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Kalsiyum kanal blokeri</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + stres</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + depresyon</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, SNRI</span><span lang=NO-BOK
  style='mso-ansi-language:NO-BOK'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=NO-BOK style='font-size:
  12.0pt;line-height:115%;mso-ansi-language:NO-BOK'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + insomni</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + epilepsi</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, valproat*</span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:7'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + tremor<o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L<o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker, gabapentin<o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:8'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + parkinsonizm<o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L<o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Kalsiyum kanal blokeri<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:9'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren + obezite</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span></p>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>J</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat, flunarizin, amitriptilin</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:10'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +ast�m</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:11'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +Raynaud <span class=GramE>fenomeni</span></span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Beta-bloker</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:12'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +ya�l� hasta</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, kalsiyum kanal blokeri</span><span
  lang=DE style='font-size:12.0pt;line-height:115%;mso-ansi-language:DE'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:13'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +zay�f beden</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat, beta-bloker</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:14'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +dikkat gerektiren i�</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Trisiklik antidepresan, topiramat</span><span
  lang=EN-US style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:15'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +karaci�er hastal���</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Valproat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:16'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +glokom</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:17;mso-yfti-lastrow:yes'>
  <td width=205 valign=top style='width:153.5pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Migren +b�brek ta��</span><span lang=EN-US
  style='font-size:12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=55 valign=top style='width:40.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
  text-align:center'><span style='font-size:10.0pt;line-height:115%;font-family:
  Wingdings;mso-ansi-language:TR'>L</span><span lang=EN-US style='font-size:
  12.0pt;line-height:115%'><o:p></o:p></span></p>
  </td>
  <td width=355 valign=top style='width:266.2pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
  mso-ansi-language:TR'>Topiramat</span><span lang=EN-US style='font-size:12.0pt;
  line-height:115%'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;* </span><span style='mso-bidi-font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>valproat do�urganl�k �a��nda kad�n olgularda kesinlikle
kullan�lmamal�d�r </span><span lang=EN-US style='font-size:13.5pt;line-height:
115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><i><span style='font-size:10.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='text-align:justify'><i><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Migren statusu</span></i><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;72
saatten uzun s�ren ataklar veya 4 saatten k�sa s�ren a�r�s�z d�nemlerin d���nda
devam eden ataklar veya standart atak tedavisine cevaps�z uzam�� migren
�eklinde tan�mlanabilir. Hastan�n h�zla kortikosteroidler (deksametazon 16 mg
�V gibi), antiemetik (�V), antiepileptik (�V), magnezyum (1 gr �V), ketodolak
veya gere�inde opioidler gibi se�eneklerle tedavisi sa�lanmal�d�r. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Yeni
Geli�tirilen Tedaviler <o:p></o:p></span></i></b></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>5HT1F resept�r agonistleri,</span></i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'> triptanlardan farkl� olarak kan damarlar�
�zerindeki serotonin resept�rlerine etki etmedi�i i�in koroner ve serebral
vazokonstriksiyona neden olmaz. Bu grupta yer alan lasmiditan (100-200mg, oral)
migren atak tedavisinde etkili bulunmu�tur. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>CGRP ve resept�rlerinin trigeminal ganglion, trigeminal sinirde
sonlanmalar� ve dural arterler �evresindeki da��l�m� migren ba�a�r�s�nda ana
hedefi olu�turmaktad�r. <i style='mso-bidi-font-style:normal'>K���k molek�l
CGRP <span class=GramE>antagonisti</span></i> olan <i style='mso-bidi-font-style:
normal'>gepantlar, </i>atak kontrol�nde olduk�a etkili; triptanlar gibi
vask�ler hemodinami �zerinde etki g�stermedi�inden de koroner ve periferik
arter hastal�klar�nda g�venli bulunmu�tur. Ancak ilk geli�tirilen gepant grubu
molek�ller kullan�m zorlu�u ya da sistemik yan etkiler gibi �e�itli olumsuz
y�nleri nedeniyle klinik prati�e ge�ememi�tir. Bu grupta, hem atak hem
profilaksi tedavisinde kullan�lmas� amac�yla yeni molek�ller
geli�tirilmektedir. CGRP molek�l�ne veya resept�r�ne ba�lanarak <span
class=GramE>n�tralize</span> eden <i style='mso-bidi-font-style:normal'>anti-CGRP
monoklonal antikorlar�</i> ise, migren proflaksisinde �ne ��kan yeni se�enekler
aras�ndad�r. Bunlar kan-beyin bariyerini ge�meyen, karaci�er veya b�brekten
at�lmayan, peptid do�as� nedeniyle oral kullan�lamayan ve yar� �mr� haftalar
olan b�y�k molek�llerdir. Erenumab (70-140mg, ayl�k deri alt� injeksiyon)
Amerika ve baz� Avrupa �lkelerinde gereken bilimsel ve idari onaylar� alm��t�r,
fremanezumab onu izlemi�tir, galcanezumab ve eptinezumab gibi molek�llerin
�al��malar� da ba�ar�l� �ekilde devam etmektedir. Bu maliyeti y�ksek ve uzun
d�nem yan etkileri hen�z iyi bilinmeyen ila�lar�n di�er profilaksi tedavilerine
yan�t vermeyen migren hastalar�nda kullan�lmas� �nerilebilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><b><i><span style='font-size:13.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Giri�imsel
Tedaviler<o:p></o:p></span></i></b></p>

<p class=MsoNormal style='text-align:justify'><i style='mso-bidi-font-style:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Botulinum n�rotoksini, </span></i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>kronik migren profilaksisinde
kullan�lmaktad�r, epizodik migren tedavisinde etkinli�ini g�steren yeterli
kan�t yoktur. Deriyi inerve eden trigeminal sinir u�lar�ndan retrograd
transport ile santrale ta��nd��� ve CGRP ve P-maddesi gibi n�ropeptidlerin
sal�n�m�n� bask�layarak etki olu�turdu�u d���n�lmektedir. Kranyal ve servikal
b�lgede 31 farkl� noktaya, 3 ay aral�klarla uygulan�r. Pahal� ve giri�imsel bir
tedavi se�ene�idir, e�itimli ellerde y�ksek bir riski yoktur, ge�ici fel�ler
olabilir. Kozmetik ama�l� kullan�m� da olmas� baz� hastalarda sempati
yaratmaktad�r.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>S�k atakl� migrende, �zellikle kronik migrende <span class=GramE>lokal</span>
anestetikler ile <i style='mso-bidi-font-style:normal'>b�y�k oksipital sinir
(GON: great occipital nerve) blokaj�</i> g�venli ve etkili giri�imsel tedaviler
aras�nda g�r�lmektedir. Ancak bu ucuz y�ntem ile ilgili hen�z bir
standardizasyon geli�tirilmemi�tir; tek tarafl� <span class=GramE>blokaj</span>
yeterlidir; kranyal defekti, injeksiyon yeri infeksiyonu ve lokal anestetiklere
alerjisi olanlara yap�lmamal�d�r. <i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Son y�llarda, �zellikle medikal tedaviye yan�t al�namayan migren
hastalar�nda <i style='mso-bidi-font-style:normal'>n�rostim�lasyon uygulamalar�</i>
g�ndeme gelmi�tir. Non-invazif y�ntemler aras�nda transkranyal manyetik
stim�lasyon, transkranyal do�ru ak�m uyar�m� ve non-invazif vagal sinir
stim�lasyonu (VSS); invazif y�ntemler aras�nda ise oksipital sinir stim�lasyonu
ve implante VSS yer almaktad�r. Hen�z rutin klinik kullan�mlar� yoktur.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Son y�llarda �zellikle kronik diren�li migren olgular�nda ba�ar�l� oldu�u
�ne s�r�len cerrahi baz� giri�imler ise, ulusal ve uluslararas� d�zeyde idari
olarak kabul edilmeyen ve tedavi k�lavuzlar�nda yer almayan uygulamalard�r.
�stelik bu y�ntemler, geri d�n���ms�z <span class=GramE>komplikasyonlara</span>
yol a�abilmekte ve izlemde tedaviye diren�li n�ropatik a�r� geli�imine neden
olabilmektedir. �Migren cerrahisi� ad�yla duyurulmaya �al���lan bu y�ntemlerin
kullan�mlar� bilimsel kan�tlar ve bilimsel onaylar� olmad���ndan sak�ncal�d�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><i><span
style='font-size:12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Migren tedavisinde ba�ar�s�zl���n nedenleri</span></i></b><span
style='font-size:12.0pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tan� eksik veya yanl��t�r</span><span style='font-size:12.0pt;
     mso-ansi-language:TR'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tan� konmam�� ba�ka bir hastal��a ba�l� sekonder ba�a�r�s� bozuklu�u
     mevcuttur</span><span lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Yanl�� tan� konmu� ba�ka bir primer ba�a�r�s� bozuklu�u mevcuttur</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>�ki veya daha fazla farkl� ba�a�r�s� bozuklu�u mevcuttur</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l19 level1 lfo20;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>�nemli tetikleyici fakt�rler g�zden ka��r�lm��t�r</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Hormonal tetikler, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Psikososyal fakt�rler (depresyon ve madde ba��ml�l���), <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Ba�a�r�lar�n� tetikleyen di�er ila�lar, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:70.8pt;margin-bottom:.0001pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Ya�am �eklinin ba�a�r�s�n� tetiklemesi (stres, uykusuzluk,
alkol kullan�m� vb.)<o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>�la� a��r� kullan�m� vard�r</span><span lang=EN-US style='font-size:
     12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Kafein a��r� kullan�m� vard�r</span><span lang=EN-US style='font-size:
     12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l13 level1 lfo21;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tedavi dozlar� ve yakla��m yetersizdir</span><span lang=EN-US
     style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Etkisiz ila�, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Y�ksek ba�lang�� dozu, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yetersiz devam dozu, <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:35.4pt;margin-bottom:.0001pt;text-indent:35.4pt;line-height:normal'><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Yetersiz tedavi s�resi</span><span style='font-size:12.0pt;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Hastan�n ger�ek�i olmayan y�ksek beklenti d�zeyi</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Tedaviyi zorla�t�ran di�er komorbid hastal�klar�n varl���</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Atak tedavisinde kusma oldu�u halde oral yolla uygulama</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Bulant� ve gastrik staz olan olgularda �nce anti-emetik verilmemesi</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>�� verimi �ok d��t��� halde basit analjeziklerle yetinilmeye
     �al���lmas�</span><span lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:black;margin-bottom:0cm;margin-bottom:.0001pt;
     line-height:normal;mso-list:l24 level1 lfo22;tab-stops:list 36.0pt'><span
     style='font-size:12.0pt;font-family:"Tahoma","sans-serif";mso-ansi-language:
     TR'>Kombine analjeziklerin ve Ergo preparatlar�n�n yo�un kullan�m�</span><span
     lang=EN-US style='font-size:12.0pt'><o:p></o:p></span></li>
</ul>

<p class=MsoNormal><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:12.0pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>GER�L�M
T�P� BA�A�RILARI </span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Primer ba�a�r�lar� i�inde en s�k kar��la��lan tip gerilim tipi
ba�a�r�lar�d�r (GTB). T�rkiye�de y�ll�k prevalans� yakla��k %32�dir. GTB�ler
migrenden daha s�k g�r�lmekle birlikte, g�rece daha hafif ba�a�r�lar�na neden
olduklar�ndan hekime ba�vuruda daha geri plandad�r. S�kl�kla 20 ya� civar�nda
ba�lar, her ya�ta g�r�lebilir. Kad�nlarda biraz daha s�k g�r�lmekle birlikte
aradaki fark migrende oldu�u kadar �arp�c� de�ildir. GTB�nin lokalizasyonu
de�i�kendir ve <span class=GramE>semptomlar�</span> ayn� hastada bile tek tip
de�ildir. Bu nedenle bir ���p sepeti� tan�s� gibi ele alan yazarlar vard�r.
Baz� ara�t�rmac�lar ise migren ile ayn� spektrumun di�er ucu oldu�u
g�r���ndedir. GTB�li olgular�n %10 kadar�nda ba�a�r�s� zonklay�c� gibi
hissedilebilir ve ba�ka olgularda tek yanl� a�r� olabilir. Kaslarda gerginlik
%80 olguda palpasyonla saptan�r ve hastalar s�kl�kla dikkat eksikli�inden
yak�n�rlar. Depresif ruh durumu, anksiyete bozuklu�u, somatoform bozukluklar ve
di�er yak�nmalar e�lik edebilir. Baz� hastalarda fibromiyalji ve miyofasyal
a�r� <span class=GramE>sendromu</span> birlikteli�i vard�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm;text-align:justify'><span style='font-size:13.5pt;line-height:
115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>A�r�n�n,
ataklar �eklinde gelebildi�i gibi, kronikle�mi� halde de g�r�lmesi seyrek
de�ildir. GTB, IHS s�n�flamas�nda&nbsp;<b>Tablo 7�</b>de g�r�ld��� gibi seyrek,
s�k ve kronik olarak grupland�r�lm��t�r ve bu hasta i�in sorun olma boyutu ve
tedaviyi y�nlendirmek a��s�ndan anlaml�d�r.&nbsp;<b><i> Kronik gerilim tipi
ba�a�r�s�</i></b>&nbsp;g�nl�k olarak veya �ok s�k g�r�len epizodik GTB�den
geli�en bir&nbsp;durumdur. Ba�ka bir&nbsp;hastal�kla&nbsp;ili�kili olmad���n�n
g�sterilmesi �nem ta��r. Yurdumuzda olduk�a s�k rastlanan (%5�in �st�nde) ve
polikliniklere s�k ba�vuran grubu olu�turmaktad�r. Ya�am kalitesi �zerine
olumsuz etkisi olan bir durumdur. �la� a��r� kullan�m�na yol a�abilir ve baz�
olgularda kronik migrenden ayr�m� sorun yaratabilir. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'>Tablo 7.&nbsp;</span></b><span style='font-size:12.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>Uluslararas�
Ba�a�r�s� Derne�i (IHS) 2018 S�n�flama Sistemine G�re Gerilim Tipi Ba�a�r�s�</span><b
style='mso-bidi-font-weight:normal'><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'><span style='mso-spacerun:yes'>���� </span><o:p></o:p></span></b></p>

<p class=ListeParagraf1CxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Seyrek epizodik
gerilim tipi ba�a�r�s� </span></i><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'>tan�s� i�in:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C <span class=GramE>kriterlerine</span> uyan, 30
dakikadan uzun ve 7 g�nden k�sa s�reyle, ayda ortalama 1 g�nden (y�lda 12
g�nden) az olan, en az 10 ba�a�r�s� ata�� gereklidir.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>S�k epizodik
gerilim tipi ba�a�r�s� </span></i><span style='font-size:12.0pt;line-height:
115%;mso-ansi-language:TR'>tan�s� i�in:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C kriterlerine uyan, 30 dakikadan uzun ve 7 g�nden k�sa
s�reyle, 3 aydan uzun s�redir ayda ortalama 1-<span class=GramE>14<span
style='mso-spacerun:yes'>� </span>g�n</span> olan,<span
style='mso-spacerun:yes'>� </span>en az 10 ba�a�r�s� ata�� gereklidir.<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><i style='mso-bidi-font-style:normal'><span
style='font-size:12.0pt;line-height:115%;mso-ansi-language:TR'>Kronik gerilim
tipi ba�a�r�s� </span></i><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>tan�s� i�in:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:18.0pt;margin-bottom:.0001pt;mso-add-space:auto;
tab-stops:18.0pt 54.0pt'><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A-C <span class=GramE>kriterlerine</span> uyan, saatler
ya da g�nler s�ren ya da hi� ge�meyen ba�a�r�s�n�n, 3 aydan uzun s�redir ayda
15 g�n veya daha fazla olmas� gereklidir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;tab-stops:
18.0pt 54.0pt'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;line-height:115%;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=ListeParagraf1CxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 54.0pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>A.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A�a��daki �zelliklerden en az ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Bilateral lokalizasyonda<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Bask�l� veya s�k��t�r�c� karakterde<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Hafif veya orta �iddette<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l20 level1 lfo24;tab-stops:18.0pt 31.5pt 67.5pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Rutin fiziksel aktivite ile k�t�le�me yok<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 67.5pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>B.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>A�adaki �zelliklerden ikisi:<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l11 level1 lfo25;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Bulant� veya kusma yok<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:72.0pt;margin-bottom:.0001pt;mso-add-space:auto;
text-indent:-18.0pt;mso-list:l11 level1 lfo25;tab-stops:18.0pt 31.5pt 54.0pt'><![if !supportLists]><span
style='font-size:12.0pt;line-height:115%;mso-bidi-font-family:Calibri;
mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>Fotofobi veya fonofobi bulgular�ndan en fazla biri var<o:p></o:p></span></p>

<p class=ListeParagraf1CxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt;
mso-add-space:auto;text-indent:-18.0pt;mso-list:l23 level1 lfo23;tab-stops:
18.0pt 31.5pt 54.0pt'><![if !supportLists]><span style='font-size:12.0pt;
line-height:115%;mso-bidi-font-family:Calibri;mso-ansi-language:TR'><span
style='mso-list:Ignore'>C.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:12.0pt;line-height:115%;
mso-ansi-language:TR'>S�n�flamada yer alan ba�ka bir ba�a�r�s� tan�s�na
uymamaktad�r<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm'><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:2.0pt;margin-right:0cm;margin-bottom:2.0pt;
margin-left:0cm'><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-style:
italic'>Gerilim Tipi Ba�a�r�s�nda Patofizyoloji </span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>GTB�lerin
patofizyolojisi net de�ildir, �ok fakt�rl� oldu�u �ng�r�lmektedir. Muhtemelen
sadece anormal kas kas�lmas�n�n de�il, anormal n�ron duyarl�l��� ve a�r�n�n
kolayla�mas�n�n bir klinik yans�mas�d�r. Nitrik oksitin (NO) gerilim tipi
ba�a�r�s�nda <span class=GramE>lokal</span> bir arac� madde oldu�u
savunulmaktad�r. Primer olarak kas k�kenli bir ba�a�r�s� oldu�u iddia edilmi�se
de kan�t yoktur ve artm�� EMG aktivitesi olmamas�, botulinum toksin
uygulamalar�n�n ba�ar�s�z olmas� buna ters d��mektedir. Trigeminal siniri motor
n�ronlara ba�layan intern�ronlarda anormal bir mod�lasyon bulundu�u d���n�lmektedir.
Bu anormallik bazal gangliadan, limbik sistemden veya dorsal raphe
nukleusundaki serotoninerjik n�ronlardan kaynaklanabilir. Bir g�r��e g�re
kronik gerilim tipinde supraspinal fasilitasyon sonucu trigeminal kaudal
nukleus n�ronlar� a��r� duyarl� hale gelmektedir. E�er migrende damarsal
nosisept�r�n a��r� duyarl�l��� s�z konusu ise, kronik GTB�de de b�y�k
olas�l�kla perikranyal kaslarda miyofasyal nosisept�r�n a��r� duyarl�l��� ile
giden bir bozukluk s�z konusu olabilir. Sekonder segmental santral duyarl�la�ma,
uyar�lar�n supraspinal mod�lasyon bozuklu�u ve miyofasyal dokudan do�an uzam��
a�r�l� uyar�lar�n kronik forma d�n���n�n de �nemli oldu�u d���n�lmektedir. Akut
atak fiziksel veya psikolojik stresle, ya da fizyolojik olmayan �al��ma
ko�ullar� sonucu ortaya ��kabilir. Ge�mi�te GTB�nin �nemli bir psikolojik
boyutu oldu�unu savunanlar olsa da bu konuda bir kan�t elde edilememi�tir,
stres fakt�rlerinin n�rofizyolojik mekanizmalar� tetikledi�i d���n�lmektedir.
Zorlanan kaslardan gelen nosisepsiyon art��� a�r� mod�lasyonu bozulmu� bir
ki�ide ata�� tetikleyebilir. Emosyonel mekanizmalar da endojen antinosiseptif
sistemi bask�layabilir. Nosiseptif n�ronlar�n uzun vadeli potansiyasyonu ve
antinosiseptif sistemin aktivitesinin azalmas� kronik GTB�ne yol a�abilir.
Trigeminal kaudal nukleus n�ronlar�n�n duyarl�la�mas� normalde a�r�ya yol
a�mayacak uyaranlar�n a�r�l� olmas� ve tetik noktalar� olu�turarak migren ve
GTB belirtilerinin �ak��mas�na ve trigeminal vask�ler sistemin de aktivasyonuna
yol a�abilir. MSS kas tonusunu gama eferent n�ronlar yoluyla kontrol etmekte ve
buradan hareketle kas i�lerine giden alfa-motor n�ronlar etkilenmektedir.
Renshaw h�creleri GABA arac�l���yla sinaptik sisteme etki etmektedir.
Ba�a�r�s�z d�nemlerde de perikranyal kas hassasiyetinin varl��� �nemlidir ve
tek ba��na kas kas�lmas�n�n ba�a�r�s�ndan sorumlu olmad���n� g�stermektedir, bu
hassasiyetin nedeni tam bilinmemekle birlikte �izgili kastaki kan damarlar�
�evresindeki nosisept�rlerin rol� olabilir. Ayr�ca kas yorgunlu�una yol a�an
metabolik ve n�rokimyasal de�i�iklikler �nemlidir. Di�er kronik a�r�l�
durumlara benzer �ekilde kronik GTB formunun voksel tabanl� morfometrik MRG
�al��malar�nda beyin yap�s�nda de�i�ikliklerle seyretti�i, a�r� yollar�yla
ili�kili gri maddede anlaml� azalmalar oldu�u son y�llarda g�sterilmi�tir. GTB
patofizyolojisi alan�ndaki �al��malar�n yetersizli�i bu hastal���n s�kl��� ve
yaratt��� y�k d���n�ld���nde �ok dikkat �ekicidir. Son y�llarda yap�lm�� olan
ve hen�z do�rulanma bekleyen baz� ufak boyutlu �al��malar interl�kin-8,
adiponektin ve n�rotrofik fakt�rlerin rol� �zerinde durmaktad�r.<span
style='mso-spacerun:yes'>� </span>GTB ve migrenin tamamen ayr� hastal�klar m�
yoksa primer ba�a�r�s� spektrumunun iki ucu mu oldu�u sorusunun yan�t� da hen�z
tart��mal�d�r. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-style:
italic'>Gerilim Tipi Ba�a�r�s�nda Tedavi </span></b><span style='font-size:
13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Gerilim tipi ba�a�r�s�n�n tedavisi migrene benzer prensipler i�ermektedir
ve daha az se�eneklidir. Atak s�ras�nda genelde parasetamol gibi <i
style='mso-bidi-font-style:normal'>basit analjezikler veya NSA� ila�lar </i>yeterlidir,
herhangi birinin di�erlerine �st�nl��� g�sterilmemi�tir. Tedavide hasta temelli
bir yakla��m uygundur. Kronik GTB�de <i style='mso-bidi-font-style:normal'>antidepresan
ila�lar</i> kullan�l�r. Profilaksisinde antidepresanlar�n antinosiseptif etkisi
antidepresan etkiden kaynaklanmamaktad�r. Profilakside amitriptilin en etkili
ila�lardand�r. Sersemlik hissi, a��z kurulu�u, ta�ikardi, kalpte ileti blo�u,
n�bet, g�rme bozuklu�u, idrar retansiyonu gibi yan etkileri vard�r ve ileri
ya�ta, obez hastalarda ve MAO inhibit�r� kullanma �yk�s� olanlarda
kullan�lmamal�d�r. SSRI grubunun da (Paroksetin 20 mg, Fluoksetin 20 mg,
Citalopram 10-20 mg, Sertralin&nbsp; 50-100 mg, Fluvoksamin 50-100 mg ve
di�erleri) etkinli�i vard�r. Bulant�, uyuklama, terleme, a��z kurulu�u,
impotans, ekstrapiramidal bozukluklar ve n�bet gibi yan etkiler olduk�a
seyrektir. MAO inhibit�r� kullanan, karaci�er yetmezli�i ve renal yetmezlik
olan hastada verilmemelidir. Baz� olgular tizanidin 2-8 mg/g�n kullan�m�ndan
yarar g�rebilir. GTB�de ila� tedavisi ile birlikte gev�eme teknikleri, stresle
m�cadele y�ntemleri, �e�itli egzersizler ve masaj gibi uygulamalar�n yap�ld���
ila� d��� tedaviler de ba�ar�l� sonu�lar vermektedir. Baz� merkezlerde
oksipital sinir <span class=GramE>blokaj�</span> �eklinde teknikler ila�
tedavisine yan�ts�z kronik olgularda denenmektedir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>TR�GEM�NAL
OTONOM�K SEFALALJ�LER </span></b><span style='font-size:14.0pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>Trigeminal otonomik
sefalaljiler </span><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR;mso-bidi-font-weight:
bold'>(TOS)</span><b><span style='font-size:14.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;trigeminal sinir da��l�m�na uyan
b�lgede ba�a�r�s� ve bununla birlikte kranyal otonomik aktivasyon ile
karakterize bir dizi ba�a�r�s� <span class=GramE>sendromundan</span> olu�ur. En
s�k g�r�len tipi k�me ba�a�r�s�d�r. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:12.0pt;text-align:justify'><span
class=GramE><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-style:italic'>TOS</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;i�in ortak �zellikler a�r�n�n �ok �iddetli
olu�u, her zaman tek yanl� olu�u, otonomik belirtilerin ata�a mutlaka e�lik
etmesi (g�zde ya�arma, k�zarma, �i�me, burunda o yanda t�kanma veya ak�nt�,
al�nda veya y�zde terleme gibi), herg�n veya g�n a��r� olu�u ve �nceki say�lan
ba�a�r�l� durumlara g�re k�sa s�reli olu�u ve ayn� g�n i�inde
tekrarlayabilmeleridir (<b>Tablo 5</b>). </span></span><span style='font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>A�r� yerle�imi ve karakteri t�m TOS i�in benzer
olabilmekle birlikte, a�r� s�releri ve tekrarlama say�lar� en ay�rdedici
�zellikleridir.&nbsp;<span style='mso-bidi-font-style:italic'>K�me ba�a�r�s�</span>,
otonomik sefalaljiler i�erisinde yukar�da da anlat�ld��� gibi en uzun s�reli
olan� olup ataklar 15 dakika ile 3 saat aras� s�rebilir ve g�n a��r� bir kez
ile g�nde 8 kez aras�nda de�i�en s�kl�kta gelebilir.&nbsp;<span
style='mso-bidi-font-style:italic'>Paroksizmal hemikranya</span>&nbsp;ve&nbsp;<span
style='mso-bidi-font-style:italic'>SUNCT/SUNA&nbsp;</span>ise �ok daha nadir
durumlar olup k�me ba�a�r�s�ndan daha k�sa s�reli olu�lar�yla ayr�l�rlar. </span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
color:black;mso-ansi-language:TR'>K�me (Demet, Cluster) Ba�a�r�s�<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>K�me ba�a�r�s�, gerilim ve migren ba�a�r�s�ndan sonra en s�k g�r�len primer
ba�a�r�s�d�r. Her ya�ta rastlanmakla birlikte daha yayg�n olarak 20-40 ya�
aras� ortaya ��kmaktad�r. �ocuklarda ve ya�l�larda �ok seyrek g�r�l�r,
erkeklerde ve sigara i�enlerde daha s�kt�r. A�r�n�n tipik �zellikleri tek
tarafl�, �ok �iddetli ve migrene g�re k�sa s�reli olmas�d�r. K�me ba�a�r�s�
olarak adland�r�lmas�n�n en belirgin nedeni periyodik �ekilde ortaya
��kmas�d�r. Bu ba�a�r�s� primer olabilece�i gibi, nadir de olsa, sekonder bir
nedenle de ortaya ��kabilir. Deneysel �al��malar ve insanda fonksiyonel
g�r�nt�leme incelemeleri ile olu�an bilgi birikimi, bu ba�a�r�s� tipinde
fizyolojik trigeminal parasempatik refleksin aktive olarak sekonder kranyal
sempatik disfonksiyona neden oldu�unu d���nd�rmektedir ve hipotalamusun
nosiseptif ve otonom yollara mod�lat�r rol� �zerinde durulmaktad�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>&nbsp;</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Orbital, supraorbital, temporal tek tarafl�, 15-180 dakika s�ren ve g�n
a��r� bir kez ile g�nde 8 defaya kadar ortaya ��kan �iddetli
ataklard�r.&nbsp;Bilinmeyen nedenlerle erkeklerde kad�nlara g�re 3-4 kez daha
s�kt�r.&nbsp;�o�u hasta atak s�ras�nda huzursuz ya da ajitedir. Ba�a�r�s� ile
ayn� tarafta olmak �zere, ataklara a�a��dakilerden biri ya da daha fazlas�
e�lik edebilir:</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>�&nbsp;&nbsp;&nbsp;
Parsiyel Horner <span class=GramE>sendromu</span> (miyoz, pitoz)<br>
�&nbsp;&nbsp;&nbsp; Burun t�kan�kl��� veya ak�nt�s�<br>
�&nbsp;&nbsp;&nbsp; G�z ya�armas� (nazolakrimal kanal�n blokaj�na ba�l� olarak)<br>
�&nbsp;&nbsp;&nbsp; Konjuktival kanlanma<br>
�&nbsp;&nbsp;&nbsp; Al�n ve y�zde terleme art��� (nadir)<br>
�&nbsp;&nbsp;&nbsp; Ate� basmas� (nadir)<br>
�&nbsp;&nbsp;&nbsp; Y�z� ve g�z kapa��n� i�eren �dem (�ok seyrek)<br>
�&nbsp;&nbsp;&nbsp; Supraorbital �cold spot� (termografi ile saptanm��)</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Sistemik belirtiler<br>
�&nbsp;&nbsp;&nbsp; Bradikardi<br>
�&nbsp;&nbsp;&nbsp; Hipertansiyon<br>
�&nbsp;&nbsp;&nbsp; Gastrik salg� �retiminde art��</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ataklar, al���ld�k bi�imde aylar ya da y�llar s�ren d�zelme d�nemleri ile
ayr�lm�� olan, haftalarca ya da aylarca s�ren diziler (k�me d�nemleri)
bi�iminde ortaya ��kar. Ancak hastalar�n yakla��k %10-15�inde d�zelme
olmaks�z�n kronik belirtiler olur ve bu durum �kronik k�me� olarak
adland�r�l�r. Bir k�me d�nemi s�ras�nda ve kronik tipte, ataklar d�zenli olarak
ortaya ��kar ve alkol, histamin ya da nitrogliserin ile uyar�labilir. A�r� her
bir k�me d�nemi s�ras�nda hemen hemen de�i�meksizin ayn� yerde ortaya ��kar. Hastalar
genellikle uzanamazlar ve tipik olarak dola�mak zorunda kal�rlar. Akut
ataklarda posterior hipotalamik gri maddenin aktivasyonu olur. K�me ba�a�r�s�,
olgular�n yakla��k&nbsp; %5�inde kal�tsal olabilir. Baz� hastalarda sadece bir
tek k�me d�nemi de olabilmektedir. Trigeminal nevralji ile birlikte olan k�me
ba�a�r�s� (<i>k�me-tik <span class=GramE>sendromu</span></i>) da
tan�mlanm��t�r.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Klinik olarak, ba�a�r�s� konusunda tecr�be kazanmam�� hekimler s�kl�kla
k�me ba�a�r�s� ile migreni kar��t�rmaktad�rlar. K�me ba�a�r�s� tipik olarak 6-12
hafta s�ren senelik ataklar halinde orta ya�l� erkeklerde ortaya ��kar. Bu
�k�me� d�nemlerinde, sabah erkenden (�alar saat ba�a�r�s�) ya da uyuduktan
sonra bir saat i�inde a�r�yla uyan�rlar. Alkol ald�ktan sonra 20-30 dakika
i�inde kriz d�nemi ba�lar ve hastalar doktor taraf�ndan s�z� edilmeden �nce
bile alkolden ka��nmalar� gerekti�ini bilirler. Periyodik olmas� ana
�zelli�idir, epizodlar� en �ok ilkbahar ve sonbaharda g�r�l�r. Atak d�nemi 2-3
ay s�rer ve remisyon devri 1-2 y�l (s�n�rlar� 2 ay-20 y�ld�r) devam eder.
Atakta aura yoktur ve a�r� 10-15 dakikada en y�ksek seviyeye ula��r. </span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-fareast-language:TR'>A�r�n�n en �nemli
�zelliklerinden biri huzursuzluk hissi olarak da tarif edilen <span
class=GramE>ajitasyonun</span> e�lik etmesidir. Yeni tan� kriterlerine g�re
otonom bulgu olmadan <span class=GramE>ajitasyon</span> varl��� ile ayn�
�ekilde k�me ba�a�r�s� tan�s� koyulabilece�i unutulmamal�d�r. </span><span
style='font-size:13.5pt;line-height:115%;font-family:"Times New Roman","serif";
color:black;mso-ansi-language:TR;mso-fareast-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tedavi</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Akut atakta 5-8 litre/dakika oksijen inhalasyonu %70 oran�nda ba�ar�l�
olmaktad�r. Medikal tedavi olarak intramusk�ler dihidroergotamin, tercihen
subk�tan veya oral triptanlar ve akut atakta kortikosteroidler kullan�labilir.
K�me ba�a�r�s�n�n tipik �zelli�i analjezik ila�lara ve migrenin tipik
profilaksisine �o�u kez yan�ts�zl�klar�d�r. Verapamil, lityum ve steroidlerle
profilaksiye ise yan�t verirler.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:10.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Patofizyoloji</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:10.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>K�menin ba�a�r�s� da
trigeminal sinirin nosiseptif oftalmik dallar� yoluyla ta��n�r. CGRP insanda
bilinen en g��l� vazodilatat�rlerdendir ve sal�n�m� sonucunda n�rojenik bir
inflamasyon tetiklenir ve dural kan damarlar� geni�ler. K�me ba�a�r�s�nda da
trigeminovask�ler sistemin aktive oldu�u hastalar�n k�me ata�� s�ras�nda
eksternal j�g�ler venlerinde CGRP d�zeylerinin artt���n�n g�sterilmesi ile
kesinle�mi�tir. Otonom bulgular ise kranyal parasempatik liflerin aktivasyonuna
sekonderdir. Bu lifler superior salivator nukleustan kaynaklan�r ve trigeminal
nukleus kaudalis ile fonksiyonel bir beyinsap� ba�lant�lar� vard�r. Bu lifler
7.sinir ile seyreder ve pterigopalatin ganglionda sinaps yaparlar.
Postganglionik lifler beyin damarlar�na ve nazal mukozaya vazomotor ve sekretomotor
inervasyon sa�larlar. K�me ba�a�r�l� ki�ilerde bu yolda aktivasyon oldu�u, VIP
kan d�zeylerinin atak s�ras�nda belirgin �ekilde artt���n�n g�sterilmesi ile
desteklenmi�tir. Horner <span class=GramE>sendromu</span> geli�mesi
postganglioniktir ve karotid sempatik pleksusunun tutulumu ile ba�lant�l�d�r.
Karotis kavern�z par�as�, bu d�zeyde parasempatik, sempatik ve trigeminal
lifler biraraya geldi�inden en uygun lokalizasyon gibi g�r�nmektedir.
G�r�nt�leme �al��malar� da kavern�z sin�sde arteryel geni�leme ve ven�z d�n��te
obstr�ks�yon g�stermi�tir. Sendromun periodisitesi ise hen�z a��kl��a kavu�mu�
de�ildir. Oreksinler gibi baz� genlerde mutasyon varl��� spek�le edilmektedir.
Verapamile yan�t, erkeklerde s�k olmas� ve sigara ile ba�lant� da hen�z yeterli
�ekilde a��klanabilmi� de�ildir. Profilaktik tedavide g��l� bir
anti-inflamatuar olan steroide �ok h�zl� ve iyi yan�t al�nmas� k�me
ba�a�r�s�n�n temelinde inflamasyonun yatt���n� akla getirmektedir ancak bu
alanda bir kan�t yoktur. Hastal���n an�lan �ekilde sirkadyen ve d�nemsel
�zellikler g�stermesi ve yeni g�r�nt�leme verileri patofizyolojisinde
hipotalamusun rol�n� desteklemektedir. Patofizyolojisi hen�z net anla��lamam��
olan bu tablonun n�ronal, vask�ler, genetik ve imm�n mekanizmalar�n kar��l�kl�
etkile�imi sonucu olu�tu�u kan�s�na var�lm��t�r. CGRP monoklonal antikorlar�n�n
bu tabloda da ba�ar�l� sonu�lar verdi�i hen�z yeni ara�t�rmalarda dikkati
�ekmektedir.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:10.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Paroksizmal
Hemikranya<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastad
ve Dale taraf�ndan 1974�de tan�mlanm�� olan paroksizmal hemikranya (PH), �ok
seyrek g�r�len bir primer ba�a�r�s�d�r. Kad�nlarda daha s�k g�r�l�r ve 25-40
ya� aras�ndaki ki�ilerde rastlanmaktad�r. A�r� kesinlikle hep ayn� tarafta
�iddetli olarak ortaya ��kar, k�sa s�ren ve remisyonsuz ba�a�r�lar�d�r.
S�kl�kla kroniktir, ancak epizodik formu da tan�mlanm��t�r. Ki�i hemen bir yere
oturma ya da yatma ihtiyac� duyar. A�r�n�n yap�s� zonklay�c�, damar atar gibi,
oyucu, delici olarak tan�mlanabilir. Ataklar�n ortalama g�nl�k s�kl��� 5-20
aras�ndad�r ve her seferinde a�r� </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:TR'>s�resi 2-30 dakika<span style='color:black'> aras�ndad�r.
�li�kili otonom de�i�iklikler k�me ba�a�r�s�ndakine �ok benzer ancak&nbsp;<i>tipik
�zellik indometazinle 3 g�n i�inde tam kontrol edilebilmesidir</i>. �li�kili
otonom belirtilerin hemen hemen tamam� kranyal parasempatik aktivasyonla ili�kilidir.
Tek istisnas� muhtemelen k�smi bir sempatik defisite ba�l� olan Horner <span
class=GramE>sendromudur</span>. PH ay�r�c� tan�s�nda sekonder nedenler MRG ile
ara�t�r�lmal�d�r. &nbsp;<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>Tedavisi</span></i><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'>, g�nde �� kez 25 mg
indometazindir. E�er cevap al�namazsa yava��a 225 mg�a ��kar�lmas�
�nerilmektedir. �ndometazine cevaps�zl�k ancak 150 mg oral (100 mg IM) veya
�zeri dozlarda de�erlendirilebilir. T�m hastalarda olas� gastrointestinal yan
etkilerine kar�� �nlem al�nmal�d�r. Epizodik formda indometazin genellikle
tahmin edilen atak s�resinden daha uzun bir s�re verilir ve azalt�larak
kesilir. Remisyon d�nemleri olsa da, kronik formda �ok uzun s�reli tedavi
gerekir. �ndometazinin etki mekanizmas� bilinmemektedir ve NO �retimini
azalt�c� etkisi ve CGRP ve VIP �zerinden etkili oldu�u san�lmaktad�r.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR;
mso-bidi-font-style:italic'>Hemikranya Kontinua<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><i><span style='font-size:13.5pt;font-family:
"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastad
ve Spierings taraf�nda 1984�de tan�mlanm��t�r. Unilateral, otonom bulgu ve </span><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
"Times New Roman";mso-ansi-language:TR'>migren�z bulgular�n eklendi�i,
�iddetlenmelerle giden 3 aydan uzun bir s�redir varolan devaml� bir
ba�a�r�s�d�r. Otonom bulgular di�er TOS�lara g�re geri plandad�r. Saplan�c�
komponenti de vard�r. Asl�nda �ok nadir olmad��� ve kronik g�nl�k a�r�lar�n
i�inde tan�nmad��� d���n�lmektedir. Ay�r�c� tan�s�nda di�er TOS�lar d���nda
kronik migren, kronik GTB ve&nbsp;<i>yeni g�nl�k s�re�en ba�a�r�s�</i>&nbsp;vard�r.
Patofizyolojisi tam bilinmemektedir; migren ve TOS aras� ge�i� formu olarak
kabul edilmektedir. Fonksiyonel MRG kontralateral posterior hipotalamus
aktivasyonu ve ipsilateral mezensefalona uzanan dorsal pons aktivasyonu
g�stermi�tir. �ndometazine yan�tl� bir a�r�d�r. <span style='color:black'>�apraz
bir �al��mada oksipital sinir stim�lasyonu 6 hasta �zerinde ba�ar�l�
bulunmu�tur.<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
"Times New Roman";color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>SUNCT
Sendromu</span></b><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>&nbsp;(Tek
tarafl� g�z ya�armas� ve k�zarmas�n�n e�lik etti�i k�sa s�reli nevraljiform
a�r�lar)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:TR'>Sjaastad��n
1978�de tan�mlad��� bu tablo primer ba�a�r�lar�n�n en seyrek
g�r�lenlerindendir. Patofizyolojisinde trigeminohipotalamik yola��n rol ald���
�ne s�r�lmektedir. Di�er a�r�lardan farkl� olarak ileri ya�larda ortaya ��kar,
ortalama g�r�lme ya�� 50�dir. Erkeklerde </span><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:TR'>daha s�k g�r�l�r. A�r�n�n yap�s� �iddetli, yak�c�, oyucu,
elektrik �arpm�� gibidir, 1-600 saniye s�ren paroksizmler halinde gelir. Tan�
i�in g�nde en az bir kez olmas� gerekti�i kabul edilmektedir. �te yandan<sup>&nbsp;</sup>bir
saatte 5-6 atak ve g�nde 200 atak gibi bir s�kl��a ula�abilir. Status formu da
bildirilmi�tir. Ba�a�r�s�na ayr� tarafta, g�z k�zarmas� veya ya�armas�; burun
t�kan�kl��� veya burun ak�nt�s�, g�z �demi, al�n ve y�zde terleme, miyoz veya
pitoz gibi otonom belirtilerden en az biri e�lik etmelidir. Ataklar genelde
g�nd�z olur, baz� olgularda ataklar trigeminal veya boyun gibi b�lgelerde
bas�n�, �i�neme veya hareketle tetiklenebilir. Tedavide denenen ila�lar�n �o�u
ba�ar�s�zd�r. En �ok antiepileptik ila�lardan (Lamotrijin 200-400mg,&nbsp;
topiramat 50-300mg, gabapentin eklenmesi) yararlanabilir. Sekonder SUNCT <span
class=GramE>sendromu</span> g�steren bir�ok olgu sunumu vard�r ve s�kl�kla arka
�ukur lezyonlar� ile ili�kilidir; bu durum hastalara MRG incelemesi
yap�lmas�n�n gereklili�ini ortaya koymaktad�r.<b>&nbsp;</b>Fonksiyonel MRG ile
bir hastada ipsilateral hipotalamik aktivasyon bildirilmi�tir. Diren�li
olgularda&nbsp; kortikostreoidler, azotioprin ve �e�itli invazif <span
class=GramE>prosed�rler</span> �nerilmi�tir.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-align:
justify;line-height:normal'><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>G�z k�zarmas�
ya da ya�armas�ndan yaln�z birinin oldu�u ya da ikisinin de g�r�lmedi�i
ba�a�r�s� formuna ise �</span><span style='font-size:13.5pt;font-family:"Tahoma","sans-serif";
mso-ansi-language:TR'>kranyal otonomik <span class=GramE>semptomlar�n</span>
e�lik etti�i k�sa s�reli tek yanl� nevraljiform ba�a�r�s� (SUNA)�
denilmektedir.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:12.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tablo
8.&nbsp;</span></b><span style='font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>K�sa s�reli baz�
ba�a�r�lar�nda ay�r�c� tan� <o:p></o:p></span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=541
 style='width:405.8pt;mso-cellspacing:0cm;margin-left:-.05pt;border:solid white 1.0pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0cm 0cm 0cm 0cm'>
 <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes;height:25.7pt'>
  <td width=96 valign=top style='width:72.0pt;border:solid windowtext 1.0pt;
  border-right:none;padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�zellik</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>K�me</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>KPH</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>EPH</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>SUNCT/SUNA</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border-top:solid windowtext 1.0pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Saplan�c�</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>ba�a�r�s�</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 0cm 0cm 0cm;height:25.7pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Trigeminal nevralji</span></b><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:1;height:19.6pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Cinsiyet
  (E:K)</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>3-<span
  class=GramE>4:1</span></span><span lang=EN-US style='font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1:2</span></span><span
  style='font-size:10.0pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
  "Times New Roman";mso-ansi-language:TR'>-3</span><span lang=EN-US
  style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
  "Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1:1</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2.3:1</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>K&gt;E</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:19.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>K&gt;E</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Atak S�resi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>15-180 dakika</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2-45 dak</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>2-30 dak</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-600saniye</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&lt;1s</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&lt;1s</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Atak s�kl���</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-8/g�n</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1-40/g</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>3-30/g</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>1/g�n-30/saat</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>de�i�ken</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>de�i�ken</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;height:28.4pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Otonom
  bulgular</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:28.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;height:21.6pt'>
  <td width=96 valign=top style='width:72.0pt;border:none;border-left:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>Tedavi</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�zg�l</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman";background:yellow;mso-highlight:
  yellow'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span class=GramE><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>zor</span></span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>&nbsp;</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border:none;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>CBZ</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes;height:21.6pt'>
  <td width=96 valign=top style='width:72.0pt;border-top:none;border-left:solid windowtext 1.0pt;
  border-bottom:solid windowtext 1.0pt;border-right:none;padding:0cm 0cm 0cm 0cm;
  height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>�ndometazin
  etkisi</span><span lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=59 valign=top style='width:44.25pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+/-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=47 valign=top style='width:35.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=70 valign=top style='width:52.45pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=101 valign=top style='width:75.95pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:63.15pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>+</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
  <td width=84 valign=top style='width:62.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 0cm 0cm 0cm;height:21.6pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif";
  mso-fareast-font-family:"Times New Roman";mso-ansi-language:TR'>-</span><span
  lang=EN-US style='font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>KPH: kronik paroksizmal
hemikranya EPH: epizodik paroksizmal hemikranya</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>SUNCT: Tek tarafl� g�z ya�armas�
ve k�zarmas�n�n e�lik etti�i k�sa s�reli nevraljiform a�r�lar</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:9.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>SUNA: </span><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
mso-ansi-language:TR'>kranyal otonomik <span class=GramE>semptomlar�n</span>
e�lik etti�i k�sa s�reli tek yanl� nevraljiform ba�a�r�s�<span
style='color:black'>&nbsp;</span></span><span lang=EN-US style='font-size:9.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:14.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>�LA� A�IRI KULLANIM BA�A�RISI (�AKB)</span></b><span style='font-size:14.0pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>A��r�
analjezik ila� kullanmaya ba�l� ba�a�r�s�, ergotamin, triptan, basit
analjezikler, opioidler veya kombine analjeziklerin ayda 10-15 g�nden fazla
al�nmas�na ba�l� olarak geli�en sekonder nitelikte ba�a�r�s�d�r (Tablo 1B).
Tipik bir klinik tablosu yoktur, genelde altta migren gibi primer bir ba�a�r�s�
vard�r. T�m ba�a <span class=GramE>lokalize</span>, k�nt, s�k��t�r�c� veya
zonklay�c� olabilir. Genelde hafif, e�lik�i <span class=GramE>semptomu</span>
olmayan devaml� bir a�r�d�r, zaman zaman �iddetlenebilir. IHS taraf�ndan
belirlenen <span class=GramE>kriterler</span>; �ncesinde primer bir ba�a�r�s�
olmas�, g�nl�k veya �ok s�k a�r� (&gt; 15 g�n/ay); analjezik ila�lar�n uygunsuz
kullan�m� (ila� kullan�m� &gt; 10 g�n/ay ve &gt; 3 ay� a�an zamandan
beri)&nbsp; ve ila�lar�n b�rak�lmas� ile d�zelme �eklinde �zetlenebilir.
Kad�nlarda erkeklerden 3-4 kat fazla rastlanmaktad�r, ortalama 40 ya�lar�nda
tan� konulur. Baz� hastalarda primer ba�a�r�s�n�n devam s�resi 20 y�l, k�t�
kullan�m�n s�resi 10 y�l gibi s�releri a�abilmektedir. Migren ve GTBA�dan sonra
3. en s�k tip ba�a�r�s�d�r ve kronik g�nl�k ba�a�r�s� olgular�n�n 1/3�� bu
tan�y� almaktad�r. Ergenlik �a��nda ve hatta �ocuklarda artan oranlar
bildirilmesi endi�e vericidir. Genel <span class=GramE>pop�lasyonda</span> %3
s�kl�kta hatta daha s�k oldu�u bildirilmektedir. �lgin� bir durum, devaml� NSA�
kullanmak durumunda olan artritlilerde seyrek geli�mesi ve sadece migreni olan
artritlilerde ortaya ��kmas�d�r. Bu durum genetik yatk�nl�k ile a��klanabilir.
�la� ba��ml�l��� (psikolojik ve fiziksel) ile benzer mekanizmalar i�erdi�i,
santral sensitizasyonun ve resept�r <span class=GramE>reg�lasyonunun</span>
(serotonin vs siklooksijenaz sistemleri) rol� oldu�u ileri s�r�lmektedir.
Kronik suma- ve zolmitriptan tedavisi ile hayvan modellerinde korteks ve
beyinsap� serotonin resept�rlerinde anlaml� azalma g�sterilmi�tir. Arka k�k
n�ronlar�nda artm�� uyar�labilirli�in yan� s�ra n�roplastik kal�c� de�i�iklikler
oldu�u ileri s�r�lm��t�r.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Yurdumuzda �AKB�ye en s�k yol a�an ila� grubu hala ergo bile�ikleridir.
Triptanlar�n daha k�sa s�rede �AKB�ya yol a�abildi�i ama tedavisinin de daha
kolay oldu�u bilinmektedir. Ancak basit analjeziklerle ortaya ��km�� �ok say�da
�AKB olgusu da vard�r. Tedavide esas olan bu ila�lar�n tamamen kesilmesi, bu
d�nemdeki geri �ekilme semptomlar�n�n tedavisi ve ileriye y�nelik n�ks� �nlemek
i�in ve ba�a�r�s� s�kl���n� kontrol i�in profilaksi <span class=GramE>dahil</span>
�nlemlerin al�nmas�d�r. �AKB�de n�kslerin s�k oldu�u bilinmektedir. Kombine
ila�lar ve opioidlerle n�ks daha s�kt�r.&nbsp;&nbsp;<o:p></o:p></span></p>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;font-weight:normal'>Hastaya yeterli �ekilde durumu a��klamak ve <span
class=GramE>motivasyonu</span> sa�lamak tedavide esast�r, ayaktan veya yatarak
ila� kesme konusunda hasta ve hekim birlikte karar verebilir. Genelde a��r�
ila� kullan�m�n� s�k poliklinik kontrolleri ile kesmek tercih edilmektedir.
Rutin a�r� tedavisinin b�rak�lmas�n� k�pr� tedavisi (genelde amitriptilin ve
anti-emetik; kortizon veya di�er) ve yoksunluk <span class=GramE>semptomlar�n�n</span>
giderilmesi (2-10 g�n) izler. Hastalar �zellikle ilk bir hafta i�erisinde
kar��la�acaklar� yoksunluk belirtileri (sinirlilik, huzursuzluk, ba�a�r�s�nda
�iddetlenme, bulant�, kusma, uykusuzluk, diyare ve tremor gibi) a��s�ndan
uyar�lmal� ve destek olunmal�d�r. E�lik eden davran�� modifikasyon tedavileri,
ayl�k dozlar�n s�n�rlanmas� ve hastaya uygun profilaksi ba�lanmas� �nemlidir.<o:p></o:p></span></h2>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>ENDER
G�R�LEN&nbsp;D��ER </span></b><b><span style='font-size:14.0pt;line-height:
115%;font-family:"Tahoma","sans-serif";mso-ansi-language:TR'>PR�MER BA�A�RILARI
<span style='color:red'><o:p></o:p></span></span></b></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Hipnik ba�a�r�s�</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-style:italic'>:</span><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Tipik olarak gece yaln�z uyku s�ras�nda
ve uykuya dald�ktan birka� saat sonra ortaya ��kan, uykudan uyand�ran orta
�iddette ba�a�r�lar�d�r. �ok seyrek rastlan�r ve genelde 50 ya� �st�nde
g�r�l�r. A�r� genellikle zonklama �eklindedir, birden ba�lar ve t�m ba�a
yay�l�r. Birlikte g�r�len herhangi bir organik etken yoktur. Tart��mal� olmakla
birlikte genellikle uykunun REM d�neminde ortaya ��kar ve ki�iyi uyand�r�r.
Ataklar 15 dakika ile 4 saat aras�nda de�i�en s�relerde g�r�l�r, gecede birka�
kez tekrarlayabilir. Tek tarafl� olabilse de bu a�r�lar genellikle yayg�nd�r.
Etkili tedavi i�in �zellikle k�me ba�a�r�s�ndan ay�r�m �nemlidir. Bu t�r
ba�a�r�lar� bulunan hastalar genellikle yatarken al�nan kafein, melatonin veya
200-600mg lityum karbonata cevapl�d�r.</span><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Primer saplan�c� ba�a�r�s�:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Altta yatan organik bir bozukluk
olmaks�z�n, kendili�inden ortaya ��kan ge�ici ve yerel/b�lgesel saplan�c�
a�r�lard�r. Genelde trigeminal alandad�r ama ba�ka b�lgelerde de olabilir ve
yer de�i�tirebilir. Saplanmalar�n birka� saniye i�inde (%80�i 3 saniye veya
daha k�sa s�rede) sonlanarak g�n i�inde pek �ok kez de�i�en s�kl�kta yeniden
ortaya ��kmas� olas�d�r. Seyrek olarak baz� olgularda b��ak saplan�r tarzda
a�r�lar g�nler boyunca tekrarlar. Saplanmalar ayn� ba� yar�s� veya kar�� yar�da
bir alandan di�erine hareket edebilir. Saplanma a�r�lar�, genellikle a�r�
hissetmeye al���lm�� olan ba� b�lgesinde hissedilmek �zere, s�kl�kla migren
(yakla��k %40) veya k�me ba�a�r�s� (yakla��k %30) tan�s� alan hastalar
taraf�ndan bildirilmektedir. Tedavisi i�in kontroll� �al��malar olmasa da
indometazine olumlu yan�t al�nm�� olgular bildirilmi�tir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Num�ler ba�a�r�s�</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>: �Para �eklinde� ba�a�r�s� olarak ifade
edilen bu a�r� altta yatan yap�sal bir lezyon olmaks�z�n ortaya ��kan, s�kl�kla
kronikle�en, kafa derisinde 1-6cm �ap�nda gibi k���k bir alanda ve s�resi
olduk�a de�i�ken bir ba�a�r�s� olarak tan�mlanmaktad�r. Bu tip ba�a�r�s�nda
�zellikle yap�sal ve dermatolojik lezyonlar; �yk�, fizik muayene ve uygun
ara�t�rmalarla d��lanmal�d�r. Num�ler ba�a�r�s� nadir g�r�len primer
ba�a�r�lar� aras�nda s�n�fland�r�lmaktad�r. Patogenezi tam olarak
ayd�nlat�lamam�� olan bu ba�a�r�s�na sahip hastalar i�in net bir tedavi
algoritmas� yoktur. A�r� �iddeti hafif olan olgular tedaviye ihtiya�
duymayabilirler. Hastalar�n yar�s�ndan �o�unun bilinen analjeziklere (NSA�,
parasetamol gibi) yan�tl� oldu�u bildirilmektedir. Bu bilgilere ra�men,
�iddetli a�r�s� olan, a�r�s� s�reklilik g�steren ve NSAݒye yan�t vermeyen
hastalarda gabapentin, trisiklik antidepresanlar gibi koruyucu tedavi
gerekebilir.<s><o:p></o:p></s></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>�ks�r�k ba�a�r�s�:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;�ks�r�kle, hap��r�kla ortaya ��kan,
eskiden Valsalva manevras� ba�a�r�s� denen nadir bir ba�a�r�s�d�r.&nbsp;<span
style='mso-bidi-font-style:italic'>Selim �ks�r�k ba�a�r�s�&nbsp;</span>yani bu
tablonun primer �ekli �ok nadir bir durumdur. K�rk ya��n �st�ndeki bireylerde
ve erkeklerde daha s�k g�r�l�r. Ba�a�r�s� �ks�r�k, hap��r�k veya bir Valsalva
manevras�ndan (a��rl�k kald�rma, zorlanma, d��k�larken �k�nma, s�mk�rme, a�lama
veya �ark� s�yleme) hemen sonra veya birka� saniye i�inde ortaya ��kar.
Ba�a�r�s� �ok �iddetlidir ve patlay�c� bir nitelik g�sterir, saniyeler veya
saatler (1 saniye-2 saat) s�rer, genellikle iki yanl�d�r, en yo�un a�r�
vertekste veya di�er b�lgelerde hissedilir. �ks�r���n �nlenmesi ile ba�a�r�s�
engellenebilir.<sup>&nbsp;</sup>N�rolojik muayene genellikle normaldir.
Kusman�n bulunmas�, ba�a�r�s�n�n alt�nda organik bir neden oldu�unu d���nd�r�r.<sup>&nbsp;</sup>�nc�l
bir solunum yolu infeksiyonu bazen bulunur. Hastalar�n �o�u atak aralar�nda
a�r�s�zd�r, ancak baz� olgularda ataklar�n ard�ndan k�nt bir a�r� birka� saat
boyunca s�rebilir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>�ks�r�k ba�a�r�lar�n�n yakla��k %40�� semptomatiktir ve bu olgular�n
�o�unlu�unda Arnold Chiari Tip I malformasyonu bildirilmi�tir. �ks�r�k
ba�a�r�s�n�n di�er bildirilen nedenleri aras�nda karotis veya vertebrobaziler
sistem hastal�klar� ve beyin anevrizmalar� yer almaktad�r. Ba�lang�� ya��&nbsp;<span
style='mso-bidi-font-style:italic'>semptomatik �ks�r�k ba�a�r�s�</span>&nbsp;hastalar�nda
selim �ks�r�k ba�a�r�s� hastalar�na oranla daha gen�tir. &nbsp;<span
style='mso-bidi-font-style:italic'>Bu nedenle bu tip ba�a�r�lar�nda MRG mutlaka
yap�lmal�d�r.&nbsp;</span>Semptomatik �ks�r�k ba�a�r�s�, selim �ks�r�k
ba�a�r�s�n�n aksine indometazine cevaps�z da olabilir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Egzersiz ba�a�r�s�:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Egzersizin herhangi bir �e�idi ile
alevlenen ba�a�r�lar�d�r. Genelde migren tipi ba�a�r�s� g�r�l�r, zonklay�c�d�r,
5 dakika-48 saat s�rer. Bu tipte ba�a�r�s� ilk kez ortaya ��kt���nda
subaraknoid kanama ve arteryel diseksiyonun d��lanmas� zorunludur. Primer
egzersiz ba�a�r�lar� �zellikle s�cak hava veya y�ksek irtifada ortaya ��kar.
Ergotamin al�m� ile baz� olgularda ba�a�r�lar�n�n �nlenebildi�i bildirilmi�tir.
Olgular�n pek �o�unda indometazin etkili bulunmu�tur. Tedavide spordan yar�m
saat �nce NSA� verilmesi sorunu ��zebilir. �ks�r�k ba�a�r�s�ndan daha erken
ya�ta ba�layan bir tablodur.</span><span style='font-size:13.5pt;line-height:
115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>S<span style='mso-bidi-font-style:italic'>emptomatik <span class=GramE>efor</span>
ba�a�r�s�</span>&nbsp;genellikle daha �iddetlidir, iki tarafl�d�r ve ba�lang�c�
patlay�c� niteliktedir. �e�itli etyolojik nedenler aras�nda subaraknoid kanama,
sin�zit ve beyin kitleleri say�labilir. Di�er ba�a�r�s� tipleri de <span
class=GramE>eforla</span> tetiklenebilir. Migren, LP sonras� ba�a�r�s� ve
intrakranyal hipertansiyona ba�l� a�r� da �ks�r�kle �iddetlenebilir. Ayr�ca
Monro forameninden BOS ak�m�n� engelleyen III. ventrik�l kolloid kisti bulunan
hastalarda da kafai�i bas�nc�n ani y�kselmelerine ba�l� olarak paroksizmal
ba�a�r�s� bulunabilir. Yan ventrik�l t�m�rleri, kranyofaringioma, pinealoma,
serebral ve serebellar t�m�rleri bulunan hastalarda da benzer ba�a�r�lar�
g�r�lebilir. Feokromasitomalar da �zellikle egzersiz s�ras�nda paroksizmal
ba�a�r�lar�na yol a�abilirler.<sup>&nbsp;</sup>&nbsp;Bu nedenle bu ba�a�r�s�
tipinde de mutlaka ayr�nt�l� incelemeler yap�lmal�d�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Cinsel ili�ki ile ili�kili ba�a�r�s�:</span></b><b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span></b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Cinsel etkinlik s�ras�nda ortaya ��kan ve cinsel uyar�lma ile artan a�r�
genellikle iki yanl� �ok �iddetli ve patlar gibi ortaya ��kar, nadiren
zonklay�c� veya saplan�c� �zellik g�sterebilir. Erkeklerde daha s�kt�r ve
hastan�n ya�am kalitesini olumsuz etkiler. S�resi de�i�kendir, 1 dakikadan k�sa
s�rebildi�i gibi 3 saati a�abilir, 72 saate kadar uzayabildi�i de
bildirilmi�tir. S�kl��� do�rudan cinsel ili�ki veya mast�rbasyon s�kl���na
ba�l�d�r. Hastalar�n yakla��k ��te birinde fiziksel egzersizle benzer
ba�a�r�lar� ortaya ��kar. Koitus s�ras�nda ortaya ��kan patlay�c� ba�a�r�s� bir
subaraknoid kanamaya ba�l� olabilece�i gibi, primer bir ba�a�r�s� da olabilir.
Bu hastalar�n uzun vadeli prognozu olumludur. Ba�a�r�lar� s�k ve �iddetli ise,
ataklar�n k�sa s�reli olmas� atak tedavisini anlams�z k�laca��ndan, profilaktik
tedavi gerekebilir. Baz� hastalar indometazine veya naproksene iyi cevap
verirler.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Tan�mlanan farkl� tipler aras�nda&nbsp;<span style='mso-bidi-font-style:
italic'>preorgazmik ba�a�r�s�</span>&nbsp;boyun veya �ene kas�lmalar�n�n e�lik
etti�i k�nt tipte, ba� ve boyunda yerle�en, cinsel heyecan d�zeyi artt�k�a
�iddetlenen bir ba�a�r�s�d�r.&nbsp;<span style='mso-bidi-font-style:italic'>Orgazmik
ba�a�r�s�,</span>&nbsp;orgazm s�ras�nda ortaya ��kan ani ba�lang��l� ve
�iddetli bir ba�a�r�s�d�r.&nbsp;<span style='mso-bidi-font-style:italic'>Post�ral
tip</span>&nbsp;ise koitus sonras�nda d���k BOS bas�nc� ba�a�r�s�n� and�ran
post�ral de�i�kenlik g�steren ba�a�r�s�d�r. Kafai�i bozukluk olmaks�z�n cinsel
etkinlik ile tetiklenen ba�a�r�s�, genellikle cinsel uyar�lma ile k�nt iki
yanl� a�r� olarak ba�lar ve orgazm s�ras�nda aniden yo�un hale gelir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Yeni g�nl�k s�re�en ba�a�r�s�:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;<span style='mso-spacerun:yes'>�
</span>�ok net olarak tan�mlanabilen ba�lang�� an�ndan itibaren aral�ks�z devam
etmesi �zelli�i ile benzeri olmayan bir tablodur. A�r� en az 3 ayd�r devam
etmektedir ve migren veya GTB tipinde olabilir. Ancak ani ve net ba�lang��
�zelli�inden dolay� kronik migren veya kronik GTB olarak s�n�fland�r�lmaz.
D���k BOS hacmi ba�a�r�s�, y�ksek BOS bas�nc� ba�a�r�s�, posttravmatik
ba�a�r�s�, infeksiyonlara ba�l� (�zellikle viral) ba�a�r�s� ve �AKB gibi
sekonder ba�a�r�lar� uygun ara�t�rma y�ntemleri ile d��lanmal�d�r. Tipik olarak
aylar i�inde tedavisiz d�zelen kendini s�n�rlayan bir formu ve yo�un tedavi
program�na ra�men devam eden diren�li �ekli vard�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Atipik y�z a�r�s�:</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Muayenede ve geni� ay�r�c� tan�
listesinin g�zden ge�irilmesini gerektiren incelemelerde bir bulgu saptanmayan
devaml� idyopatik y�z a�r�s�d�r. Derin veya y�zeyel, genelde tek yanl�
periferik n�roanatomik s�n�rlara uymayan, yay�lan ve hafif subjektif duyusal
yak�nmalar�n eklendi�i ve patofizyolojisi iyi anla��lamam�� bir durumdur. Altta
yatan bir n�ropatik durum oldu�u, hafif hasarlar�n tetikledi�i uzun s�reli
n�roplastik de�i�iklikler ve deaferantasyona ba�l� oldu�u d���n�lmektedir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Kranyal Nevraljiler</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;<b><span style='mso-bidi-font-style:
italic'><o:p></o:p></span></b></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ba� ve boyun a�r�s� trigeminal, intermedyal, glossofaringeal, vagal,
oksipital sinirler arac�l��� ile �st servikal k�klerin afferent lifleri
taraf�ndan ta��n�r. Bu sinirlerin bas�ya, distorsiyona, so�uk veya di�er
zararl� uyar�lara maruz kalmas� veya santral yollarda ortaya ��kan bir lezyonla
uyar�lmas� sonucunda semptomatik olarak ya da s�k olarak da idyopatik olarak
ilgili sinirin innerve etti�i alanda akut saplan�c� veya sabit bir a�r� ortaya
��kar. Bu tablolar uluslararas� s�n�flamada farkl� bir grup olarak ele
al�nmaktad�r.</span><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>En s�k g�r�len&nbsp;<b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-style:italic'>trigeminal nevralji</span></b><span
style='mso-bidi-font-style:italic'>&nbsp;</span>iyi tan�nan bir tablodur ve ay�r�c�
tan�da genelde problem yaratmaz. Trigeminal nevralji tek tarafl�, k�sa
�im�ekvari a�r�lar ile karakterize, ani ba�lay�p ani sonlanan ve trigeminal
sinirin ikinci veya ���nc� dal�n�n da��l�m alan� ile s�n�rl� (birinci dalda %5)
bir durumdur. A�r� genelde y�z y�kama, tra� olma, sigara i�me, konu�ma ve/veya
di� f�r�alama (tetik fakt�rler) gibi uyaranlarla ortaya ��kabildi�i gibi,
s�kl�kla spontan da olabilir. Nazolabial oluk ve/veya �enedeki k���k alanlar
(tetik alanlar�) a�r�n�n tetiklenmesine e�ilimli b�lgelerdir. Tetik
noktalar�n�n daha �ok idyopatik tipte oldu�u d���n�lmektedir. A�r�lar de�i�ik
d�nemler boyunca durabilir. Bazen zeminde k�nt bir a�r� devam edebilir.
Nevraljiler idyopatik veya nadiren semptomatik&nbsp; (herpes zoster infeksiyonu
veya MRG ile g�sterilmi� yap�sal bir lezyon �eklinde) olabilir. Giderek artan
g�r�nt�leme incelemeleri sonucunda bu tabloda y�ksek oranda trigeminal sinir
k�k�n�n geni� ve k�vr�ml� damarlar taraf�ndan bas�ya u�rad��� g�sterilmi�tir.
Olgularda ince kesitli bir MRG incelemesi mutlaka yap�lmal�d�r. A�r� kar��ya
ge�mez, bilateral g�r�ld���nde multipl skleroz gibi bir tablodan
ku�kulan�lmal�d�r. A�r� s�ras�nda o taraf y�z kaslar�nda spazm geli�ebilir
(a�r�l� tik). Di�er s�z� edilen sinir alanlar�na ait nevraljiler de tan�mlanm��t�r
ama olduk�a seyrektir.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Tedavide analjezikler etkisizdir, alt�n standart olarak kabul g�ren
karbamazepin (200-1200 mg yava��a yan�t al�nana dek titre edilerek ve l�kosit, elektrolit
ile transaminazlar izlenerek) veya benzer etkide oldu�u bildirilen
okskarbazepin ilk se�enek ila�lard�r. Gabapentin, pregabalin gibi di�er baz�
epilepsi ila�lar� da yan�ts�z olgularda veya yan etki varl���nda ek olarak
kullan�l�r. Tedavi baz� hastalarda d���k dozlarla da sa�lanabilece�i i�in d���k
dozla ba�lan�p klinik duruma g�re yan etkiler a��s�ndan takip edilerek
artt�r�lmal�d�r. Giri�imsel �e�itli sinir <span class=GramE>blokaj</span>
tedavileri deneyimli ellerde ba�ar�l� olarak bildirilmektedir; ila� tedavisine
yan�ts�z olgularda denenebilir. �ok az say�da diren�li olguda sinirin s�k��t���
b�lgeyi rahatlatmaya y�nelik cerrahi giri�im yap�labilir.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Tolosa-Hunt <span class=GramE>sendromu</span>:&nbsp;</span></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>���nc�, d�rd�nc� ve/veya alt�nc� kranyal
sinirlerin paralizisi ile giden, genellikle kendili�inden d�zelen, ancak
alevlenme ve yat��ma e�ilimleri sergileyen epizodik bir tablodur. Bazen
trigeminal birinci dal ve optik, fasyal veya akustik sinir tutulumu da
eklenebilir. Tedavi edilmezse haftalarca devam eden tek yanl� orbital a�r� s�z
konusudur. Bu sendromda kavern�z sin�s, superior orbital fiss�r ve/veya
orbitada MR (<span class=GramE>kontrast</span> verilmesi genellikle
gerekmektedir) ve biyopsi ile gran�lomat�z bir lezyonun varl��� g�sterilebilir.
Kortikosteroidlerle genellikle 3 g�n i�inde d�zelme g�zlenir. Di�er a�r�l�
oftalmopleji nedenleri �rne�in t�m�rler, vask�lit, bazal menenjit, sarkoidoz,
IgG 4 birikimi, diyabet ve oftalmoplejik migren uygun y�ntemlerle
d��lanmal�d�r.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify'><b
style='mso-bidi-font-weight:normal'><span style='font-size:10.0pt;line-height:
115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><a
href="http://www.itfnoroloji.org/basagrisi/basagrisi5.jpg">�ekil 5.</a></span></b><span
style='font-size:10.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'> Tolosa Hunt <span class=GramE>sendromu</span>
tan�s�yla izlenen bir olgunun koronal MR kesitinde kavern�z sin�ste tutulum
dikkati �ekmektedir.<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>BAZI
SEKONDER BA�A�RILARI</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR;mso-bidi-font-style:italic'>Tekrarlayan A�r�l� Oftalmoplejik N�ropati
(Oftalmoplejik migren)<i> </i></span></b><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Eskiden migren alt grubu olarak s�n�fland�r�lmas�na ra�men art�k kranyal
n�ropatiler grubunda yer almaktad�r ve �tekrarlayan a�r�l� oftalmoplejik
n�ropati� olarak isimlendirilmektedir. S�kl�kla 3. kranyal sinir olmak �zere
bir ya da daha fazla ok�ler kranyal sinirde parezi ile birlikte ipsilateral
migren benzeri ba�a�r�s� ile karakterizedir. Bu tan� i�in hastan�n benzer
�zellikleri g�steren en az iki atak ge�irmi� olmas� ve kranyal
g�r�nt�lemelerinde orbital, parasellar ve arka �ukur lezyonlar�n�n d��lanm��
olmas� gerekmektedir. Olduk�a nadir bir tablodur. Ba�a�r�s� ve kranyal
n�ropatinin bir hafta ya da daha uzun s�reli olabilece�i bilinmektedir. Hatta
ba�a�r�s�n�n ok�ler kranyal n�ropatiden 2 hafta kadar �nce ba�layabilece�i de
bildirilmi�tir. Parezi saptanan ok�ler kranyal sinirin kranyal g�r�nt�lemelerde
<span class=GramE>kontrast</span> tutulumu <span class=GramE>g�stermesi</span>
nedeniyle patofizyolojik s�recin demiyelinizasyonla seyreden bir durum
olabilece�i �ng�r�lmektedir. Ayr�ca nadir g�r�len bir durum olsa da bu
hastalar�n steroid tedavisine iyi yan�t vermeleri de bu patofizyolojik s�rece
ait d���nceleri desteklemektedir. Hastalar�n hem ba�a�r�s� ataklar�, hem de
oftalmoparezileri steroide �ok iyi cevap vermekte ve tam d�zelme g�r�lmektedir.
Tekrarlayan ataklarda ise steroid yan�t�n�n ilk atakta oldu�u kadar iyi
olmayabilece�i bildirilmi� ancak �tekrarlayan a�r�l� oftalmoplejik n�ropati�
tan�s� i�in hen�z netle�mi� bir tedavi algoritmas� olu�turulamam��t�r.<b>&nbsp;</b></span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Hipertansif
Ensefalopati</span></b><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Akut hipertansiyon, akut ba�a�r�s�nda �nemli ancak olduk�a yanl�� yorumlara
da yol a�abilen bir ay�r�c� tan� olas�l���d�r. MRG <span class=GramE>dahil</span>
bir�ok ileri inceleme ve �ok say�da tedavi uygulamas� ile kontrol edilemeyen
bir ba�a�r�s�n�n nedeni hipertansiyon olabilir, bu nedenle her hastada mutlaka
arteryel tansiyon �l��lmelidir. G�z dibi bozuklu�u, n�betler, mental de�i�iklik
tabloya e�lik edebilir. Yeni ba�layan hipertansiyon veya malin hipertansiyonun
dekompansasyonlar� bu tabloya neden olabilir. Ancak hipertansiyonun tan�s�
konmu� ve tedavisi d�zenlenmi� oldu�u durumlarda ba�a�r�s�n� hipertansiyona
ba�lamak yanl�� bir yakla��md�r. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:14.0pt;
mso-bidi-font-size:12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR;mso-bidi-font-weight:bold;mso-bidi-font-style:
italic'>Ba�a�r�s� gerek artm�� gerekse azalm�� kafai�i bas�nc�n�n s�k g�r�len
bir klinik belirtisidir</span><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>&nbsp;(Bak�n�z:&nbsp;</span><u><span
style='font-size:14.0pt;mso-bidi-font-size:12.0pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:blue;mso-ansi-language:TR;mso-bidi-font-weight:
bold'><a href="http://www.itfnoroloji.org/kibas/kibas.htm">Kafa i�i bas�n�
de�i�iklikleri</a></span></u><span style='font-size:14.0pt;mso-bidi-font-size:
12.0pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>).</span><span
style='font-size:16.0pt;mso-bidi-font-size:14.0pt;line-height:115%;color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Akut
Sin�zit</span></b><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Seyrek g�r�len bir ba�a�r�s� nedeni olan akut sin�zit genellikle nazal yollarda
p�r�lan ak�nt� ve infeksiyon b�lgesine g�re de�i�en bir a�r� <span class=GramE>profili</span>
ile karakterizedir.&nbsp;<span style='mso-bidi-font-style:italic'>Sin�sler
�zerindeki a�r�n�n mutlaka sin�zite ba�l� olmas� gerekti�i �eklindeki yanl��
inan� nedeni ile ba�a�r�s� nedeni olarak sin�zit tan�s� fazla s�k ve hatal�
olarak konmaktad�r.</span>&nbsp;Asl�nda frontal b�lge yerle�imli ataklarla
giden ba�a�r�s� en s�k migren ve GTB nedeniyle g�r�l�r. Burun t�kan�kl���n�n
ba�a�r�s�na yol a��p a�mad��� da tart��mal� bir konudur. Sfenoid sin�zit hem
klinik �zellikler hem tedavi a��s�ndan farkl�l�klar g�sterir ve s�k atlan�r.
T�m sin�zit olgular�n�n sadece %3��n� sfenoid sin�zitler olu�turmas�na kar��n,
ya�am� tehdit edebilen bir durum olmas� nedeniyle �nem ta��maktad�r.</span><span
style='font-size:13.5pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal><b><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Temporal
Arterit</span></b><span style='font-size:13.5pt;line-height:115%;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Di�er ad�yla&nbsp;<span style='mso-bidi-font-style:italic'>dev h�creli
arterit,&nbsp;</span>ba�l�ca orta boy arterleri etkileyen bir sistemik
vask�littir. Belirti ve bulgular� aras�nda ba�a�r�s� d���nda, g�rme kayb�,
halsizlik, kilo kayb� ve miyaljiler yer al�r. Elli ya��ndan �nce g�r�lmesi �ok
nadirdir, kad�nlarda erkeklere g�re �� kat daha s�k g�r�l�r.<sup>&nbsp;</sup>Yeni
ortaya ��kan ba�a�r�s� bulunan veya ba�a�r�s� paterninde belirgin bir
de�i�iklik tan�mlayan ya�l� bir hastada mutlaka bu tan� akla gelmelidir. En
belirgin bulgusu olan ba�a�r�s�, olgular�n %70-90��nda mevcuttur ve ��te
birinde de ilk belirtidir. Aral�kl� veya s�rekli olabilir; tipik olarak
�akaklarda <span class=GramE>lokalize</span>, zonklay�c� bir a�r�d�r. S�kl�kla
beraberinde kafa derisi hassasiyeti ve tutulan damarlar�n �zerinde cilt
hassasiyeti bulunur. Kas a�r�s� ve eklem kat�l��� gibi belirtileri olan <i
style='mso-bidi-font-style:normal'>�<span style='mso-bidi-font-style:italic'>polimiyalji
romatika</span></i><span style='mso-bidi-font-style:italic'>�</span> ate�, kilo
kayb�, gece terlemeleri, �ene (masseter) klodikasyosu (�zellikle �i�nerken
ortaya ��kan yorulma), amarozis fugaks (hastalar�n yar�s�nda iki yanl�
olabilir), kal�c� k�rl�k (s�kl�kla herhangi bir uyar� olmaks�z�n) veya k�smi
g�rme kayb� (s�kl�kla anterior iskemik optik n�ropatiye ba�l� olarak)
g�r�lebilir. Diplopi ve kranyal sinir felci nadir g�r�l�r. Ayr�ca seyrinde
koroner, mezenterik, hepatik ve renal arter iskemisi, aort r�pt�r�, inme ve
ge�ici iskemik ataklar da g�r�lebilir. En tutarl� laboratuvar bulgusu eritrosit
sedimentasyon h�z�ndaki art��t�r. Bunun d���nda, C-reaktif protein art��� ve
karaci�er enzimlerinde hafif bir y�kselme ile hafif bir anemi de s�k g�r�l�r.
�ok nadiren eritrosit sedimentasyon h�z� normal bulunabilir. Baz� olgularda, ba�lang��ta
normal olan eritrosit sedimentasyon h�z�n�n daha sonra y�kselmesi, hastal�k
progresyonu ile ili�kili bulunmu�tur.<sup>&nbsp;</sup>Aspirin, NSA� veya
sistemik steroid kullanan hastalarda eritrosit sedimentasyon h�z� d��erek
yalanc� negatif sonu� verebilir. Temporal arter biyopsisi tan�da alt�n
standartt�r ve m�mk�nse steroid tedavisinin ba�lanmas�ndan sonra en ge� 48 saat
i�inde yap�lmal�d�r. Biyopside klinik olarak etkilenmi� (hassasiyet, endurasyon
veya nab�z zay�fl��� bulunan) bir arter se�ilir. Biyopsi negatifse (hastal�k
yama tarz� lezyonlar olu�turdu�u i�in bu m�mk�nd�r), pozitiflik oran�n�
artt�rmak i�in birden fazla kesit incelenmelidir. Biyopsi negatifse ve tan�
olas�l��� y�ksekse, di�er temporal arterden tekrarlanmal�d�r. Bazen teknik
nedenlerle biyopsi tekrar� da negatif kalabilir, klinik ��phe netse ve
sedimentasyon y�ksekse temporal arterit tan�s�ndan vazge�ilmemelidir. Tipik
bulgular ve eritrosit sedimentasyon h�z�nda art�� g�r�len bir hastada, temporal
arter biyopsi sonucu beklenirken hemen tedaviye ba�lanmal�d�r. Tedavinin
ba�l�ca hedefi ani geli�en ve geri d�n���ms�z g�rme kayb�n�n �nlenmesidir.
Ba�lang��taki prednizon dozu g�nl�k 60-80 mg�d�r; baz� uzmanlar ilk dozlar�
intraven�z yolla vermeyi tercih etmektedir. E�er hasta akut bir n�rolojik <span
class=GramE>sendromla</span> veya h�zla k�t�le�en bir n�rolojik tabloyla
ba�vurmu�sa, intraven�z pulse steroid (1000 mg/g�n) ile veya �ok y�ksek doz
oral steroidle (120 mg/g�n prednizon) tedaviye ba�lanmal�d�r.<sup>&nbsp;</sup>Ba�a�r�s�
ve sistemik belirtiler tipik olarak steroid ba�land�ktan k�sa bir s�re sonra
d�zelme g�sterir. Hasta belirtilerin kontrol� i�in en az 6 ay-1 y�l s�re ile
bir idame dozu almal�d�r. Eldeki s�n�rl� veriler, steroidlerin d���nda en
tutarl� bi�imde etkili immunsupresif ilac�n siklofosfamid oldu�unu ve bir n�ks
sonras�nda verildi�inde steroidin daha h�zl� azalt�larak kesilebilmesini
sa�layabildi�ini d���nd�rmektedir. Ayr�ca azatioprin kullan�m�n� da savunan
klinisyenler vard�r.</span><span style='font-size:13.5pt;line-height:115%;
color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='line-height:21.75pt'><b><span style='font-size:12.0pt;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Tablo 9. </span></b><span
style='font-size:12.0pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR;mso-bidi-font-weight:bold'>Akut �iddetli ba�a�r�s�nda
ay�r�c� tan� listesi</span><span style='font-size:12.0pt;color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Subaraknoidal kanama</span><span
style='font-size:12.0pt;line-height:115%;color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Di�er kanay�c� serebrovask�ler hastal�klar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>subdural</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>ekstradural</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>intraserebral hematom</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Serebral ven�z sin�s trombozu (Beh�et
Hastal��� veya di�er etyolojilere ba�l�)</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Kafa <span class=GramE>travmas�</span>
sonras� �e�itli sekonder nedenler</span><span style='color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Ge�ici iskemik atak ve inmede ek bir <span
class=GramE>semptom</span> olarak</span><span style='color:black;mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hipofizer apopleksi</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Spontan intrakranyal hipotansiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�ntermittan hidrosefali</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Arnold-Chiari malformasyonu</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�dyopatik intrakranyal hipertansiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hipertansif ensefalopati</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Servikosefalik arteryel diseksiyon</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>MSS ve di�er akut infeksiyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
menengoensefalit (bakteryel, viral, fungal)</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
serebral abse</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Optik n�rit, akut glokom gibi g�z
hastal�klar�</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Temporal arterit ve di�er vask�litler</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Feokromasitoma</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Tiroid hastal�klar�</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Hiperkarbi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Preeklampsi</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Yer kaplay�c� lezyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�ntoksikasyon (�rne�in karbonmonoksid)</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�la� k�t�ye kullan�m�</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�dyopatik g�kg�r�lt�s� ba�a�r�s�</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>K�me ba�a�r�s� ve benzer tablolar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Akut migren</span><span style='color:black;
mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Selim <span class=GramE>efor</span>, �ks�r�k
ve orgazm ba�a�r�s�</span><span style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
style='font-size:9.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Akut sin�zit ve dental infeksiyonlar</span><span
style='color:black;mso-ansi-language:TR'><o:p></o:p></span></p>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;font-weight:
normal'><o:p>&nbsp;</o:p></span></h2>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR;font-weight:
normal'><o:p>&nbsp;</o:p></span></h2>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:windowtext;mso-ansi-language:TR;
mso-bidi-font-weight:normal'>Gebelikte Ba�a�r�s� ve Tedavi Yakla��m� <o:p></o:p></span></h2>

<h2 style='margin-top:0cm;text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US;font-weight:
normal'>Gebeli�in ilk trimesterinde artan �strojen seviyesi ba�a�r�s�na neden
olabilirken, 2. ve 3. trimesterde �strojen seviyesinin <span class=GramE>stabille�mesi</span>
ve artan endorfin seviyeleri ile ba�a�r�lar� azalabilir. Gebelikle birlikte
migren ba�a�r�lar�nda azalma olabilirse de %4-8 kadar hastada ataklar artarak
devam edebilir. �lk migren ata��n� gebelik d�neminde ya�ayan hastalar da
olabilir. �lk migren ata��nda ya da ataklar� k�t�le�en hastalarda tan�
zorlay�c� olabilir ve �ncelikle sekonder nedenlerin d��lanmas� (preeklampsi, eklampsi,
sin�s ven trombozu gibi) gereklidir. Migren i�in koruyucu tedavi kullanan hasta
gebelik planl�yorsa, kulland��� ila� ya da ila�lar azalt�larak kesilmelidir.
Antiepileptikler, ergotamin preparatlar�, triptanlar gibi farkl� tedavi
se�eneklerinden bu d�nemde ka��n�lmal�d�r. Gebelikte kullan�labilecek ila�lar
i�erisinde A kategorisi bir se�enek olmamakla birlikte parasetamol, kafein,
metoklopromid, kodein, meperidin, ondansetron, hidrokodon ve siproheptadin
kategori B olmakla birlikte kullan�labilir. Gebelik d�neminde hastay� kad�n
do�um uzmanlar� ile birlikte takip ederek, tedavi se�eneklerini birlikte g�zden
ge�irmekte yarar vard�r. Tedaviye hastan�n durumuna ve atak �zelliklerine g�re
g�venli ila�larla devam etmek gereklidir. Etkinli�i tart��mal� olsa bile
parasetamol gebelik d�neminde �nerilebilecek tedavi se�eneklerinden biridir.
Yine bu d�nemde ila� d��� tedavi y�ntemleri (so�uk uygulama, pilates, masaj ve
uygun egzersiz gibi) �nerilmelidir.<o:p></o:p></span></h2>

<p class=MsoNormal><span style='mso-ansi-language:TR'><o:p>&nbsp;</o:p></span></p>

<h2 style='margin-top:0cm'><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:Calibri;color:black;
mso-ansi-language:TR;mso-fareast-language:EN-US;mso-bidi-font-weight:normal'>Ya�l�larda
Ba�a�r�s� ve Tedavi Yakla��m�<o:p></o:p></span></h2>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ba�a�r�lar� ya�la birlikte de�i�iklikler g�sterebilmektedir. Eri�kin ya�ta
ba�a�r�lar�n�n b�y�k �o�unlu�unu (yakla��k %90) primer ba�a�r�lar�
olu�tururken, ileri ya�larda sekonder ba�a�r�lar� �n plana ge�mektedir. Ya�l�
hasta grubunda da ba�a�r�s� kad�nlarda daha s�k bir <span class=GramE>semptomdur</span>.
<o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>�leri ya�taki migren hastalar�nda ortaya ��kan ge�ici g�rme kayb�,
beyinsap� bulgular�, duysal <span class=GramE>semptomlar</span> gibi fokal
n�rolojik bulgular� migren ile ili�kilendirmeden �nce ge�ici iskemik atak ile
ay�r�c� tan�s�n�n yap�lmas� �nemlidir. Vask�ler risk fakt�rleri olan hastalarda
dikkat edilmesi gereken noktalardan biri triptan ve ergotamin preparatlar�ndan
ka��n�lmas�d�r. Yine ileri ya� grubunda komorbidite olas�l��� y�ksek
olaca��ndan tedavi se�iminde di�er hastal�klar�n da g�z �n�nde bulundurulmas�
gerekmektedir. Di�er �nemli nokta ise hangi ila� tercih edilecekse d���k doz
ile ba�lanmas� ve yava� titre edilmesidir. Ya�l� migren hastalar�n�n atak
tedavisinde parasetamol, NSA� ya da bazen kombine analjezikler tercih
edilebilirken, koruyucu tedavi <span class=GramE>i�in<span
style='mso-spacerun:yes'>� </span>hastan�n</span> komorbiditesine g�re
beta-blokerler, kalsiyum kanal blokerleri, antidepresanlar ya da antiepileptik
ila�lar tercih edilebilir. <o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><b style='mso-bidi-font-weight:
normal'><span style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>�ocuklarda ba�a�r�s�<o:p></o:p></span></b></p>

<p class=MsoNormal style='text-align:justify'><span style='font-size:13.5pt;
line-height:115%;font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:
TR'>Ba�a�r�s� �ocuk ya� grubunda ve ergenlerde de s�k g�r�len yak�nmalar�n
ba��ndad�r. �zellikle k���k �ocuklar ba�a�r�s�n� tan�mlamada s�k�nt�
�ekebilirler. Bu d�nemde de ba�a�r�lar�n�n �o�u primer ba�a�r�lar� ve iyi huylu
nedenlere ba�l� olanlar olmakla birlikte, sekonder nedenlerin d��lanmas� �nem
ta��maktad�r. �ocuk hastalarda �ncelikle ila� d��� tedavilerin tercih edilmesi,
ya�am <span class=GramE>hijyeni</span> ve al��kanl�klar�n g�zden ge�irilmesi ve
farmakolojik tedavi se�eneklerinin komorbid sorunlar g�z �n�ne al�narak
de�erlendirilmesi �nerilmektedir. <o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";background:lime;mso-highlight:lime;mso-ansi-language:
TR'><span style='mso-spacerun:yes'>�</span></span><b><span style='font-size:
13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'><br clear=all>
</span></b><b><span style='font-size:14.0pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>KAYNAKLAR </span></b><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal><span style='font-size:13.5pt;line-height:115%;font-family:
"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>&nbsp;</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Baykan B, Ertas M, Karli N, Akat-Aktas S, Uzunkaya O,
Zarifoglu M, Siva A,Saip S; MIRA-Neurology Study Group. The burden of headache
in neurology outpatient clinics in Turkey. Pain Pract 2007; <span class=GramE>7:313</span>-23.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Erta� M, Baykan B. Ba�a�r�lar�na Yakla��m ve Akut
Ba�a�r�lar�. Ekspres Bask�, �stanbul 2007.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Dodick DW. Migraine. Lancet 2018; 391: 1315�30. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Headache Classification Committee of the International
Headache Society (IHS). The International Classification of Headache Disorders,
3rd edition. Cephalalgia 2018;<span class=GramE>38:1</span>-211. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Bartleson JD, Black DF, Swanson JW. Cranial and facial
pain. (Chapter 20) ��inde: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL.
(edit�rler). Bradley�s Neurology in Clinical Practice. 7th edition. 2016,
Elsevier Inc; <span class=GramE>London :197</span>-203.<span
style='mso-spacerun:yes'>� </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt;
line-height:normal;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Tahoma;color:black;mso-ansi-language:TR'><span style='mso-list:Ignore'>6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";color:black;
mso-ansi-language:TR'>Garza I, Schwedt TJ, Robertson CE, Smith JH. Headache and
other craniofacial pain. ��inde: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy
SL. (edit�rler). Bradley�s Neurology in Clinical Practice. 7th edition. 2016,
Elsevier Inc; <span class=GramE>London :1686</span>-1719.<o:p></o:p></span></p>

<pre style='margin-left:36.0pt;text-align:justify;text-indent:-18.0pt;
mso-list:l14 level1 lfo26'><![if !supportLists]><span style='font-size:13.5pt;
font-family:"Tahoma","sans-serif";mso-fareast-font-family:Tahoma;color:black;
mso-ansi-language:TR;mso-fareast-language:EN-US'><span style='mso-list:Ignore'>7.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]><span
style='font-size:13.5pt;font-family:"Tahoma","sans-serif";mso-fareast-font-family:
Calibri;color:black;mso-ansi-language:TR;mso-fareast-language:EN-US'>Holle D, Obermann M. Rare primary headaches. Curr Opin Neurol. 2014 Jun;27(3):332-6. <o:p></o:p></span></pre>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;mso-list:l14 level1 lfo26;tab-stops:list 36.0pt'><![if !supportLists]><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
mso-fareast-font-family:Tahoma;color:black;mso-ansi-language:TR'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-size:13.5pt;line-height:115%;
font-family:"Tahoma","sans-serif";color:black;mso-ansi-language:TR'>Ba�a�r�s�
Tan� ve Tedavi G�ncel Yakla��mlar, T�rk N�roloji Derne�i Ba�a�r�s� �al��ma
Grubu Uygulamalar�. Galenos Yay�nevi, �stanbul. 2018<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><b><i><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>Te�ekk�r:</span></i></b><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;Prof Dr Mustafa Erta� ve Prof Dr Halil
Atilla �driso�lu�na ge�mi�teki katk�lar�ndan dolay� te�ekk�r ederiz.</span><span
lang=EN-US style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
style='font-size:13.5pt;line-height:115%;font-family:"Tahoma","sans-serif";
color:black;mso-ansi-language:TR'>&nbsp;</span><span lang=EN-US
style='font-size:13.5pt;line-height:115%;color:black'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:list 36.0pt left 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=EN-US><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
